{"status": "ok", "message-type": "work-list", "message-version": "1.0.0", "message": {"facets": {}, "total-results": 21949, "items": [{"indexed": {"date-parts": [[2019, 11, 18]], "date-time": "2019-11-18T21:37:33Z", "timestamp": 1574113053889}, "reference-count": 41, "publisher": "Wiley", "issue": "4", "license": [{"URL": "http://doi.wiley.com/10.1002/tdm_license_1.1", "start": {"date-parts": [[2015, 9, 1]], "date-time": "2015-09-01T00:00:00Z", "timestamp": 1441065600000}, "delay-in-days": 4261, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Genes Chromosom. Cancer"], "published-print": {"date-parts": [[2004, 4]]}, "DOI": "10.1002/gcc.20004", "type": "journal-article", "created": {"date-parts": [[2004, 2, 18]], "date-time": "2004-02-18T10:00:27Z", "timestamp": 1077098427000}, "page": "324-334", "source": "Crossref", "is-referenced-by-count": 20, "title": ["Identification of a novel RAS GTPase-activating protein (RASGAP) gene at 9q34 as anMLL fusion partner in a patient with de novo acute myeloid leukemia"], "prefix": "10.1002", "volume": "39", "author": [{"given": "Anne R. M.", "family": "von Bergh", "sequence": "first", "affiliation": []}, {"given": "Pauline M.", "family": "Wijers", "sequence": "additional", "affiliation": []}, {"given": "Arjan J.", "family": "Groot", "sequence": "additional", "affiliation": []}, {"given": "Shama", "family": "van Zelderen-Bhola", "sequence": "additional", "affiliation": []}, {"given": "J. H. Frederik", "family": "Falkenburg", "sequence": "additional", "affiliation": []}, {"given": "Philip M.", "family": "Kluin", "sequence": "additional", "affiliation": []}, {"given": "Ed", "family": "Schuuring", "sequence": "additional", "affiliation": []}], "member": "311", "published-online": {"date-parts": [[2004]]}, "reference": [{"key": "10.1002/gcc.20004-BIB1", "author": "Ahmadian", "volume": "4", "first-page": "686", "year": "1997", "journal-title": "Nat Struct Biol", "DOI": "10.1038/nsb0997-686", "doi-asserted-by": "crossref"}, {"key": "10.1002/gcc.20004-BIB2", "author": "Boettner", "volume": "97", "first-page": "9064", "year": "2000", "journal-title": "Proc Natl Acad Sci USA", "DOI": "10.1073/pnas.97.16.9064", "doi-asserted-by": "crossref"}, {"key": "10.1002/gcc.20004-BIB3", "author": "Borkhardt", "volume": "97", "first-page": "9168", "year": "2000", "journal-title": "Proc Natl Acad Sci USA", "DOI": "10.1073/pnas.150079597", "doi-asserted-by": "crossref"}, {"key": "10.1002/gcc.20004-BIB4", "author": "Cawthon", "volume": "7", "first-page": "555", "year": "1990", "journal-title": "Genomics", "DOI": "10.1016/0888-7543(90)90199-5", "doi-asserted-by": "crossref"}, {"key": "10.1002/gcc.20004-BIB5", "author": "Chen", "volume": "79", "first-page": "573", "year": "2002", "journal-title": "Genomics", "DOI": "10.1006/geno.2002.6739", "doi-asserted-by": "crossref"}, {"key": "10.1002/gcc.20004-BIB6", "author": "Corral", "volume": "85", "first-page": "853", "year": "1996", "journal-title": "Cell", "DOI": "10.1016/S0092-8674(00)81269-6", "doi-asserted-by": "crossref"}, {"key": "10.1002/gcc.20004-BIB7", "author": "Cullen", "volume": "376", "first-page": "527", "year": "1995", "journal-title": "Nature", "DOI": "10.1038/376527a0", "doi-asserted-by": "crossref"}, {"key": "10.1002/gcc.20004-BIB8", "author": "Domer", "volume": "90", "first-page": "7884", "year": "1993", "journal-title": "Proc Natl Acad Sci USA", "DOI": "10.1073/pnas.90.16.7884", "doi-asserted-by": "crossref"}, {"key": "10.1002/gcc.20004-BIB9", "author": "Drugan", "volume": "275", "first-page": "35021", "year": "2000", "journal-title": "J Biol Chem", "DOI": "10.1074/jbc.M004386200", "doi-asserted-by": "crossref"}, {"key": "10.1002/gcc.20004-BIB10", "author": "Fuchs", "volume": "98", "first-page": "8756", "year": "2001", "journal-title": "Proc Natl Acad Sci USA", "DOI": "10.1073/pnas.121433898", "doi-asserted-by": "crossref"}, {"key": "10.1002/gcc.20004-BIB11", "author": "Garcia-Cuellar", "volume": "19", "first-page": "1744", "year": "2000", "journal-title": "Oncogene", "DOI": "10.1038/sj.onc.1203506", "doi-asserted-by": "crossref"}, {"key": "10.1002/gcc.20004-BIB12", "author": "Gu", "volume": "54", "first-page": "2326", "year": "1994", "journal-title": "Cancer Res"}, {"key": "10.1002/gcc.20004-BIB13", "author": "Huret", "year": "2001", "journal-title": "Atlas Genet Cytogenet Oncol Haematol"}, {"key": "10.1002/gcc.20004-BIB14", "author": "Joh", "volume": "15", "first-page": "1681", "year": "1997", "journal-title": "Oncogene", "DOI": "10.1038/sj.onc.1201332", "doi-asserted-by": "crossref"}, {"key": "10.1002/gcc.20004-BIB15", "author": "Kashige", "volume": "97", "first-page": "2093", "year": "2000", "journal-title": "Proc Natl Acad Sci USA", "DOI": "10.1073/pnas.040547997", "doi-asserted-by": "crossref"}, {"key": "10.1002/gcc.20004-BIB16", "author": "Kourlas", "volume": "97", "first-page": "2145", "year": "2000", "journal-title": "Proc Natl Acad Sci USA", "DOI": "10.1073/pnas.040569197", "doi-asserted-by": "crossref"}, {"key": "10.1002/gcc.20004-BIB17", "author": "Li", "volume": "35", "first-page": "625", "year": "1996", "journal-title": "Genomics", "DOI": "10.1006/geno.1996.0412", "doi-asserted-by": "crossref"}, {"key": "10.1002/gcc.20004-BIB18", "author": "Lu", "volume": "97", "first-page": "441", "year": "2003", "journal-title": "Cancer", "DOI": "10.1002/cncr.11037", "doi-asserted-by": "crossref"}, {"key": "10.1002/gcc.20004-BIB19", "author": "Mahgoub", "volume": "21", "first-page": "270", "year": "1998", "journal-title": "Genes Chromosomes Cancer", "DOI": "10.1002/(SICI)1098-2264(199803)21:3<270::AID-GCC14>3.0.CO;2-T", "doi-asserted-by": "crossref"}, {"key": "10.1002/gcc.20004-BIB20", "author": "Miao", "volume": "271", "first-page": "15322", "year": "1996", "journal-title": "J Biol Chem", "DOI": "10.1074/jbc.271.26.15322", "doi-asserted-by": "crossref"}, {"key": "10.1002/gcc.20004-BIB21", "author": "Nilson", "volume": "93", "first-page": "966", "year": "1996", "journal-title": "Br J Haematol", "DOI": "10.1046/j.1365-2141.1996.d01-1748.x", "doi-asserted-by": "crossref"}, {"key": "10.1002/gcc.20004-BIB22", "author": "Noto", "volume": "441", "first-page": "127", "year": "1998", "journal-title": "FEBS Letters", "DOI": "10.1016/S0014-5793(98)01530-0", "doi-asserted-by": "crossref"}, {"key": "10.1002/gcc.20004-BIB23", "author": "Pendergast", "volume": "75", "first-page": "175", "year": "1993", "journal-title": "Cell", "DOI": "10.1016/S0092-8674(05)80094-7", "doi-asserted-by": "crossref"}, {"key": "10.1002/gcc.20004-BIB24", "author": "Rebecchi", "volume": "27", "first-page": "503", "year": "1998", "journal-title": "Annu Rev Biophys Biomol Struct", "DOI": "10.1146/annurev.biophys.27.1.503", "doi-asserted-by": "crossref"}, {"key": "10.1002/gcc.20004-BIB25", "author": "Repp", "volume": "9", "first-page": "210", "year": "1995", "journal-title": "Leukemia"}, {"key": "10.1002/gcc.20004-BIB26", "author": "Romero", "volume": "19", "first-page": "963", "year": "1995", "journal-title": "Leuk Res", "DOI": "10.1016/0145-2126(95)00080-1", "doi-asserted-by": "crossref"}, {"key": "10.1002/gcc.20004-BIB27", "author": "Schuuring", "volume": "6", "first-page": "185", "year": "1998", "journal-title": "Cell Adhes Commun", "DOI": "10.3109/15419069809004475", "doi-asserted-by": "crossref"}, {"key": "10.1002/gcc.20004-BIB28", "author": "Shaw", "volume": "18", "first-page": "35", "year": "1996", "journal-title": "Bioessays", "DOI": "10.1002/bies.950180109", "doi-asserted-by": "crossref"}, {"key": "10.1002/gcc.20004-BIB29", "author": "Sheng", "volume": "21", "first-page": "697", "year": "1997", "journal-title": "Leuk Res", "DOI": "10.1016/S0145-2126(97)00036-2", "doi-asserted-by": "crossref"}, {"key": "10.1002/gcc.20004-BIB30", "author": "Slany", "volume": "18", "first-page": "122", "year": "1998", "journal-title": "Mol Cell Biol", "DOI": "10.1128/MCB.18.1.122", "doi-asserted-by": "crossref"}, {"key": "10.1002/gcc.20004-BIB31", "author": "So", "volume": "94", "first-page": "2563", "year": "1997", "journal-title": "Proc Natl Acad Sci USA", "DOI": "10.1073/pnas.94.6.2563", "doi-asserted-by": "crossref"}, {"key": "10.1002/gcc.20004-BIB32", "author": "So", "volume": "14", "first-page": "594", "year": "2000", "journal-title": "Leukemia", "DOI": "10.1038/sj.leu.2401692", "doi-asserted-by": "crossref"}, {"key": "10.1002/gcc.20004-BIB33", "author": "Strissel", "volume": "92", "first-page": "3793", "year": "1998", "journal-title": "Blood"}, {"key": "10.1002/gcc.20004-BIB34", "author": "Taki", "volume": "96", "first-page": "14535", "year": "1999", "journal-title": "Proc Natl Acad Sci USA", "DOI": "10.1073/pnas.96.25.14535", "doi-asserted-by": "crossref"}, {"key": "10.1002/gcc.20004-BIB35", "author": "Viskochil", "volume": "62", "first-page": "187", "year": "1990", "journal-title": "Cell", "DOI": "10.1016/0092-8674(90)90252-A", "doi-asserted-by": "crossref"}, {"key": "10.1002/gcc.20004-BIB36", "author": "von Bergh", "volume": "28", "first-page": "14", "year": "2000", "journal-title": "Genes Chromosomes Cancer", "DOI": "10.1002/(SICI)1098-2264(200005)28:1<14::AID-GCC2>3.0.CO;2-X", "doi-asserted-by": "crossref"}, {"key": "10.1002/gcc.20004-BIB37", "author": "von Bergh", "volume": "35", "first-page": "92", "year": "2002", "journal-title": "Genes Chromosomes Cancer", "DOI": "10.1002/gcc.10091", "doi-asserted-by": "crossref"}, {"key": "10.1002/gcc.20004-BIB38", "author": "Wang", "volume": "2", "first-page": "453", "year": "1991", "journal-title": "Cell Regul"}, {"key": "10.1002/gcc.20004-BIB39", "author": "Wang", "volume": "277", "first-page": "12622", "year": "2002", "journal-title": "J Biol Chem", "DOI": "10.1074/jbc.M110568200", "doi-asserted-by": "crossref"}, {"key": "10.1002/gcc.20004-BIB40", "author": "Wilke", "volume": "4", "first-page": "315", "year": "2003", "journal-title": "Hematol J", "DOI": "10.1038/sj.thj.6200318", "doi-asserted-by": "crossref"}, {"key": "10.1002/gcc.20004-BIB41", "author": "Yamamoto", "volume": "270", "first-page": "30557", "year": "1995", "journal-title": "J Biol Chem", "DOI": "10.1074/jbc.270.51.30557", "doi-asserted-by": "crossref"}], "container-title": ["Genes, Chromosomes and Cancer"], "language": "en", "link": [{"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fgcc.20004", "content-type": "unspecified", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://onlinelibrary.wiley.com/doi/full/10.1002/gcc.20004", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2018, 7, 31]], "date-time": "2018-07-31T13:04:15Z", "timestamp": 1533042255000}, "score": 82.07254, "issued": {"date-parts": [[2004]]}, "references-count": 41, "journal-issue": {"published-print": {"date-parts": [[2004, 4]]}, "issue": "4"}, "URL": "http://dx.doi.org/10.1002/gcc.20004", "relation": {"cites": []}, "ISSN": ["1045-2257", "1098-2264"], "issn-type": [{"value": "1045-2257", "type": "print"}, {"value": "1098-2264", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 20]], "date-time": "2019-11-20T18:26:25Z", "timestamp": 1574274385991}, "reference-count": 37, "publisher": "Wiley", "issue": "3", "license": [{"URL": "http://doi.wiley.com/10.1002/tdm_license_1.1", "start": {"date-parts": [[2015, 9, 1]], "date-time": "2015-09-01T00:00:00Z", "timestamp": 1441065600000}, "delay-in-days": 8370, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Genes Chromosom. Cancer"], "published-print": {"date-parts": [[1992, 10]]}, "DOI": "10.1002/gcc.2870050309", "type": "journal-article", "created": {"date-parts": [[2007, 2, 21]], "date-time": "2007-02-21T23:09:24Z", "timestamp": 1172099364000}, "page": "227-234", "source": "Crossref", "is-referenced-by-count": 63, "title": ["Characterization of the translocation breakpoint sequences of twoDEK-CAN fusion genes present in t(6;9) acute myeloid leukemia and aSET-CAN fusion gene found in a case of acute undifferentiated leukemia"], "prefix": "10.1002", "volume": "5", "author": [{"given": "Marieke", "family": "Von Lindern", "sequence": "first", "affiliation": []}, {"given": "Dimitri", "family": "Breems", "sequence": "additional", "affiliation": []}, {"given": "Sjoz\u00e8f", "family": "Van Baal", "sequence": "additional", "affiliation": []}, {"given": "Henk", "family": "Adriaansen", "sequence": "additional", "affiliation": []}, {"given": "Gerard", "family": "Grosveld", "sequence": "additional", "affiliation": []}], "member": "311", "reference": [{"key": "10.1002/gcc.2870050309-BIB1", "author": "Adriaansen", "volume": "2", "first-page": "136", "year": "1988", "journal-title": "Leukemia"}, {"key": "10.1002/gcc.2870050309-BIB2", "author": "Adriaansen", "volume": "4", "first-page": "404", "year": "1990", "journal-title": "Leukemia"}, {"key": "10.1002/gcc.2870050309-BIB3", "author": "Adriaansen", "volume": "5", "first-page": "744", "year": "1991", "journal-title": "Leukemia"}, {"key": "10.1002/gcc.2870050309-BIB4", "author": "Alt", "volume": "79", "first-page": "4118", "year": "1982", "journal-title": "Proc Natl Acad Sci USA", "DOI": "10.1073/pnas.79.13.4118", "doi-asserted-by": "crossref"}, {"key": "10.1002/gcc.2870050309-BIB5", "author": "Begley", "volume": "86", "first-page": "2031", "year": "1989", "journal-title": "Proc Natl Acad Sci USA", "DOI": "10.1073/pnas.86.6.2031", "doi-asserted-by": "crossref"}, {"key": "10.1002/gcc.2870050309-BIB6", "author": "Boehm", "volume": "3", "first-page": "2344", "year": "1989", "journal-title": "FASEB J", "DOI": "10.1096/fasebj.3.12.2676678", "doi-asserted-by": "crossref"}, {"key": "10.1002/gcc.2870050309-BIB7", "author": "Boehm", "volume": "8", "first-page": "2621", "year": "1989", "journal-title": "EMBO J", "DOI": "10.1002/j.1460-2075.1989.tb08402.x", "doi-asserted-by": "crossref"}, {"key": "10.1002/gcc.2870050309-BIB8", "author": "Brown", "volume": "9", "first-page": "3343", "year": "1990", "journal-title": "EMBO J", "DOI": "10.1002/j.1460-2075.1990.tb07535.x", "doi-asserted-by": "crossref"}, {"key": "10.1002/gcc.2870050309-BIB9", "author": "Chen", "volume": "9", "first-page": "415", "year": "1990", "journal-title": "EMBO J", "DOI": "10.1002/j.1460-2075.1990.tb08126.x", "doi-asserted-by": "crossref"}, {"key": "10.1002/gcc.2870050309-BIB10", "author": "Chen", "volume": "2", "first-page": "261", "year": "1988", "journal-title": "Leukemia"}, {"key": "10.1002/gcc.2870050309-BIB11", "author": "Chen", "volume": "4", "first-page": "195", "year": "1989", "journal-title": "Oncogene"}, {"key": "10.1002/gcc.2870050309-BIB12", "author": "Ceary", "volume": "66", "first-page": "619", "year": "1991", "journal-title": "Cell", "DOI": "10.1016/0092-8674(91)90105-8", "doi-asserted-by": "crossref"}, {"key": "10.1002/gcc.2870050309-BIB13", "author": "Croce", "volume": "49", "first-page": "155", "year": "1987", "journal-title": "Cell", "DOI": "10.1016/0092-8674(87)90552-6", "doi-asserted-by": "crossref"}, {"key": "10.1002/gcc.2870050309-BIB14", "author": "Cuneo", "volume": "42", "first-page": "209", "year": "1989", "journal-title": "Cancer Genet Cytogenet", "DOI": "10.1016/0165-4608(89)90089-7", "doi-asserted-by": "crossref"}, {"key": "10.1002/gcc.2870050309-BIB15", "author": "De Klein", "volume": "14", "first-page": "7071", "year": "1986", "journal-title": "Nucleic Acids Res", "DOI": "10.1093/nar/14.17.7071", "doi-asserted-by": "crossref"}, {"key": "10.1002/gcc.2870050309-BIB16", "author": "Fanning", "volume": "910", "first-page": "203", "year": "1987", "journal-title": "Biochim Biophys Acta", "DOI": "10.1016/0167-4781(87)90112-6", "doi-asserted-by": "crossref"}, {"key": "10.1002/gcc.2870050309-BIB17", "author": "Finger", "volume": "234", "first-page": "982", "year": "1986", "journal-title": "Science", "DOI": "10.1126/science.3490692", "doi-asserted-by": "crossref"}, {"key": "10.1002/gcc.2870050309-BIB18", "author": "Finger", "volume": "86", "first-page": "5039", "year": "1989", "journal-title": "Proc Natl Acad Sci USA", "DOI": "10.1073/pnas.86.13.5039", "doi-asserted-by": "crossref"}, {"key": "10.1002/gcc.2870050309-BIB19", "author": "Hsieh", "volume": "4", "first-page": "1951", "year": "1990", "journal-title": "Genes Dev", "DOI": "10.1101/gad.4.11.1951", "doi-asserted-by": "crossref"}, {"key": "10.1002/gcc.2870050309-BIB20", "author": "Kiyama", "volume": "88", "first-page": "10450", "year": "1991", "journal-title": "Proc Natl Acad Sci USA", "DOI": "10.1073/pnas.88.23.10450", "doi-asserted-by": "crossref"}, {"key": "10.1002/gcc.2870050309-BIB21", "author": "Krowczynska", "volume": "18", "first-page": "1121", "year": "1990", "journal-title": "Nuclei. Acids Res", "DOI": "10.1093/nar/18.5.1121", "doi-asserted-by": "crossref"}, {"key": "10.1002/gcc.2870050309-BIB22", "author": "Landau", "volume": "7", "first-page": "3237", "year": "1987", "journal-title": "Mol Cell Biol", "DOI": "10.1128/MCB.7.9.3237", "doi-asserted-by": "crossref"}, {"key": "10.1002/gcc.2870050309-BIB23", "author": "Papadopoulos", "volume": "1", "first-page": "233", "year": "1990", "journal-title": "Genes Chrom Cancer", "DOI": "10.1002/gcc.2870010308", "doi-asserted-by": "crossref"}, {"key": "10.1002/gcc.2870050309-BIB24", "author": "Pear", "volume": "2", "first-page": "499", "year": "1988", "journal-title": "Oncogene"}, {"key": "10.1002/gcc.2870050309-BIB25", "author": "Rabbitts", "volume": "3", "first-page": "99", "year": "1988", "journal-title": "Oncogene"}, {"key": "10.1002/gcc.2870050309-BIB26", "author": "Sanger", "volume": "74", "first-page": "5463", "year": "1977", "journal-title": "Proc Natl Acad Sci USA", "DOI": "10.1073/pnas.74.12.5463", "doi-asserted-by": "crossref"}, {"key": "10.1002/gcc.2870050309-BIB27", "author": "Schmid", "volume": "216", "first-page": "1065", "year": "1982", "journal-title": "Science", "DOI": "10.1126/science.6281889", "doi-asserted-by": "crossref"}, {"key": "10.1002/gcc.2870050309-BIB28", "author": "Singer", "volume": "10", "first-page": "119", "year": "1985", "journal-title": "Trends Biochem Sci", "DOI": "10.1016/0968-0004(85)90271-3", "doi-asserted-by": "crossref"}, {"key": "10.1002/gcc.2870050309-BIB29", "author": "Soekarman", "volume": "79", "first-page": "1", "year": "1992", "journal-title": "Blood"}, {"key": "10.1002/gcc.2870050309-BIB30", "author": "Strauss", "volume": "37", "first-page": "889", "year": "1984", "journal-title": "Cell", "DOI": "10.1016/0092-8674(84)90424-0", "doi-asserted-by": "crossref"}, {"key": "10.1002/gcc.2870050309-BIB31", "author": "Tonegawa", "volume": "302", "first-page": "575", "year": "1983", "journal-title": "Nature", "DOI": "10.1038/302575a0", "doi-asserted-by": "crossref"}, {"key": "10.1002/gcc.2870050309-BIB32", "author": "van der Feltz", "volume": "17", "first-page": "1", "year": "1989", "journal-title": "Nuclei. Acids Res", "DOI": "10.1093/nar/17.1.1", "doi-asserted-by": "crossref"}, {"key": "10.1002/gcc.2870050309-BIB33", "author": "von Lindern", "volume": "4", "first-page": "75", "year": "1989", "journal-title": "Oncogene"}, {"key": "10.1002/gcc.2870050309-BIB34", "author": "von Lindern", "volume": "10", "first-page": "4016", "year": "1990", "journal-title": "Mol Cell Biol", "DOI": "10.1128/MCB.10.8.4016", "doi-asserted-by": "crossref"}, {"key": "10.1002/gcc.2870050309-BIB35", "author": "von Lindern", "volume": "12", "first-page": "1687", "year": "1992a", "journal-title": "Mol Cell Bio", "DOI": "10.1128/MCB.12.4.1687", "doi-asserted-by": "crossref"}, {"key": "10.1002/gcc.2870050309-BIB36", "author": "von Lindern", "year": "1992b", "unstructured": ", , , , (1992b) Can, a putative oncogene associated with myeloid leukemogenesis, may be activated by fusion of its 3\u2032 half to different genes: Characterization of the set gene. Mol Cell Biol (in press)."}, {"key": "10.1002/gcc.2870050309-BIB37", "author": "Yancopoulos", "volume": "5", "first-page": "325", "year": "1986", "journal-title": "EMBO J", "DOI": "10.1002/j.1460-2075.1986.tb04637.x", "doi-asserted-by": "crossref"}], "container-title": ["Genes, Chromosomes and Cancer"], "language": "en", "link": [{"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fgcc.2870050309", "content-type": "unspecified", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://onlinelibrary.wiley.com/doi/full/10.1002/gcc.2870050309", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 1, 17]], "date-time": "2019-01-17T21:26:23Z", "timestamp": 1547760383000}, "score": 32.862137, "issued": {"date-parts": [[1992, 10]]}, "references-count": 37, "journal-issue": {"published-print": {"date-parts": [[1992, 10]]}, "issue": "3"}, "URL": "http://dx.doi.org/10.1002/gcc.2870050309", "relation": {"cites": []}, "ISSN": ["1045-2257", "1098-2264"], "issn-type": [{"value": "1045-2257", "type": "print"}, {"value": "1098-2264", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 22]], "date-time": "2019-11-22T14:13:40Z", "timestamp": 1574432020344}, "reference-count": 0, "publisher": "INIST-CNRS", "issue": "1", "content-domain": {"domain": [], "crossmark-restriction": false}, "DOI": "10.4267/2042/38272", "type": "journal-article", "created": {"date-parts": [[2011, 12, 9]], "date-time": "2011-12-09T15:28:29Z", "timestamp": 1323444509000}, "source": "Crossref", "is-referenced-by-count": 0, "title": ["t(9;11)(q34;q23) AF9q34/MLL"], "prefix": "10.4267", "author": [{"given": "ARM", "family": "von Bergh", "sequence": "first", "affiliation": []}], "member": "2793", "published-online": {"date-parts": [[2011, 2]]}, "container-title": ["Atlas of Genetics and Cytogenetics in Oncology and Haematology"], "deposited": {"date-parts": [[2011, 12, 9]], "date-time": "2011-12-09T15:28:43Z", "timestamp": 1323444523000}, "score": 30.582985, "issued": {"date-parts": [[2011, 2]]}, "references-count": 0, "journal-issue": {"published-online": {"date-parts": [[2011, 2]]}, "issue": "1"}, "URL": "http://dx.doi.org/10.4267/2042/38272", "ISSN": ["1768-3262"], "issn-type": [{"value": "1768-3262", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T18:36:40Z", "timestamp": 1574534200796}, "reference-count": 29, "publisher": "Springer Science and Business Media LLC", "issue": "4", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2001, 4, 1]], "date-time": "2001-04-01T00:00:00Z", "timestamp": 986083200000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Leukemia"], "published-print": {"date-parts": [[2001, 4]]}, "DOI": "10.1038/sj.leu.2402050", "type": "journal-article", "created": {"date-parts": [[2011, 8, 11]], "date-time": "2011-08-11T10:32:51Z", "timestamp": 1313058771000}, "page": "595-600", "source": "Crossref", "is-referenced-by-count": 21, "title": ["Cryptic t(4;11) encoding MLL-AF4 due to insertion of 5\u2032 MLL sequences in chromosome 4"], "prefix": "10.1038", "volume": "15", "author": [{"given": "A", "family": "von Bergh", "sequence": "first", "affiliation": []}, {"given": "P", "family": "Gargallo", "sequence": "additional", "affiliation": []}, {"given": "B", "family": "De Prijck", "sequence": "additional", "affiliation": []}, {"given": "H", "family": "Vranckx", "sequence": "additional", "affiliation": []}, {"given": "R", "family": "Marschalek", "sequence": "additional", "affiliation": []}, {"given": "I", "family": "Larripa", "sequence": "additional", "affiliation": []}, {"given": "Ph", "family": "Kluin", "sequence": "additional", "affiliation": []}, {"given": "E", "family": "Schuuring", "sequence": "additional", "affiliation": []}, {"given": "A", "family": "Hagemeijer", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2001, 5, 1]]}, "reference": [{"key": "BF2402050_CR1", "doi-asserted-by": "publisher", "first-page": "173", "DOI": "10.1007/BF00291919", "volume": "46", "author": "H Van den Berge", "year": "1979", "unstructured": "Van den Berge H, David G, Broeckaert-Van Orshoven A, Louwagie A, Verwilghen R, Casteels-Van Daele M, Eggermont E, Eeckels R . A new chromosome anomaly in acute lymphoblastic leukemia (ALL) Hum Genet 1979 46: 173\u2013180", "journal-title": "Hum Genet"}, {"key": "BF2402050_CR2", "doi-asserted-by": "publisher", "first-page": "701", "DOI": "10.1016/0092-8674(92)90603-A", "volume": "71", "author": "Y Gu", "year": "1992", "unstructured": "Gu Y, Nakamura T, Alder H, Prasad R, Canaani O, Cimino G, Croce CM, Canaani E . The t(4;11) chromosome translocation of human acute leukemias fuses the ALL-1 gene, related to Drosophila trithorax, to the AF-4 gene Cell 1992 71: 701\u2013708", "journal-title": "Cell"}, {"key": "BF2402050_CR3", "first-page": "3995", "volume": "91", "author": "S Faderl", "year": "1998", "unstructured": "Faderl S, Kantarjian HM, Talpaz M, Estrov Z . Clinical significance of cytogenetic abnormalities in adult acute lymphoblastic leukemia Blood 1998 91: 3995\u20134019", "journal-title": "Blood"}, {"key": "BF2402050_CR4", "doi-asserted-by": "publisher", "first-page": "679", "DOI": "10.1038/sj.leu.2401413", "volume": "13", "author": "NA Heerema", "year": "1999", "unstructured": "Heerema NA, Sather HN, Ge J, Arthur DC, Hilden JM, Trigg ME, Reaman GH . Cytogenetic studies of infant acute lymphoblastic leukemia: poor prognosis of infants with t(4;11) \u2013 a report of the Children's Cancer Group Leukemia 1999 13: 679\u2013686", "journal-title": "Leukemia"}, {"key": "BF2402050_CR5", "doi-asserted-by": "publisher", "first-page": "7884", "DOI": "10.1073/pnas.90.16.7884", "volume": "90", "author": "PH Domer", "year": "1993", "unstructured": "Domer PH, Fakharzadeh SS, Chen CS, Jockel J, Johansen L, Silverman GA, Kersey JH, Korsmeyer SJ . Acute mixed-lineage leukemia t(4;11)(q21;q23) generates an MLL-AF4 fusion product Proc Natl Acad Sci USA 1993 90: 7884\u20137888", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "BF2402050_CR6", "doi-asserted-by": "publisher", "first-page": "10610", "DOI": "10.1073/pnas.91.22.10610", "volume": "91", "author": "L Zeleznik", "year": "1994", "unstructured": "Zeleznik L, Harden AM, Rowley JD . 11q23 translocations split the \u2018AT-hook\u2019 cruciform DNA-binding region and the transcriptional repression domain from the activation domain of the mixed-lineage leukemia (MLL) gene Proc Natl Acad Sci USA 1994 91: 10610\u201310614", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "BF2402050_CR7", "doi-asserted-by": "publisher", "first-page": "909", "DOI": "10.1056/NEJM199309233291302", "volume": "329", "author": "M Thirman", "year": "1993", "unstructured": "Thirman M, Gill H, Burnett R, Mbangkollo D, McCabe N, Kobayashi H, Ziemin-van der Poel S, Kaneko Y, Morgan R, Sandberg A, Chaganti R, Larson RA, Le Beau MM, Diaz MO, Rowley JD . Rearrangements of the MLL gene in acute lymphoblastic and acute myeloid leukemias with 11q23 chromosomal translocations N Engl J Med 1993 329: 909\u2013914", "journal-title": "N Engl J Med"}, {"key": "BF2402050_CR8", "doi-asserted-by": "publisher", "first-page": "966", "DOI": "10.1046/j.1365-2141.1996.d01-1748.x", "volume": "93", "author": "I Nilson", "year": "1996", "unstructured": "Nilson I, Lochner K, Siegler G, Greil J, Beck JD, Fey GH, Marschalek R . Exon/intron structure of the human ALL-1 (MLL) gene involved in translocations to chromosomal region 11q23 and acute leukaemias Br J Haematol 1996 93: 966\u2013972", "journal-title": "Br J Haematol"}, {"key": "BF2402050_CR9", "first-page": "1124", "volume": "81", "author": "J Morrissey", "year": "1993", "unstructured": "Morrissey J, Tkachuk DC, Milatovich A, Francke U, Link M, Cleary ML . A serine/proline-rich protein is fused to HRX in t(4;11) acute leukemias Blood 1993 81: 1124\u20131131", "journal-title": "Blood"}, {"key": "BF2402050_CR10", "doi-asserted-by": "publisher", "first-page": "157", "DOI": "10.1046/j.1365-2141.1997.1522966.x", "volume": "98", "author": "I Nilson", "year": "1997", "unstructured": "Nilson I, Reichel M, Ennas MG, Greim R, Knorr C, Siegler G, Greil J, Fey GH, Marschalek R . Exon/intron structure of the human AF-4 gene, a member of the AF-4/LAF- 4/FMR-2 gene family coding for a nuclear protein with structural alterations in acute leukaemia Br J Haematol 1997 98: 157\u2013169", "journal-title": "Br J Haematol"}, {"key": "BF2402050_CR11", "first-page": "2943", "volume": "82", "author": "A Biondi", "year": "1993", "unstructured": "Biondi A, Rambaldi A, Rossi V, Elia L, Caslini C, Basso G, Battista R, Barbui T, Mandelli F, Masera G . Detection of ALL-1/AF4 fusion transcript by reverse transcription-polymerase chain reaction for diagnosis and monitoring of acute leukemias with the t(4;11) translocation Blood 1993 82: 2943\u20132947", "journal-title": "Blood"}, {"key": "BF2402050_CR12", "first-page": "330", "volume": "83", "author": "JR Downing", "year": "1994", "unstructured": "Downing JR, Head DR, Raimondi SC, Carroll AJ, Curcio-Brint AM, Motroni TA, Hulshof MG, Pullen DJ, Domer PH . The der(11)-encoded MLL/AF-4 fusion transcript is consistently detected in t(4;11)(q21;q23)-containing acute lymphoblastic leukemia Blood 1994 83: 330\u2013335", "journal-title": "Blood"}, {"key": "BF2402050_CR13", "first-page": "3876", "volume": "86", "author": "JM Hilden", "year": "1995", "unstructured": "Hilden JM, Frestedt JL, Moore RO, Heerema NA, Arthur DC, Reaman GH, Kersey JH . Molecular analysis of infant acute lymphoblastic leukemia: MLL gene rearrangement and reverse transcriptase-polymerase chain reaction for t(4;11)(q21;q23) Blood 1995 86: 3876\u20133882", "journal-title": "Blood"}, {"key": "BF2402050_CR14", "doi-asserted-by": "publisher", "first-page": "659", "DOI": "10.1046/j.1365-2141.1996.373909.x", "volume": "92", "author": "G Cimino", "year": "1996", "unstructured": "Cimino G, Elia L, Rivolta A, Rapanotti MC, Rossi V, Alimena G, Annino L, Canaani E, Lo CF, Biondi A . Clinical relevance of residual disease monitoring by polymerase chain reaction in patients with ALL-1/AF-4 positive-acute lymphoblastic leukaemia Br J Haematol 1996 92: 659\u2013664", "journal-title": "Br J Haematol"}, {"key": "BF2402050_CR15", "first-page": "2386", "volume": "81", "author": "CS Chen", "year": "1993", "unstructured": "Chen CS, Sorensen PH, Domer PH, Reaman GH, Korsmeyer SJ, Heerema NA, Hammond GD, Kersey JH . Molecular rearrangements on chromosome 11q23 predominate in infant acute lymphoblastic leukemia and are associated with specific biologic variables and poor outcome Blood 1993 81: 2386\u20132393", "journal-title": "Blood"}, {"key": "BF2402050_CR16", "first-page": "570", "volume": "84", "author": "JE Rubnitz", "year": "1994", "unstructured": "Rubnitz JE, Link MP, Shuster JJ, Carroll AJ, Hakami N, Frankel LS, Pullen DJ, Cleary ML . Frequency and prognostic significance of HRX rearrangements in infant acute lymphoblastic leukemia: a Pediatric Oncology Group study Blood 1994 84: 570\u2013573", "journal-title": "Blood"}, {"key": "BF2402050_CR17", "first-page": "542", "volume": "8", "author": "F Griesinger", "year": "1994", "unstructured": "Griesinger F, Elfers H, Ludwig WD, Falk M, Rieder H, Harbott J, Lampert F, Heinze B, Hoelzer D, Thiel E . Detection of HRX-FEL fusion transcripts in pre-pre-B-ALL with and without cytogenetic demonstration of t(4;11) Leukemia 1994 8: 542\u2013548", "journal-title": "Leukemia"}, {"key": "BF2402050_CR18", "doi-asserted-by": "publisher", "first-page": "14", "DOI": "10.1002/(SICI)1098-2264(200005)28:1<14::AID-GCC2>3.0.CO;2-X", "volume": "28", "author": "A Von Bergh", "year": "2000", "unstructured": "Von Bergh A, Emanuel B, Van-Zelderen-Bhola S, Smetsers T, Van Soest R, Stul M, Vranckx H, Schuuring E, Hagemeijer A, Kluin Ph . A DNA probe combination for improved detection of MLL/11q23 breakpoints by double-color FISH in acute Leukemias Genes Chromos Cancer 2000 28: 14\u201322", "journal-title": "Genes Chromos Cancer"}, {"key": "BF2402050_CR19", "doi-asserted-by": "publisher", "first-page": "261", "DOI": "10.1002/(SICI)1098-2264(199608)16:4<261::AID-GCC6>3.0.CO;2-W", "volume": "16", "author": "J Dierlamm", "year": "1996", "unstructured": "Dierlamm J, Wlodarska I, Michaux L, La Starza R, Zeller W, Mecucci C, Van den Berge H . Successful use of the same slide for consecutive fluorescence in situ hybridization experiments Genes Chromos Cancer 1996 16: 261\u2013264", "journal-title": "Genes Chromos Cancer"}, {"key": "BF2402050_CR20", "first-page": "1177", "volume": "88", "author": "JW Vaandrager", "year": "1996", "unstructured": "Vaandrager JW, Schuuring E, Zwikstra E, de Boer CJ, Kleiverda KK, Van Krieken JH, Kluin-Nelemans HC, Van Ommen GJ, Raap AK, Kluin PM . Direct visualization of dispersed 11q13 chromosomal translocations in mantle cell lymphoma by multicolor DNA fiber fluorescence in situ hybridization Blood 1996 88: 1177\u20131182", "journal-title": "Blood"}, {"key": "BF2402050_CR21", "first-page": "3357", "volume": "59", "author": "M Reichel", "year": "1999", "unstructured": "Reichel M, Gillert E, Breitenlohner I, Repp R, Greil J, Beck JD, Fey GH, Marschalek R . Rapid isolation of chromosomal breakpoints from patients with t(4;11) acute lymphoblastic leukemia: implications for basic and clinical research Cancer Res 1999 59: 3357\u20133362", "journal-title": "Cancer Res"}, {"key": "BF2402050_CR22", "first-page": "2326", "volume": "54", "author": "Y Gu", "year": "1994", "unstructured": "Gu Y, Alder H, Nakamura T, Schichman SA, Prasad R, Canaani O, Saito H, Croce CM, Canaani E . Sequence analysis of the breakpoint cluster region in the ALL-1 gene involved in acute leukemia Cancer Res 1994 54: 2326\u20132330", "journal-title": "Cancer Res"}, {"key": "BF2402050_CR23", "first-page": "210", "volume": "9", "author": "R Repp", "year": "1995", "unstructured": "Repp R, Borkhardt A, Haupt E, Kreuder J, Brettreich S, Hammermann J, Nishida K, Harbott J, Lampert F . Detection of four different 11q23 chromosomal abnormalities by multiplex-PCR and fluorescence-based automatic DNA-fragment analysis Leukemia 1995 9: 210\u2013215", "journal-title": "Leukemia"}, {"key": "BF2402050_CR24", "first-page": "810", "volume": "92", "author": "FM Uckun", "year": "1998", "unstructured": "Uckun FM, Herman-Hatten K, Crotty ML, Sensel MG, Sather HN, Tuel-Ahlgren L, Sarquis MB, Bostrom B, Nachman JB, Steinherz PG, Gaynon PS, Heerema N . Clinical significance of MLL-AF4 fusion transcript expression in the absence of a cytogenetically detectable t(4;11)(q21;q23) chromosomal translocation Blood 1998 92: 810\u2013821", "journal-title": "Blood"}, {"key": "BF2402050_CR25", "doi-asserted-by": "publisher", "first-page": "237", "DOI": "10.1002/gcc.2870080406", "volume": "8", "author": "A Hagemeijer", "year": "1993", "unstructured": "Hagemeijer A, Buijs A, Smit E, Janssen B, Creemers GJ, Van der Plas D, Grosveld G . Translocation of BCR to chromosome 9: a new cytogenetic variant detected by FISH in two Ph-negative, BCR-positive patients with chronic myeloid leukemia Genes Chromos Cancer 1993 8: 237\u2013245", "journal-title": "Genes Chromos Cancer"}, {"key": "BF2402050_CR26", "doi-asserted-by": "publisher", "first-page": "17", "DOI": "10.1016/S0165-4608(99)00036-9", "volume": "114", "author": "L Vieira", "year": "1999", "unstructured": "Vieira L, Alves AC, Marques B, Reis I, Jorge G, Ambrosio AP, de Sousa AB, Boavida MG . Insertion of the 5\u2032 part of BCR within the ABL gene at 9q34 in a Philadelphia-negative chronic myeloid leukemia Cancer Genet Cytogenet 1999 114: 17\u201321", "journal-title": "Cancer Genet Cytogenet"}, {"key": "BF2402050_CR27", "first-page": "4876", "volume": "90", "author": "D Grimwade", "year": "1997", "unstructured": "Grimwade D, Gorman P, Duprez E, Howe K, Langabeer S, Oliver F, Walker H, Culligan D, Waters J, Pomfret M, Goldstone A, Burnett A, Freemont P, Sheer D, Solomon E . Characterization of cryptic rearrangements and variant translocations in acute promyelocytic leukemia Blood 1997 90: 4876\u20134885", "journal-title": "Blood"}, {"key": "BF2402050_CR28", "doi-asserted-by": "publisher", "first-page": "165", "DOI": "10.1002/(SICI)1098-2264(199902)24:2<165::AID-GCC12>3.0.CO;2-1", "volume": "24", "author": "S Taviaux", "year": "1999", "unstructured": "Taviaux S, Brunel V, Dupont M, Fernandez F, Ferraz C, Carbuccia N, Sainty D, Demaille J, Birg F, Lafage-Pochitaloff M . Simple variant t(8;21) acute myeloid leukemias harbor insertions of the AML1 or ETO genes Genes Chromos Cancer 1999 24: 165\u2013171", "journal-title": "Genes Chromos Cancer"}, {"key": "BF2402050_CR29", "first-page": "343", "volume": "151", "author": "S Pittaluga", "year": "1997", "unstructured": "Pittaluga S, Wiodarska I, Pulford K, Campo E, Morris SW, Van den Berghe H, Wolf-Peeters C . The monoclonal antibody ALK1 identifies a distinct morphological subtype of anaplastic large cell lymphoma associated with 2p23/ALK rearrangements Am J Pathol 1997 151: 343\u2013351", "journal-title": "Am J Pathol"}], "container-title": ["Leukemia"], "language": "en", "link": [{"URL": "http://www.nature.com/articles/2402050.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/2402050", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/2402050.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 3, 15]], "date-time": "2019-03-15T20:56:24Z", "timestamp": 1552683384000}, "score": 29.999863, "issued": {"date-parts": [[2001, 4]]}, "references-count": 29, "journal-issue": {"published-print": {"date-parts": [[2001, 4]]}, "issue": "4"}, "alternative-id": ["BF2402050"], "URL": "http://dx.doi.org/10.1038/sj.leu.2402050", "relation": {"cites": []}, "ISSN": ["0887-6924", "1476-5551"], "issn-type": [{"value": "0887-6924", "type": "print"}, {"value": "1476-5551", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 22]], "date-time": "2019-11-22T18:07:54Z", "timestamp": 1574446074828}, "reference-count": 122, "publisher": "Wiley", "issue": "1", "license": [{"URL": "http://doi.wiley.com/10.1002/tdm_license_1.1", "start": {"date-parts": [[2015, 9, 1]], "date-time": "2015-09-01T00:00:00Z", "timestamp": 1441065600000}, "delay-in-days": 2321, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "DOI": "10.1111/j.1600-0609.1996.tb00483.x", "type": "journal-article", "created": {"date-parts": [[2010, 7, 18]], "date-time": "2010-07-18T05:48:28Z", "timestamp": 1279432108000}, "page": "1-16", "source": "Crossref", "is-referenced-by-count": 48, "title": ["Cell differentiation in acute myeloid leukemia"], "prefix": "10.1111", "volume": "57", "author": [{"given": "Inge", "family": "Olsson", "sequence": "first", "affiliation": []}, {"given": "G\u00f6sta", "family": "Bergh", "sequence": "additional", "affiliation": []}, {"given": "Mats", "family": "Ehinger", "sequence": "additional", "affiliation": []}, {"given": "Urban", "family": "Gullberg", "sequence": "additional", "affiliation": []}], "member": "311", "published-online": {"date-parts": [[2009, 4, 24]]}, "reference": [{"key": "10.1111/j.1600-0609.1996.tb00483.x-BIB1|cit1", "doi-asserted-by": "crossref", "first-page": "4480", "DOI": "10.1073/pnas.91.10.4480", "article-title": "Identification of a nonsense mutation in the granulocyte-colony-stimulating factor receptor in severe congenital neutropenia", "volume": "91", "author": "Dong", "year": "1994", "journal-title": "Proc Natl Acad Sci"}, {"key": "10.1111/j.1600-0609.1996.tb00483.x-BIB2|cit2", "first-page": "631", "article-title": "Uncoupling of the proliferation and differentiation signals mediated by the murine macrophage colony-stimulating factor receptor expressed in myeloid FDC-P1 cells", "volume": "6", "author": "Bourette", "year": "1995", "journal-title": "Cell Growth Diff"}, {"key": "10.1111/j.1600-0609.1996.tb00483.x-BIB3|cit3", "doi-asserted-by": "crossref", "first-page": "4955", "DOI": "10.1074/jbc.270.10.4955", "article-title": "Transcription factors and hematopoietic development", "volume": "270", "author": "Orkin", "year": "1995", "journal-title": "J Biol Chem"}, {"key": "10.1111/j.1600-0609.1996.tb00483.x-BIB4|cit4", "doi-asserted-by": "crossref", "first-page": "1821", "DOI": "10.1126/science.7997877", "article-title": "Cell cycle control and cancer", "volume": "266", "author": "Hartwell", "year": "1994", "journal-title": "Science"}, {"key": "10.1111/j.1600-0609.1996.tb00483.x-BIB5|cit5", "first-page": "841", "article-title": "Role of the cyclin-dependent kinase inhibitors in the development of cancer", "volume": "86", "author": "Hirama", "year": "1995", "journal-title": "Blood"}, {"key": "10.1111/j.1600-0609.1996.tb00483.x-BIB6|cit6", "doi-asserted-by": "crossref", "first-page": "2869", "DOI": "10.1073/pnas.92.7.2869", "article-title": "Erythropoietin-induced cellular differentiation requires prolongation of the G1 phase of the cell cycle", "volume": "92", "author": "Carroll", "year": "1995", "journal-title": "Proc Natl Acad Sci"}, {"key": "10.1111/j.1600-0609.1996.tb00483.x-BIB7|cit7", "first-page": "160", "article-title": "Expression of oncogenes and cell cycle related genes in acute and chronic leukemias", "volume": "2", "author": "Ferrari", "year": "1988", "journal-title": "Leukemia"}, {"key": "10.1111/j.1600-0609.1996.tb00483.x-BIB8|cit8", "first-page": "382", "article-title": "The effects of combination of recombinant growth factors GM-CSF, G-CSF, IL-3 and CSF-1 on leukemic blast cells in suspension culture", "volume": "2", "author": "Miyachi", "year": "1989", "journal-title": "Leukemia"}, {"key": "10.1111/j.1600-0609.1996.tb00483.x-BIB9|cit9", "first-page": "200", "article-title": "Recombinant human IL-3 and G-CSF act synergistically in stimulating growth of acute myeloid leukemia cells", "volume": "3", "author": "Pebusque", "year": "1989", "journal-title": "Leukemia"}, {"key": "10.1111/j.1600-0609.1996.tb00483.x-BIB10|cit10", "doi-asserted-by": "crossref", "first-page": "143", "DOI": "10.1038/372143a0", "article-title": "Chromosomal translocations in human cancer", "volume": "372", "author": "Rabbitts", "year": "1994", "journal-title": "Nature"}, {"key": "10.1111/j.1600-0609.1996.tb00483.x-BIB11|cit11", "doi-asserted-by": "crossref", "first-page": "641", "DOI": "10.1016/0092-8674(91)90057-6", "article-title": "Translocations, master genes, and differences between the origins of acute and chronic leukemias", "volume": "67", "author": "Rabbitts", "year": "1991", "journal-title": "Cell"}, {"key": "10.1111/j.1600-0609.1996.tb00483.x-BIB12|cit12", "first-page": "10", "article-title": "Acute promyelocytic leukemia: from genetics to treatment", "volume": "83", "author": "Grignani", "year": "1994", "journal-title": "Blood"}, {"key": "10.1111/j.1600-0609.1996.tb00483.x-BIB13|cit13", "first-page": "1", "article-title": "AML1 and the 8;21 and 3;21 translocations in acute and chronic myeloid leukemia", "volume": "86", "author": "Nucifora", "year": "1995", "journal-title": "Blood"}, {"key": "10.1111/j.1600-0609.1996.tb00483.x-BIB14|cit14", "first-page": "2289", "article-title": "Molecular pathogenesis of the chromosome 16 inversion in the M4Eo subtype of acute myeloid leukemia", "volume": "85", "author": "Liu", "year": "1995", "journal-title": "Blood"}, {"key": "10.1111/j.1600-0609.1996.tb00483.x-BIB15|cit15", "doi-asserted-by": "crossref", "first-page": "211", "DOI": "10.1016/S0046-8177(87)80002-3", "article-title": "Association between morphology, karyotype, and clinical features in myeloid leukemias", "volume": "18", "author": "Bitter", "year": "1987", "journal-title": "Human Pathol"}, {"key": "10.1111/j.1600-0609.1996.tb00483.x-BIB16|cit16", "first-page": "1825", "article-title": "Identification of breakpoints in t(8;21) acute myelogenous leukemia and isolation of a fusion transcript, AML1/ETO, with similarity to Drosophila segmentation gene, runt", "volume": "80", "author": "Erickson", "year": "1992", "journal-title": "Blood"}, {"key": "10.1111/j.1600-0609.1996.tb00483.x-BIB17|cit17", "doi-asserted-by": "crossref", "first-page": "2715", "DOI": "10.1002/j.1460-2075.1993.tb05933.x", "article-title": "The t(8, 21) translocation in acute myeloid leukemia results in production of an AML1-MTG8 fusion transcript", "volume": "12", "author": "Miyoshi", "year": "1993", "journal-title": "EMBO J"}, {"key": "10.1111/j.1600-0609.1996.tb00483.x-BIB18|cit18", "first-page": "2594", "article-title": "A recurring chromosomal abnormality in therapy-related myelodysplastic syndrome and acute myeloid leukemia", "volume": "76", "author": "Rubin", "year": "1990", "journal-title": "Blood"}, {"key": "10.1111/j.1600-0609.1996.tb00483.x-BIB19|cit19", "first-page": "2728", "article-title": "Involvement of the AML1 gene in the t(3;21) in therapy-related leukemia and in chonic myeloid leukemia in blast crisis", "volume": "81", "author": "Nucifora", "year": "1993", "journal-title": "Blood"}, {"key": "10.1111/j.1600-0609.1996.tb00483.x-BIB20|cit20", "doi-asserted-by": "crossref", "first-page": "504", "DOI": "10.1002/j.1460-2075.1994.tb06288.x", "article-title": "Generation of the AML1-EVI-1 fusion gene in the t(3;21)(q26;q22) causes blastic crisis in chronic myelocytic leukemia", "volume": "13", "author": "Mitani", "year": "1994", "journal-title": "EMBO J"}, {"key": "10.1111/j.1600-0609.1996.tb00483.x-BIB21|cit21", "doi-asserted-by": "crossref", "first-page": "4004", "DOI": "10.1073/pnas.91.9.4004", "article-title": "Consistent intergenic splicing and production of multiple transcripts between AML1 at 21q22 and unrelated genes at 3q26 in (3;21)(q26;q22) translocations", "volume": "91", "author": "Nucifora", "year": "1994", "journal-title": "Proc Natl Acad Sci"}, {"issue": "suppl 1", "key": "10.1111/j.1600-0609.1996.tb00483.x-BIB22|cit22", "first-page": "532a", "article-title": "Detection of rare 21q22 translocation breakpoints within the AML1 gene in myeloid neoplasms by fluorescense in situ hybridization", "volume": "82", "author": "Roulston", "year": "1993", "journal-title": "Blood"}, {"key": "10.1111/j.1600-0609.1996.tb00483.x-BIB23|cit23", "doi-asserted-by": "crossref", "first-page": "338", "DOI": "10.1016/0168-9525(93)90026-E", "article-title": "The runt domain identifies a new family of heteromeric transcriptional regulators", "volume": "9", "author": "Kagoshima", "year": "1993", "journal-title": "Trends Genet"}, {"key": "10.1111/j.1600-0609.1996.tb00483.x-BIB24|cit24", "doi-asserted-by": "crossref", "first-page": "2141", "DOI": "10.1128/MCB.13.4.2141", "article-title": "The murine myeloperoxidase promoter contains several functional elements, one of which binds a cell type-restricted transcription factor, myeloid nuclear factor 1. (MyNF1)", "volume": "13", "author": "Suzow", "year": "1993", "journal-title": "Mol Cell Biol"}, {"key": "10.1111/j.1600-0609.1996.tb00483.x-BIB25|cit25", "doi-asserted-by": "crossref", "first-page": "5558", "DOI": "10.1128/MCB.14.8.5558", "article-title": "PEBP2/CBF, the murine homolog of the human myeloid AML1 and PEBP2\u03b2/CBF\u03b2 proto-oncoproteins, regulates the murine myeloperoxidase and neutrophil elastase genes in immature myeloid cells", "volume": "14", "author": "Nuchprayoon", "year": "1994", "journal-title": "Mol Cell Biol"}, {"key": "10.1111/j.1600-0609.1996.tb00483.x-BIB26|cit26", "doi-asserted-by": "crossref", "first-page": "89", "DOI": "10.1128/MCB.12.1.89", "article-title": "Purification of core-binding factor, a protein that binds the conserved core site in murine leukemia virus enhancers", "volume": "12", "author": "Wang", "year": "1992", "journal-title": "Mol Cell Biol"}, {"key": "10.1111/j.1600-0609.1996.tb00483.x-BIB27|cit27", "doi-asserted-by": "crossref", "first-page": "341", "DOI": "10.1002/j.1460-2075.1995.tb07008.x", "article-title": "An acute myeloid leukemia gene, AML1, regulates hemopoietic myeloid cell differentiation and transcriptional activation antagonistically by two alternative spliced forms", "volume": "14", "author": "Tanaka", "year": "1995", "journal-title": "EMBO J"}, {"key": "10.1111/j.1600-0609.1996.tb00483.x-BIB28|cit28", "doi-asserted-by": "crossref", "first-page": "1974", "DOI": "10.1128/MCB.15.4.1974", "article-title": "The t(8;21) fusion protein interferes with AML-1B-dependent transcriptional activation", "volume": "15", "author": "Meyers", "year": "1995", "journal-title": "Mol Cell Biol"}, {"key": "10.1111/j.1600-0609.1996.tb00483.x-BIB29|cit29", "doi-asserted-by": "crossref", "first-page": "7153", "DOI": "10.1073/pnas.90.15.7153", "article-title": "A dominant negative retinoic acid receptor blocks neutrophil differentiation at the promyelocyte stage", "volume": "90", "author": "Tsai", "year": "1993", "journal-title": "Proc Natl Acad Sci"}, {"key": "10.1111/j.1600-0609.1996.tb00483.x-BIB30|cit30", "doi-asserted-by": "crossref", "first-page": "177", "DOI": "10.1056/NEJM199307153290307", "article-title": "Acute promyelocytic leukemia", "volume": "329", "author": "Warrel", "year": "1993", "journal-title": "N Engl J Med"}, {"key": "10.1111/j.1600-0609.1996.tb00483.x-BIB31|cit31", "doi-asserted-by": "crossref", "first-page": "173", "DOI": "10.1111/j.1600-0609.1992.tb00592.x", "article-title": "PML/RARA rearrangement in acute promyelocytic leukaemias apparently lacking the t(15;17) translocation", "volume": "48", "author": "Coco", "year": "1992", "journal-title": "Eur J Haematol"}, {"key": "10.1111/j.1600-0609.1996.tb00483.x-BIB32|cit32", "first-page": "1615", "article-title": "The t(15;17) translocation in acute promyelocytic leukemia", "volume": "8", "author": "Lavau", "year": "1994", "journal-title": "Leukemia"}, {"key": "10.1111/j.1600-0609.1996.tb00483.x-BIB33|cit33", "doi-asserted-by": "crossref", "first-page": "423", "DOI": "10.1016/0092-8674(93)80044-F", "article-title": "The acute promyelocytic leukemia-specific PML-RAR\u03b1 fusion protein inhibits differentiation and promotes survival of myeloid precursor cells", "volume": "74", "author": "Grignani", "year": "1993", "journal-title": "Cell"}, {"key": "10.1111/j.1600-0609.1996.tb00483.x-BIB34|cit34", "first-page": "545", "article-title": "The PML-RARA gene product of the t(15;17) translocation inhibits retinoic acid-induced granulocytic differentiation and mediated transactivation in human myeloid cells", "volume": "9", "author": "Rousselot", "year": "1994", "journal-title": "Oncogene"}, {"key": "10.1111/j.1600-0609.1996.tb00483.x-BIB35|cit35", "doi-asserted-by": "crossref", "first-page": "359", "DOI": "10.1038/355359a0", "article-title": "9-cis retinoic acid stereoisomer binds and activates the nuclear receptor RXR alpha", "volume": "355", "author": "Levin", "year": "1992", "journal-title": "Nature"}, {"key": "10.1111/j.1600-0609.1996.tb00483.x-BIB36|cit36", "doi-asserted-by": "crossref", "first-page": "397", "DOI": "10.1016/0092-8674(92)90479-V", "article-title": "9-cis retinoic acid is a high affinity ligand for the retinoid X receptor", "volume": "68", "author": "Heyman", "year": "1992", "journal-title": "Cell"}, {"key": "10.1111/j.1600-0609.1996.tb00483.x-BIB37|cit37", "doi-asserted-by": "crossref", "first-page": "3171", "DOI": "10.1002/j.1460-2075.1993.tb05986.x", "article-title": "PMLRAR homodimers: distinct DNA binding properties and heteromeric interactions with RXR", "volume": "12", "author": "Perez", "year": "1993", "journal-title": "EMBO J"}, {"key": "10.1111/j.1600-0609.1996.tb00483.x-BIB38|cit38", "doi-asserted-by": "crossref", "first-page": "224", "DOI": "10.1096/fasebj.2.3.3280376", "article-title": "The vitamin D story: a collaborative effort of basic science and clinical medicine", "volume": "2", "author": "DeLuca", "year": "1988", "journal-title": "FASEB J"}, {"key": "10.1111/j.1600-0609.1996.tb00483.x-BIB39|cit39", "doi-asserted-by": "crossref", "first-page": "6858", "DOI": "10.1128/MCB.14.10.6858", "article-title": "PML, a growth suppressor disrupted in acute promyelocytic leukemia", "volume": "14", "author": "Mu", "year": "1994", "journal-title": "Mol Cell Biol"}, {"key": "10.1111/j.1600-0609.1996.tb00483.x-BIB40|cit40", "doi-asserted-by": "crossref", "first-page": "333", "DOI": "10.1016/0092-8674(94)90340-9", "article-title": "A novel macromolecular structure is a target of the promyelocyte-retinoic acid receptor oncoprotein", "volume": "76", "author": "Dyck", "year": "1994", "journal-title": "Cell"}, {"key": "10.1111/j.1600-0609.1996.tb00483.x-BIB41|cit41", "doi-asserted-by": "crossref", "first-page": "345", "DOI": "10.1016/0092-8674(94)90341-7", "article-title": "Retinoic acid regulates aberrant nuclear localization of PML-RAR\u03b1 in acute promyelocytic leukemia cells", "volume": "76", "author": "Weis", "year": "1994", "journal-title": "Cell"}, {"key": "10.1111/j.1600-0609.1996.tb00483.x-BIB42|cit42", "doi-asserted-by": "crossref", "first-page": "276", "DOI": "10.1038/newbio237276a0", "article-title": "Normal differentiation of myeloid leukemic cells induced by a differentiation-inducing protein", "volume": "237", "author": "Fibach", "year": "1972", "journal-title": "Nature, New Biol."}, {"key": "10.1111/j.1600-0609.1996.tb00483.x-BIB43|cit43", "doi-asserted-by": "crossref", "first-page": "535", "DOI": "10.1038/274535a0", "article-title": "Control of normal cell differentiation and phenotypic reversion of malignancy in myeloid leukemia", "volume": "274", "author": "Sachs", "year": "1978", "journal-title": "Nature"}, {"key": "10.1111/j.1600-0609.1996.tb00483.x-BIB44|cit44", "doi-asserted-by": "crossref", "first-page": "1", "DOI": "10.1016/S0065-230X(08)60250-X", "article-title": "The adventures of a biologist: prenatal diagnosis, hematopoiesis, leukemia, carcinogenesis, and tumor suppression", "volume": "66", "author": "Sachs", "year": "1995", "journal-title": "Adv Cancer Res"}, {"key": "10.1111/j.1600-0609.1996.tb00483.x-BIB45|cit45", "first-page": "41", "article-title": "Regulation by bcl-2, c-myc and p53 of susceptibility to induction of apoptosis by heat shock and cancer chemotherapy compounds in differentiation competent and defective myeloid leukemic cells", "volume": "4", "author": "Lotem", "year": "1993", "journal-title": "Cell Growth Diff"}, {"key": "10.1111/j.1600-0609.1996.tb00483.x-BIB46|cit46", "doi-asserted-by": "crossref", "first-page": "63", "DOI": "10.1038/299063a0", "article-title": "Participation of myeloid of myeloid leukemic cells injected into embryos in hematopoietic differentiation in adult mice", "volume": "299", "author": "Gootwin", "year": "1982", "journal-title": "Nature"}, {"key": "10.1111/j.1600-0609.1996.tb00483.x-BIB47|cit47", "first-page": "1177", "article-title": "Fundamentals of chemo-differentiation therapy of myeloid leukemia", "volume": "14", "author": "Hozumi", "year": "1994", "journal-title": "Anticancer Res"}, {"key": "10.1111/j.1600-0609.1996.tb00483.x-BIB48|cit48", "doi-asserted-by": "crossref", "first-page": "347", "DOI": "10.1038/270347a0", "article-title": "Continuous growth and differentiation of human myeloid leukemic cells in suspension culture", "volume": "270", "author": "Collins", "year": "1977", "journal-title": "Nature"}, {"key": "10.1111/j.1600-0609.1996.tb00483.x-BIB49|cit49", "doi-asserted-by": "crossref", "first-page": "565", "DOI": "10.1002/ijc.2910170504", "article-title": "Establishment and characterization of a human histiocytic lymphoma cell-line (U-937)", "volume": "17", "author": "Sundstr\u00f6m", "year": "1976", "journal-title": "Int J Cancer"}, {"key": "10.1111/j.1600-0609.1996.tb00483.x-BIB50|cit50", "first-page": "321", "article-title": "Human chronic myelogeneous leukemia cell-line with positive Philadelphia chromosome", "volume": "45", "author": "Lozzio", "year": "1975", "journal-title": "Blood"}, {"key": "10.1111/j.1600-0609.1996.tb00483.x-BIB51|cit51", "doi-asserted-by": "crossref", "first-page": "2936", "DOI": "10.1073/pnas.77.5.2936", "article-title": "Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid", "volume": "77", "author": "Breitman", "year": "1980", "journal-title": "Proc Natl Acad Sci"}, {"key": "10.1111/j.1600-0609.1996.tb00483.x-BIB52|cit52", "first-page": "510", "article-title": "Isolation and characterization of a T-lymphocyte derived differentiation inducing factor (DIF) for myeloid leukemic cells", "volume": "63", "author": "Olsson", "year": "1984", "journal-title": "Blood;"}, {"key": "10.1111/j.1600-0609.1996.tb00483.x-BIB53|cit53", "doi-asserted-by": "crossref", "first-page": "1694", "DOI": "10.1172/JCI112764", "article-title": "Effects of recombinant tumor necrosis factor on proliferation and differentiation of leukemic and normal hemopoietic cells in vitro - relationship to cell surface receptor", "volume": "78", "author": "Peetre", "year": "1986", "journal-title": "J Clin Invest"}, {"key": "10.1111/j.1600-0609.1996.tb00483.x-BIB54|cit54", "doi-asserted-by": "crossref", "first-page": "937", "DOI": "10.1016/0006-291X(81)91628-4", "article-title": "1alpha,25-dihydroxyvitamin D3 induces differentiation of human myeloid leukemia cells", "volume": "102", "author": "Miyaura", "year": "1981", "journal-title": "Biochem Biophys Res Commun"}, {"key": "10.1111/j.1600-0609.1996.tb00483.x-BIB55|cit55", "first-page": "5862", "article-title": "Induction of differentiation of the human histiocytic lymphoma cell line U-937 by 1alpha,25-dihydroxycholecalciferol", "volume": "53", "author": "Olsson", "year": "1983", "journal-title": "Cancer Res"}, {"key": "10.1111/j.1600-0609.1996.tb00483.x-BIB56|cit56", "author": "Breitman", "first-page": "257", "year": "1982", "volume-title": "Expression of Differentiated Functions in Cancer Cells"}, {"key": "10.1111/j.1600-0609.1996.tb00483.x-BIB57|cit57", "first-page": "3928", "article-title": "Priming of human myeloid leukemic cell lines (HL-60 and U-937) with retinoic acid for differentiation effects of cyclic AMP-inducing agents and the T-lymphocyte derived differentiation factor", "volume": "42", "author": "Olsson", "year": "1982", "journal-title": "Cancer Res"}, {"key": "10.1111/j.1600-0609.1996.tb00483.x-BIB58|cit58", "first-page": "2643", "article-title": "All-trans retinoic acid as differentiating agent in the treatment of acute promyelocytic leukemia", "volume": "85", "author": "Degos", "year": "1995", "journal-title": "Blood"}, {"key": "10.1111/j.1600-0609.1996.tb00483.x-BIB59|cit59", "doi-asserted-by": "crossref", "first-page": "1138", "DOI": "10.1126/science.1659741", "article-title": "Tumor suppressor genes", "volume": "254", "author": "Weinberg", "year": "1991", "journal-title": "Science"}, {"key": "10.1111/j.1600-0609.1996.tb00483.x-BIB60|cit60", "doi-asserted-by": "crossref", "first-page": "10914", "DOI": "10.1073/pnas.90.23.10914", "article-title": "Antioncogenes and human cancer", "volume": "90", "author": "Knudson", "year": "1993", "journal-title": "Proc Natl Acad Sci"}, {"key": "10.1111/j.1600-0609.1996.tb00483.x-BIB61|cit61", "doi-asserted-by": "crossref", "first-page": "1053", "DOI": "10.1016/0092-8674(91)90557-F", "article-title": "The E2F transcription factor is a cellular target for the Rb protein", "volume": "65", "author": "Srikumar", "year": "1991", "journal-title": "Cell"}, {"key": "10.1111/j.1600-0609.1996.tb00483.x-BIB62|cit62", "doi-asserted-by": "crossref", "first-page": "7813", "DOI": "10.1128/MCB.13.12.7813", "article-title": "The retinoblastoma protein binds to family of E2F transcription factors", "volume": "13", "author": "Lees", "year": "1993", "journal-title": "Mol Cell Biol"}, {"key": "10.1111/j.1600-0609.1996.tb00483.x-BIB63|cit63", "doi-asserted-by": "crossref", "first-page": "323", "DOI": "10.1016/0092-8674(95)90385-2", "article-title": "The retinoblastoma protein and cell cycle control", "volume": "81", "author": "Weinberg", "year": "1995", "journal-title": "Cell"}, {"key": "10.1111/j.1600-0609.1996.tb00483.x-BIB64|cit64", "doi-asserted-by": "crossref", "first-page": "2770", "DOI": "10.1073/pnas.87.7.2770", "article-title": "Expression and the state of phosphorylation of the retinoblastoma susceptibility gene product in cycling and noncycling human hematopoietic cells", "volume": "87", "author": "Furukawa", "year": "1990", "journal-title": "Proc Natl Acad Sci"}, {"key": "10.1111/j.1600-0609.1996.tb00483.x-BIB65|cit65", "doi-asserted-by": "crossref", "first-page": "1193", "DOI": "10.1016/0092-8674(89)90517-5", "article-title": "Phosphorylation of the retinoblastoma gene product is modulated during the cell cycle and cellular differentiation", "volume": "58", "author": "Chen", "year": "1989", "journal-title": "Cell"}, {"key": "10.1111/j.1600-0609.1996.tb00483.x-BIB66|cit66", "doi-asserted-by": "crossref", "first-page": "7195", "DOI": "10.1128/MCB.14.11.7195", "article-title": "Suppression of cyclin-dependent kinase 4 during induced differentiation of erythroleukemia cells", "volume": "14", "author": "Kiyokawa", "year": "1994", "journal-title": "Mol Cell Biol"}, {"key": "10.1111/j.1600-0609.1996.tb00483.x-BIB67|cit67", "doi-asserted-by": "crossref", "first-page": "331", "DOI": "10.1101/gad.7.3.331", "article-title": "Direct binding of cyclin D to the retinoblastoma gene product (pRB) and pRB phosphorylation by the cyclin D-dependent kinase, CDK4", "volume": "7", "author": "Kato", "year": "1993", "journal-title": "Genes Dev"}, {"key": "10.1111/j.1600-0609.1996.tb00483.x-BIB68|cit68", "doi-asserted-by": "crossref", "first-page": "11513", "DOI": "10.1073/pnas.90.24.11513", "article-title": "Inhibition of granulocyte differentiation by G1 cyclins D2 and D3 but not D1", "volume": "90", "author": "Kato", "year": "1993", "journal-title": "Proc Natl Acad Sci"}, {"key": "10.1111/j.1600-0609.1996.tb00483.x-BIB69|cit69", "doi-asserted-by": "crossref", "first-page": "288", "DOI": "10.1038/359288a0", "article-title": "Mice deficient for RB are nonviable and show defects in neurogenesis and hematopoiesis", "volume": "359", "author": "Lee", "year": "1992", "journal-title": "Nature"}, {"key": "10.1111/j.1600-0609.1996.tb00483.x-BIB70|cit70", "doi-asserted-by": "crossref", "first-page": "328", "DOI": "10.1038/359328a0", "article-title": "Requirement for a functional Rb-1 gene in murine development", "volume": "359", "author": "Clarke", "year": "1992", "journal-title": "Nature"}, {"key": "10.1111/j.1600-0609.1996.tb00483.x-BIB71|cit71", "doi-asserted-by": "crossref", "first-page": "295", "DOI": "10.1038/359295a0", "article-title": "Effects of an Rb mutation in the mouse", "volume": "359", "author": "Jacks", "year": "1992", "journal-title": "Nature"}, {"key": "10.1111/j.1600-0609.1996.tb00483.x-BIB72|cit72", "doi-asserted-by": "crossref", "first-page": "309", "DOI": "10.1016/0092-8674(93)90110-C", "article-title": "Interaction of myogenic factors and the retinoblastoma protein mediates muscle cell commitment and differentiation", "volume": "72", "author": "Gu", "year": "1993", "journal-title": "Cell"}, {"key": "10.1111/j.1600-0609.1996.tb00483.x-BIB73|cit73", "doi-asserted-by": "crossref", "first-page": "1467", "DOI": "10.1126/science.8197461", "article-title": "Reversal of the terminal differentiaton mediated by p107 in Rb-/- muscle cells", "volume": "264", "author": "Schneider", "year": "1994", "journal-title": "Science"}, {"key": "10.1111/j.1600-0609.1996.tb00483.x-BIB74|cit74", "doi-asserted-by": "crossref", "first-page": "4808", "DOI": "10.1073/pnas.92.11.4808", "article-title": "Modulation of retinoblastoma gene in normal adult hematopoiesis: peak expression and functional role in advanced erythroid differentiation", "volume": "92", "author": "Condorelli", "year": "1995", "journal-title": "Proc Natl Acad Sci"}, {"key": "10.1111/j.1600-0609.1996.tb00483.x-BIB75|cit75", "doi-asserted-by": "crossref", "first-page": "812", "DOI": "10.1038/375812a0", "article-title": "Mechanism of active transcriptional repression by the retinoblastoma protein", "volume": "375", "author": "Weintraub", "year": "1995", "journal-title": "Nature"}, {"key": "10.1111/j.1600-0609.1996.tb00483.x-BIB76|cit76", "doi-asserted-by": "crossref", "first-page": "1998", "DOI": "10.1073/pnas.91.6.1998", "article-title": "Sequence-specific transcriptional activation is essential for growth suppression by p53", "volume": "91", "author": "Pietenpol", "year": "1994", "journal-title": "Proc Natl Acad Sci"}, {"key": "10.1111/j.1600-0609.1996.tb00483.x-BIB77|cit77", "doi-asserted-by": "crossref", "first-page": "1013", "DOI": "10.1016/0092-8674(94)90379-4", "article-title": "p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest", "volume": "76", "author": "Dulic", "year": "1994", "journal-title": "Cell"}, {"key": "10.1111/j.1600-0609.1996.tb00483.x-BIB78|cit78", "first-page": "1645", "article-title": "Altered conformation of the p53 protein in myeloid leukemia cells and mitogen-stimulated normal blood cells", "volume": "7", "author": "Zhang", "year": "1992", "journal-title": "Oncogene"}, {"key": "10.1111/j.1600-0609.1996.tb00483.x-BIB79|cit79", "doi-asserted-by": "crossref", "first-page": "957", "DOI": "10.1016/0092-8674(93)90719-7", "article-title": "p53-dependent apoptosis modulates the cytotoxity of anticancer agents", "volume": "74", "author": "Lowe", "year": "1993", "journal-title": "Cell"}, {"key": "10.1111/j.1600-0609.1996.tb00483.x-BIB80|cit80", "doi-asserted-by": "crossref", "first-page": "807", "DOI": "10.1126/science.7973635", "article-title": "p53 status and the efficacy of cancer therapy in vivo", "volume": "266", "author": "Lowe", "year": "1994", "journal-title": "Science"}, {"key": "10.1111/j.1600-0609.1996.tb00483.x-BIB81|cit81", "first-page": "3148", "article-title": "p53 Mutations are associated with resistance to chemotherapy and short survival in hematologic malignancies", "volume": "84", "author": "Wattel", "year": "1994", "journal-title": "Blood"}, {"key": "10.1111/j.1600-0609.1996.tb00483.x-BIB82|cit82", "doi-asserted-by": "crossref", "first-page": "215", "DOI": "10.1038/356215a0", "article-title": "Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumors", "volume": "356", "author": "Donehower", "year": "1992", "journal-title": "Nature"}, {"key": "10.1111/j.1600-0609.1996.tb00483.x-BIB83|cit83", "doi-asserted-by": "crossref", "first-page": "8982", "DOI": "10.1073/pnas.88.20.8982", "article-title": "Involvement of wild-type p53 in pre-B-cell differentiation", "volume": "88", "author": "Shaulsky", "year": "1991", "journal-title": "Proc Natl Acad Sci"}, {"key": "10.1111/j.1600-0609.1996.tb00483.x-BIB84|cit84", "first-page": "1853", "article-title": "Expression of normal p53 gene induces differentiation of K-562 cells", "volume": "7", "author": "Feinstein", "year": "1992", "journal-title": "Oncogene"}, {"key": "10.1111/j.1600-0609.1996.tb00483.x-BIB85|cit85", "first-page": "2230", "article-title": "Wild-type p53 gene expression induces granulocytic differentiation of HL-60 cells", "volume": "83", "author": "Soddu", "year": "1994", "journal-title": "Blood"}, {"key": "10.1111/j.1600-0609.1996.tb00483.x-BIB86|cit86", "doi-asserted-by": "crossref", "first-page": "1456", "DOI": "10.1128/MCB.13.3.1456", "article-title": "Growth suppression of Friend virus-transformed erythroleukemia cells by p53 protein is accompanied by hemoglobin production and is sensitive to erythropoietin", "volume": "13", "author": "Johnson", "year": "1993", "journal-title": "Mol Cell Biol"}, {"key": "10.1111/j.1600-0609.1996.tb00483.x-BIB87|cit87", "doi-asserted-by": "crossref", "first-page": "846", "DOI": "10.1096/fasebj.7.10.8344484", "article-title": "Speculations on the role of RB in tissue-specific differentiation, tumor initiation, and tumor progression", "volume": "7", "author": "Hamel", "year": "1993", "journal-title": "FASEB J"}, {"key": "10.1111/j.1600-0609.1996.tb00483.x-BIB88|cit88", "doi-asserted-by": "crossref", "first-page": "533", "DOI": "10.1111/j.1365-2141.1994.tb04783.x", "article-title": "Decreased retinoblastoma protein expression in acute myeloblastic leukemia is associated with the autonomous proliferation of clonogenic blasts", "volume": "86", "author": "Zhu", "year": "1994", "journal-title": "Br J Haemat"}, {"key": "10.1111/j.1600-0609.1996.tb00483.x-BIB89|cit89", "first-page": "256", "article-title": "Levels of retinoblastoma protein expression in newly diagnosed acute myelogenous leukemia", "volume": "84", "author": "Kornblau", "year": "1994", "journal-title": "Blood"}, {"key": "10.1111/j.1600-0609.1996.tb00483.x-BIB90|cit90", "doi-asserted-by": "crossref", "first-page": "502", "DOI": "10.1111/j.1365-2141.1992.tb06459.x", "article-title": "Inactivation of the retinoblastoma gene in acute myelogenous leukaemia", "volume": "82", "author": "Tang", "year": "1992", "journal-title": "Br J Haematol"}, {"key": "10.1111/j.1600-0609.1996.tb00483.x-BIB91|cit91", "first-page": "3259", "article-title": "Abnormalities of the retinoblastoma gene in the pathogensis of acute leukemia", "volume": "78", "author": "Ahuja", "year": "1991", "journal-title": "Blood"}, {"key": "10.1111/j.1600-0609.1996.tb00483.x-BIB92|cit92", "first-page": "2412", "article-title": "p53 in hematologic malignancies", "volume": "84", "author": "Imamura", "year": "1994", "journal-title": "Blood"}, {"key": "10.1111/j.1600-0609.1996.tb00483.x-BIB93|cit93", "first-page": "2391", "article-title": "Structure and function of p53 in normal cells and their abberations in cancer cells: projection on the hematologic cell lineages", "volume": "84", "author": "Prokocimer", "year": "1994", "journal-title": "Blood"}, {"key": "10.1111/j.1600-0609.1996.tb00483.x-BIB94|cit94", "doi-asserted-by": "crossref", "first-page": "827", "DOI": "10.1126/science.1589764", "article-title": "Oncogenic forms of p53 inhibit p53-regulated gene expression", "volume": "256", "author": "Kern", "year": "1992", "journal-title": "Science"}, {"key": "10.1111/j.1600-0609.1996.tb00483.x-BIB95|cit95", "doi-asserted-by": "crossref", "first-page": "139", "DOI": "10.1098/rspb.1991.0100", "article-title": "A conformation hypothesis for the suppressor and promote functions of p53 in cell growth control and in cancer", "volume": "245", "author": "Milner", "year": "1991", "journal-title": "Proc R Soc Lond B"}, {"key": "10.1111/j.1600-0609.1996.tb00483.x-BIB96|cit96", "first-page": "1635", "article-title": "Human wild-type p53 adopts a unique conformational and phophorylation state in vivo during growth arrest of glioblastoma cells", "volume": "7", "author": "Ullrich", "year": "1992", "journal-title": "Oncogene"}, {"key": "10.1111/j.1600-0609.1996.tb00483.x-BIB97|cit97", "unstructured": "Bergh G. Ehinger M. Olsson I. Gullberg U. Expression of antisense cDNA for the retinoblastoma tumor suppressor gene inhibits differentiation responses in the monoblastic cell line U-937 (submitted)"}, {"key": "10.1111/j.1600-0609.1996.tb00483.x-BIB98|cit98", "doi-asserted-by": "crossref", "first-page": "4234", "DOI": "10.1073/pnas.92.10.4234", "article-title": "Study of the role of the retinoblastoma protein in terminal differentiation of murine leukemic cells", "volume": "92", "author": "Zhuo", "year": "1995", "journal-title": "Proc Natl Acad Sci"}, {"key": "10.1111/j.1600-0609.1996.tb00483.x-BIB99|cit99", "first-page": "9", "article-title": "Involvement of tumor suppressor gene p53 in tumor necrosis factor-induced differentiation of the leukemic cell line K-562", "volume": "6", "author": "Ehinger", "year": "1995", "journal-title": "Cell Growth Diff"}, {"key": "10.1111/j.1600-0609.1996.tb00483.x-BIB100|cit100", "first-page": "1064", "article-title": "Expression of the p53 tumor suppressor gene induces differentiation and promotes induction of differentiation by 1,25-dihydroxycholocalciferol in leukemic U937 cells", "volume": "87", "author": "Ehinger", "year": "1996", "journal-title": "Blood"}, {"key": "10.1111/j.1600-0609.1996.tb00483.x-BIB101|cit101", "first-page": "3397", "article-title": "Induction of differentiation in human promyelocytic HL-60 leukemia cells activates p21, WAF1/CIP1, expression in the absence of p53", "volume": "9", "author": "Jiang", "year": "1994", "journal-title": "Oncogene"}, {"key": "10.1111/j.1600-0609.1996.tb00483.x-BIB102|cit102", "first-page": "668", "article-title": "p53-independent induction of WAF1/CIP1 in human leukemia cells is correlated with growth arrest accompanying monocyte/macrophage differentiation", "volume": "55", "author": "Zhang", "year": "1995", "journal-title": "Cancer Res"}, {"key": "10.1111/j.1600-0609.1996.tb00483.x-BIB103|cit103", "first-page": "3781", "article-title": "Absence of WAF1 mutations in a wide variety of human malignancies", "volume": "84", "author": "Shiohara", "year": "1994", "journal-title": "Blood"}, {"key": "10.1111/j.1600-0609.1996.tb00483.x-BIB104|cit104", "doi-asserted-by": "crossref", "first-page": "1174", "DOI": "10.1101/gad.8.10.1174", "article-title": "The DCC gene product in cellular differentiation and colorectal tumorigenesis", "volume": "8", "author": "Hedrick", "year": "1994", "journal-title": "Genes Dev"}, {"key": "10.1111/j.1600-0609.1996.tb00483.x-BIB105|cit105", "first-page": "927", "article-title": "Alterations in the deleted in colon carcinoma gene in human primary leukemia", "volume": "82", "author": "Miyake", "year": "1993", "journal-title": "Blood"}, {"key": "10.1111/j.1600-0609.1996.tb00483.x-BIB106|cit106", "doi-asserted-by": "crossref", "first-page": "635", "DOI": "10.1126/science.2116664", "article-title": "The cellular functions of small GTP-binding proteins", "volume": "249", "author": "Hall", "year": "1990", "journal-title": "Science"}, {"key": "10.1111/j.1600-0609.1996.tb00483.x-BIB107|cit107", "first-page": "1311", "article-title": "Monosomy 7 myeloproliferative disease in children with neurofibromatosis, type 1: epidemiology and molecular analysis", "volume": "79", "author": "Shannon", "year": "1992", "journal-title": "Blood"}, {"key": "10.1111/j.1600-0609.1996.tb00483.x-BIB108|cit108", "doi-asserted-by": "crossref", "first-page": "597", "DOI": "10.1056/NEJM199403033300903", "article-title": "Loss of the normal NF1 allele from the bone marrow of children with type 1 neurofibromatosis and malignant myeloid disorders", "volume": "330", "author": "Shannon", "year": "1994", "journal-title": "N Engl J Med"}, {"key": "10.1111/j.1600-0609.1996.tb00483.x-BIB109|cit109", "doi-asserted-by": "crossref", "first-page": "353", "DOI": "10.1038/ng0794-353", "article-title": "Tumour predisposition in mice heterozygous for a targeted mutation in NF1", "volume": "7", "author": "Jacks", "year": "1994", "journal-title": "Nat Genet"}, {"key": "10.1111/j.1600-0609.1996.tb00483.x-BIB110|cit110", "first-page": "1876", "article-title": "Downregulation of Wilms' tumor gene (wt1) during myelomonocytic differentiation in HL 60 cells", "volume": "83", "author": "Sekiya", "year": "1994", "journal-title": "Blood"}, {"key": "10.1111/j.1600-0609.1996.tb00483.x-BIB111|cit111", "first-page": "667", "article-title": "Wilms' tumor gene, WT1, mRNA is down-regulated during induction of erythroid and megakaryocytic differentiation of K562 cells", "volume": "5", "author": "Phelan", "year": "1994", "journal-title": "Cell Growth Diff"}, {"key": "10.1111/j.1600-0609.1996.tb00483.x-BIB112|cit112", "doi-asserted-by": "crossref", "first-page": "5944", "DOI": "10.1074/jbc.270.11.5944", "article-title": "GATA-1 transactivates the WT1 hematopoietic specific enhancer", "volume": "270", "author": "Wu", "year": "1995", "journal-title": "J Biol Chem"}, {"key": "10.1111/j.1600-0609.1996.tb00483.x-BIB113|cit113", "first-page": "1125", "article-title": "Repression of the retinoic acid receptor-\u03b1 gene by the Wilms' tumor suppressor gene product, wt1", "volume": "10", "author": "Goodyer", "year": "1995", "journal-title": "Oncogene"}, {"key": "10.1111/j.1600-0609.1996.tb00483.x-BIB114|cit114", "doi-asserted-by": "crossref", "first-page": "571", "DOI": "10.1172/JCI115341", "article-title": "Expression of the early growth response 1 and 2 zinc finger genes during induction of monocytic differentiation", "volume": "88", "author": "Kharbanda", "year": "1991", "journal-title": "J Clin Invest"}, {"key": "10.1111/j.1600-0609.1996.tb00483.x-BIB115|cit115", "doi-asserted-by": "crossref", "first-page": "9618", "DOI": "10.1073/pnas.88.21.9618", "article-title": "Alternative splicing and genomic structure of the Wilms' tumor gene wt-1", "volume": "88", "author": "Haber", "year": "1991", "journal-title": "Proc Natl Acad Sci"}, {"key": "10.1111/j.1600-0609.1996.tb00483.x-BIB116|cit116", "doi-asserted-by": "crossref", "first-page": "1550", "DOI": "10.1126/science.1654597", "article-title": "Transcriptional repression mediated by the WT-1 Wilms' tumor gene product", "volume": "253", "author": "Madden", "year": "1991", "journal-title": "Science"}, {"key": "10.1111/j.1600-0609.1996.tb00483.x-BIB117|cit117", "first-page": "1243", "article-title": "WT1, the Wilms' tumor suppressor gene product, represses transcription through an interactive nuclear protein", "volume": "10", "author": "Wang", "year": "1995", "journal-title": "Oncogene"}, {"key": "10.1111/j.1600-0609.1996.tb00483.x-BIB118|cit118", "doi-asserted-by": "crossref", "first-page": "10878", "DOI": "10.1074/jbc.270.18.10878", "article-title": "WT1-mediated transcriptional activation is inhibited by dominant negative mutant proteins", "volume": "270", "author": "Reddy", "year": "1995", "journal-title": "J Biol Chem"}, {"key": "10.1111/j.1600-0609.1996.tb00483.x-BIB119|cit119", "first-page": "415", "article-title": "Products of alternatively spliced transcripts of the Wilms' tumor suppressor gene, wt1, have altered DNA binding specificity and regulate transcription in different ways", "volume": "10", "author": "Wang", "year": "1995", "journal-title": "Oncogene"}, {"key": "10.1111/j.1600-0609.1996.tb00483.x-BIB120|cit120", "doi-asserted-by": "crossref", "first-page": "5100", "DOI": "10.1073/pnas.90.11.5100", "article-title": "Physical and functional interaction between WT1 and p53 proteins", "volume": "90", "author": "Maheswaran", "year": "1993", "journal-title": "Proc Natl Acad Sci"}, {"key": "10.1111/j.1600-0609.1996.tb00483.x-BIB121|cit121", "first-page": "3071", "article-title": "WT1 as a new prognostic factor and a new marker for the detection of minimal residual disease in acute leukemia", "volume": "84", "author": "Inoue", "year": "1994", "journal-title": "Blood"}, {"key": "10.1111/j.1600-0609.1996.tb00483.x-BIB122|cit122", "first-page": "2138", "article-title": "The expression of the Wilms' tumor gene in acute myelocytic leukemias as a possible marker for leukemic blast cells", "volume": "8", "author": "Brieger", "year": "1994", "journal-title": "Leukemia"}], "container-title": ["European Journal of Haematology"], "language": "en", "link": [{"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1600-0609.1996.tb00483.x", "content-type": "unspecified", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 3, 2]], "date-time": "2019-03-02T07:00:37Z", "timestamp": 1551510037000}, "score": 28.612705, "issued": {"date-parts": [[2009, 4, 24]]}, "references-count": 122, "journal-issue": {"issue": "1"}, "URL": "http://dx.doi.org/10.1111/j.1600-0609.1996.tb00483.x", "relation": {"cites": []}, "ISSN": ["0902-4441", "1600-0609"], "issn-type": [{"value": "0902-4441", "type": "print"}, {"value": "1600-0609", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 12, 1]], "date-time": "2019-12-01T17:26:14Z", "timestamp": 1575221174466}, "reference-count": 0, "publisher": "Elsevier BV", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2013, 5, 1]], "date-time": "2013-05-01T00:00:00Z", "timestamp": 1367366400000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Leukemia Research"], "published-print": {"date-parts": [[2013, 5]]}, "DOI": "10.1016/s0145-2126(13)70306-0", "type": "journal-article", "created": {"date-parts": [[2013, 5, 9]], "date-time": "2013-05-09T07:33:39Z", "timestamp": 1368084819000}, "page": "S139", "source": "Crossref", "is-referenced-by-count": 0, "title": ["P-259 Therapy-related MDS after curative intensive therapy for de novo acute myeloid leukemia \u2013 An emerging clinical entity?"], "prefix": "10.1016", "volume": "37", "author": [{"given": "S.", "family": "Helas", "sequence": "first", "affiliation": []}, {"given": "C.", "family": "R\u00f6llig", "sequence": "additional", "affiliation": []}, {"given": "U.", "family": "D\u00fchrsen", "sequence": "additional", "affiliation": []}, {"given": "R.", "family": "Herbst", "sequence": "additional", "affiliation": []}, {"given": "M.", "family": "Schaich", "sequence": "additional", "affiliation": []}, {"given": "C.", "family": "Thiede", "sequence": "additional", "affiliation": []}, {"given": "B.", "family": "Mohr", "sequence": "additional", "affiliation": []}, {"given": "M.", "family": "Kramer", "sequence": "additional", "affiliation": []}, {"given": "K.", "family": "Trautmann-Grill", "sequence": "additional", "affiliation": []}, {"given": "M.", "family": "Von Bonin", "sequence": "additional", "affiliation": []}, {"given": "M.", "family": "Bornh\u00e4user", "sequence": "additional", "affiliation": []}, {"given": "G.", "family": "Ehninger", "sequence": "additional", "affiliation": []}, {"given": "U.", "family": "Platzbecker", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Leukemia Research"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0145212613703060?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0145212613703060?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2018, 10, 16]], "date-time": "2018-10-16T04:27:36Z", "timestamp": 1539664056000}, "score": 28.546103, "issued": {"date-parts": [[2013, 5]]}, "references-count": 0, "alternative-id": ["S0145212613703060"], "URL": "http://dx.doi.org/10.1016/s0145-2126(13)70306-0", "ISSN": ["0145-2126"], "issn-type": [{"value": "0145-2126", "type": "print"}], "subject": ["Cancer Research", "Oncology", "Hematology"]}, {"indexed": {"date-parts": [[2019, 11, 26]], "date-time": "2019-11-26T01:41:03Z", "timestamp": 1574732463166}, "reference-count": 0, "publisher": "American Society for Microbiology", "issue": "8", "content-domain": {"domain": ["asm.org"], "crossmark-restriction": true}, "short-container-title": ["Mol. Cell. Biol."], "published-print": {"date-parts": [[1990, 8]]}, "abstract": "<jats:p>The specific (6;9)(p23;q34) chromosomal translocation is associated with a defined subtype of acute nonlymphocytic leukemia (ANLL). The 9q34 breakpoint is located at the telomeric side of the c-abl gene. Through a combination of chromosome jumping, long-range mapping, and chromosome walking, the chromosome 9 breakpoints of several t(6;9) ANLL patients were localized within a defined region of 8 kilobases (kb), 360 kb telomeric of c-abl. Subsequent cDNA cloning revealed that this region represented an intron in the middle of a gene, called Cain (can), encoding a 7.5-kb transcript. Disruption of the can gene by the translocation resulted in the expression of a new 5.5-kb can mRNA from the 6p- chromosome. Isolation of chromosome 6 sequences showed that breakpoints on 6p23 also clustered within a limited stretch of DNA. These data strongly suggest a direct involvement of the translocation in the leukemic process of t(6;9) ANLL.</jats:p>", "DOI": "10.1128/mcb.10.8.4016", "type": "journal-article", "created": {"date-parts": [[2015, 10, 1]], "date-time": "2015-10-01T21:58:12Z", "timestamp": 1443736692000}, "page": "4016-4026", "update-policy": "http://dx.doi.org/10.1128/asmj-crossmark-policy-page", "source": "Crossref", "is-referenced-by-count": 67, "title": ["The (6;9) chromosome translocation, associated with a specific subtype of acute nonlymphocytic leukemia, leads to aberrant transcription of a target gene on 9q34."], "prefix": "10.1128", "volume": "10", "author": [{"given": "M", "family": "von Lindern", "sequence": "first", "affiliation": []}, {"given": "A", "family": "Poustka", "sequence": "additional", "affiliation": []}, {"given": "H", "family": "Lerach", "sequence": "additional", "affiliation": []}, {"given": "G", "family": "Grosveld", "sequence": "additional", "affiliation": []}], "member": "235", "published-online": {"date-parts": [[1990, 8, 1]]}, "container-title": ["Molecular and Cellular Biology"], "language": "en", "link": [{"URL": "https://syndication.highwire.org/content/doi/10.1128/MCB.10.8.4016", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2016, 12, 23]], "date-time": "2016-12-23T07:39:34Z", "timestamp": 1482478774000}, "score": 27.225515, "issued": {"date-parts": [[1990, 8]]}, "references-count": 0, "journal-issue": {"published-online": {"date-parts": [[1990, 8, 1]]}, "published-print": {"date-parts": [[1990, 8]]}, "issue": "8"}, "alternative-id": ["10.1128/MCB.10.8.4016"], "URL": "http://dx.doi.org/10.1128/mcb.10.8.4016", "ISSN": ["0270-7306", "1098-5549"], "issn-type": [{"value": "0270-7306", "type": "print"}, {"value": "1098-5549", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 20]], "date-time": "2019-11-20T06:30:15Z", "timestamp": 1574231415694}, "reference-count": 24, "publisher": "S. Karger AG", "issue": "3", "license": [{"URL": "https://www.karger.com/Services/SiteLicenses", "start": {"date-parts": [[2006, 1, 1]], "date-time": "2006-01-01T00:00:00Z", "timestamp": 1136073600000}, "delay-in-days": 0, "content-version": "vor"}, {"URL": "https://www.karger.com/Services/SiteLicenses", "start": {"date-parts": [[2006, 1, 1]], "date-time": "2006-01-01T00:00:00Z", "timestamp": 1136073600000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Acta Haematol"], "published-print": {"date-parts": [[2006]]}, "DOI": "10.1159/000094683", "type": "journal-article", "created": {"date-parts": [[2006, 9, 29]], "date-time": "2006-09-29T13:05:50Z", "timestamp": 1159535150000}, "page": "207-210", "source": "Crossref", "is-referenced-by-count": 7, "title": ["Rapid Progression of Myelodysplastic Syndrome to Acute Myeloid Leukemia on Sequential Azathioprine, IFN-\u03b2 and Copolymer-1 in a Patient with Multiple Sclerosis"], "prefix": "10.1159", "volume": "116", "author": [{"given": "Florian", "family": "Then Bergh", "sequence": "first", "affiliation": []}, {"given": "Alexander", "family": "Niklas", "sequence": "additional", "affiliation": []}, {"given": "Angelika", "family": "Strauss", "sequence": "additional", "affiliation": []}, {"given": "Nicolas", "family": "von Ahsen", "sequence": "additional", "affiliation": []}, {"given": "Dietger", "family": "Niederwieser", "sequence": "additional", "affiliation": []}, {"given": "Johannes", "family": "Schwarz", "sequence": "additional", "affiliation": []}, {"given": "Armin", "family": "Wagner", "sequence": "additional", "affiliation": []}, {"given": "Haifa K.", "family": "Al-Ali", "sequence": "additional", "affiliation": []}], "member": "127", "published-online": {"date-parts": [[2006, 10, 6]]}, "reference": [{"key": "sref_1_81", "author": "Markovic-Plese S", "volume": "60", "first-page": "1849", "year": "2003", "journal-title": "Neurology", "DOI": "10.1212/01.WNL.0000071218.34009.AF", "doi-asserted-by": "crossref"}, {"key": "sref_2_82", "author": "Confavreux C", "volume": "46", "first-page": "1607", "year": "1996", "journal-title": "Neurology", "DOI": "10.1212/WNL.46.6.1607", "doi-asserted-by": "crossref"}, {"key": "sref_3_83", "unstructured": "World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, IARC Press, 2001."}, {"key": "sref_4_84", "author": "Schutz E", "volume": "46", "first-page": "1728", "year": "2000", "journal-title": "Clin Chem"}, {"key": "sref_5_85", "author": "Au WY", "volume": "43", "first-page": "1679", "year": "2002", "journal-title": "Leuk Lymphoma", "DOI": "10.1080/1042819021000003027", "doi-asserted-by": "crossref"}, {"key": "sref_6_86", "author": "Willerding-Mollmann S", "volume": "129", "first-page": "1246", "year": "2004", "journal-title": "Dtsch Med Wochenschr", "DOI": "10.1055/s-2004-826853", "doi-asserted-by": "crossref"}, {"key": "sref_7_87", "author": "Offman J", "volume": "104", "first-page": "822", "year": "2004", "journal-title": "Blood", "DOI": "10.1182/blood-2003-11-3938", "doi-asserted-by": "crossref"}, {"key": "sref_8_88", "author": "Kwong YL", "volume": "104", "first-page": "94", "year": "1998", "journal-title": "Cancer Genet Cytogenet", "DOI": "10.1016/S0165-4608(97)00456-1", "doi-asserted-by": "crossref"}, {"key": "sref_9_89", "author": "Knipp S", "volume": "90", "first-page": "691", "year": "2005", "journal-title": "Haematologica"}, {"key": "sref_10_90", "author": "Enright H", "volume": "24", "first-page": "483", "year": "1997", "journal-title": "Leuk Lymphoma", "DOI": "10.3109/10428199709055585", "doi-asserted-by": "crossref"}, {"key": "sref_11_91", "author": "Ohno T", "volume": "40", "first-page": "499", "year": "1999", "journal-title": "Rinsho Ketsueki"}, {"key": "sref_12_92", "DOI": "10.1159/000083454", "doi-asserted-by": "publisher"}, {"key": "sref_13_93", "DOI": "10.1016/0145-2126(91)90028-R", "doi-asserted-by": "publisher"}, {"key": "sref_14_94", "author": "Molldrem JJ", "volume": "137", "first-page": "156", "year": "2002", "journal-title": "Ann Intern Med", "DOI": "10.7326/0003-4819-137-3-200208060-00007", "doi-asserted-by": "crossref"}, {"key": "sref_15_95", "author": "Mundle SD", "volume": "60", "first-page": "36", "year": "1999", "journal-title": "Am J Hematol", "DOI": "10.1002/(SICI)1096-8652(199901)60:1<36::AID-AJH7>3.0.CO;2-#", "doi-asserted-by": "crossref"}, {"key": "sref_16_96", "author": "Greenberg P", "volume": "89", "first-page": "2079", "year": "1997", "journal-title": "Blood"}, {"key": "sref_17_97", "author": "Parmar S", "volume": "15", "first-page": "431", "year": "2003", "journal-title": "Curr Opin Oncol", "DOI": "10.1097/00001622-200311000-00005", "doi-asserted-by": "crossref"}, {"key": "sref_18_98", "author": "Tanvetyanon T", "volume": "37", "first-page": "77", "year": "2003", "journal-title": "Ann Pharmacother", "DOI": "10.1345/aph.1C120", "doi-asserted-by": "crossref"}, {"key": "sref_19_99", "author": "Fayad L", "volume": "11", "first-page": "767", "year": "1997", "journal-title": "Leukemia", "DOI": "10.1038/sj.leu.2400642", "doi-asserted-by": "crossref"}, {"key": "sref_20_100", "author": "Yong VW", "volume": "51", "first-page": "682", "year": "1998", "journal-title": "Neurology", "DOI": "10.1212/WNL.51.3.682", "doi-asserted-by": "crossref"}, {"key": "sref_21_101", "author": "Vicari AM", "volume": "12", "first-page": "441", "year": "1998", "journal-title": "Leukemia", "DOI": "10.1038/sj.leu.2400915", "doi-asserted-by": "crossref"}, {"key": "sref_22_102", "author": "Brassat D", "volume": "59", "first-page": "954", "year": "2002", "journal-title": "Neurology", "DOI": "10.1212/WNL.59.6.954", "doi-asserted-by": "crossref"}, {"key": "sref_23_103", "author": "Gold R", "volume": "12", "first-page": "649", "year": "2005", "journal-title": "Eur J Neurol", "DOI": "10.1111/j.1468-1331.2005.01083.x", "doi-asserted-by": "crossref"}, {"key": "sref_24_104", "author": "Herndon RM", "volume": "11", "first-page": "409", "year": "2005", "journal-title": "Mult Scler", "DOI": "10.1191/1352458505ms1209oa", "doi-asserted-by": "crossref"}], "container-title": ["Acta Haematologica"], "language": "en", "link": [{"URL": "https://www.karger.com/Article/Pdf/94683", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://www.karger.com/Article/Pdf/94683", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 1, 13]], "date-time": "2019-01-13T14:24:03Z", "timestamp": 1547389443000}, "score": 26.822918, "issued": {"date-parts": [[2006]]}, "references-count": 24, "journal-issue": {"published-online": {"date-parts": [[2006, 10, 1]]}, "issue": "3"}, "URL": "http://dx.doi.org/10.1159/000094683", "archive": ["Portico"], "relation": {"cites": []}, "ISSN": ["0001-5792", "1421-9662"], "issn-type": [{"value": "0001-5792", "type": "print"}, {"value": "1421-9662", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 12, 17]], "date-time": "2019-12-17T07:40:33Z", "timestamp": 1576568433377}, "reference-count": 0, "publisher": "American Society of Hematology", "issue": "Supplement_1", "content-domain": {"domain": ["ashpublications.org"], "crossmark-restriction": true}, "published-print": {"date-parts": [[2019, 11, 13]]}, "abstract": "<jats:p>Background:</jats:p>\n               <jats:p>Recent studies in adults revealed the complexity of the genetic profiles of AML blasts that are used for fine-tuning of the risk-adapted treatment regimens. It is known, that recurrent translocations detected at diagnosis are largely preserved at relapse in the AML blasts. However, the molecular landscape and clonal evolution of small indels and missense alterations in the blasts assessed by NGS has not been well analyzed yet for pediatric AML patients, neither for primary and relapsed children and adolescents nor for patients with secondary AML. Here, we present the implications of our amplicon-based targeted sequencing efforts in a large cohort of pediatric patients with de novo AML or secondary AML at diagnosis and relapse.</jats:p>\n               <jats:p>Patients and Methods:</jats:p>\n               <jats:p>In total, samples from 525 AML patients (age &amp;lt;18 years) registered by the AML-BFM study group in Germany from 11/2000 until 04/2019 were analyzed here (de novo AML, n=449; secondary AML, n=13; first relapse n=63). Paired diagnostic and relapse samples were available from 45 patients. Sequencing was performed using the TruSight Myeloid panel (Illumina) on a MiseqDX device detecting somatic alterations in 54 genes associated with myeloid malignancies. On average, we achieved a 500X coverage in \u226595% of the target regions. We excluded intronic, synonymous and variants with an allele frequency below 5% and a read depth below 50 reads. Five-year probabilities of overall survival (pOS) and event-free survival (pEFS) were determined by Kaplan-Meier analysis in SPSS (IBM SPSS Statistics version 25).</jats:p>\n               <jats:p>Results:</jats:p>\n               <jats:p>In this large population of 525 pediatric patients, 632 mutations were detected in 40 out of 54 genes (74%). In total, 448 (80%) mutations in 9 genes (ASXL1, CEBPA, FLT3, KIT, KRAS, NPM1, NRAS, PTPN11 and WT1) were present in \u22653% of de novo AML patients. In \u22653% of relapsed patients, 48 (78%) mutations have been identified in 10 genes (CEBPA, FLT3, KIT, NPM1, NRAS, PHF6, PTPN11, RUNX1, TP53 and WT1). Although patient numbers were limited for secondary AML, data indicate a largely overlapping profile of affected genes. The median number of mutations per patient was low (n=1) in all 3 subgroups. However, 20% of the patients with de novo AML and 12% of relapsed patients had \u2265 3 mutations. Patients with more than 4 mutations have been only identified in de novo AML. The number of mutations per patient did not have a prognostic impact, analyzed in an uniformly treated subgroup of patients (pEFS: p=0.358; pOS: p=0.261). The comparison of paired samples (diagnosis/relapse) revealed the presence of three categories: Mutations only present at diagnosis for de novo AML samples, mutations that persisted through relapse and mutations that were newly gained at relapse. 39% of initially detected mutations (28 out of 72) persisted in the respective relapse samples with the highest stability in CEBPA, FLT3, KIT and WT1. In contrast, 61% (44 out of 72 initial mutations) were not detected and 45% (25 out of 54 relapse mutations) have been gained within the disease progress. The genetic profile changed from de novo AML to relapse in most patients (n = 34; pOS= 41 \u00b1 15%). However, it has been found to be stable in 24% (n = 11; pOS 21\u00b117%; p= 0.49) of the patients.</jats:p>\n               <jats:p>Conclusions:</jats:p>\n               <jats:p>This analysis elucidates the mutational landscape of both pediatric de novo and secondary AML as well as the genetic evolution of pediatric relapsed AML. Very high numbers of mutations per patient only occurred in de novo AML patients. In contrast to the assumed stability of recurrent translocations, the mutational landscape changed during disease progression in most of the patients. Whether these altered clones detectable at relapse were already present at the initial diagnosis, albeit at low frequency, or occurred de novo during treatment is very challenging to answer in pediatric AML due to the often very limited sample sizes. Either new single-cell sequencing approaches and/or analysis after expanding the cells in xenotransplantation models will provide more insights. Of note, modification of the sequencing panel would be beneficial for future studies due to the fact, that 26% of genes included were not affected by mutations.</jats:p>\n               <jats:sec>\n                  <jats:title>Disclosures</jats:title>\n                  <jats:p>Reinhardt: Jazz: Other: Participation in Advisory Boards, Research Funding; Novartis: Other: Participation in Advisory Boards; Roche: Research Funding; CSL Behring: Research Funding.</jats:p>\n               </jats:sec>", "DOI": "10.1182/blood-2019-129778", "type": "journal-article", "created": {"date-parts": [[2019, 11, 14]], "date-time": "2019-11-14T09:42:58Z", "timestamp": 1573724578000}, "page": "1398-1398", "update-policy": "http://dx.doi.org/10.1182/blood.2019cm0000", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Mutational Landscape of Pediatric Acute Myeloid Leukemia: A Report of the AML-BFM Study Group with a Targeted NGS Approach in 525 Patients Integrating De Novo, Relapsed and Secondary AML"], "prefix": "10.1182", "volume": "134", "author": [{"given": "Christiane", "family": "Walter", "sequence": "first", "affiliation": [{"name": "Department of Pediatric Hematology and Oncology, University Hospital Essen, Essen, Germany"}]}, {"given": "Markus", "family": "Schneider", "sequence": "additional", "affiliation": [{"name": "Department of Pediatric Hematology and Oncology, University Hospital Essen, Essen, Germany"}]}, {"given": "Nils", "family": "Von Neuhoff", "sequence": "additional", "affiliation": [{"name": "Department of Pediatric Hematology and Oncology, University Hospital Essen, Essen, Germany"}]}, {"given": "Helmut", "family": "Hanenberg", "sequence": "additional", "affiliation": [{"name": "Department of Pediatric Hematology and Oncology, University Hospital Essen, Essen, Germany"}]}, {"given": "Dirk", "family": "Reinhardt", "sequence": "additional", "affiliation": [{"name": "Department of Pediatric Hematology and Oncology, University Hospital Essen, Essen, Germany"}]}, {"given": "Mareike", "family": "Rasche", "sequence": "additional", "affiliation": [{"name": "Department of Pediatric Hematology and Oncology, University Hospital Essen, Essen, Germany"}]}], "member": "234", "container-title": ["Blood"], "language": "en", "link": [{"URL": "https://ashpublications.org/blood/article/134/Supplement_1/1398/427450/Mutational-Landscape-of-Pediatric-Acute-Myeloid", "content-type": "application/pdf", "content-version": "vor", "intended-application": "syndication"}, {"URL": "https://ashpublications.org/blood/article/134/Supplement_1/1398/427450/Mutational-Landscape-of-Pediatric-Acute-Myeloid", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 12, 17]], "date-time": "2019-12-17T07:14:39Z", "timestamp": 1576566879000}, "score": 26.070553, "issued": {"date-parts": [[2019, 11, 13]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2019, 11, 13]]}, "issue": "Supplement_1"}, "URL": "http://dx.doi.org/10.1182/blood-2019-129778", "ISSN": ["0006-4971", "1528-0020"], "issn-type": [{"value": "0006-4971", "type": "print"}, {"value": "1528-0020", "type": "electronic"}], "subject": ["Immunology", "Cell Biology", "Biochemistry", "Hematology"]}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T19:23:13Z", "timestamp": 1574536993861}, "reference-count": 5, "publisher": "Informa UK Limited", "issue": "4", "content-domain": {"domain": ["www.tandfonline.com"], "crossmark-restriction": true}, "short-container-title": ["Leukemia & Lymphoma"], "published-print": {"date-parts": [[2015, 4, 3]]}, "DOI": "10.3109/10428194.2014.947609", "type": "journal-article", "created": {"date-parts": [[2014, 8, 5]], "date-time": "2014-08-05T12:54:00Z", "timestamp": 1407243240000}, "page": "1182-1183", "update-policy": "http://dx.doi.org/10.1080/tandf_crossmark_01", "source": "Crossref", "is-referenced-by-count": 1, "title": ["The efficacy and tolerability issue of generics of imatinib in the treatment of chronic myeloid leukemia: do generics really jeopardize patient safety?"], "prefix": "10.1080", "volume": "56", "author": [{"given": "Ahmet Emre", "family": "Eskazan", "sequence": "first", "affiliation": []}, {"given": "Muhlis Cem", "family": "Ar", "sequence": "additional", "affiliation": []}, {"given": "Teoman", "family": "Soysal", "sequence": "additional", "affiliation": []}], "member": "301", "published-online": {"date-parts": [[2014, 8, 20]]}, "reference": [{"key": "CIT0001", "author": "Alwan A", "year": "2014", "journal-title": "Leuk Lymphoma"}, {"key": "CIT0002", "author": "Saavedra D", "year": "2014", "journal-title": "Leuk Lymphoma"}, {"key": "CIT0003", "author": "Eskazan AE", "year": "2014", "journal-title": "Leuk Lymphoma"}, {"key": "CIT0004", "author": "Eskazan AE", "year": "2014", "journal-title": "Br J Haematol"}, {"key": "CIT0005", "DOI": "10.1056/NEJMoa062867", "doi-asserted-by": "publisher"}], "container-title": ["Leukemia & Lymphoma"], "language": "en", "link": [{"URL": "http://www.tandfonline.com/doi/pdf/10.3109/10428194.2014.947609", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2016, 12, 15]], "date-time": "2016-12-15T17:47:34Z", "timestamp": 1481824054000}, "score": 26.006845, "issued": {"date-parts": [[2014, 8, 20]]}, "references-count": 5, "journal-issue": {"published-online": {"date-parts": [[2014, 10, 30]]}, "published-print": {"date-parts": [[2015, 4, 3]]}, "issue": "4"}, "alternative-id": ["10.3109/10428194.2014.947609"], "URL": "http://dx.doi.org/10.3109/10428194.2014.947609", "relation": {"cites": []}, "ISSN": ["1042-8194", "1029-2403"], "issn-type": [{"value": "1042-8194", "type": "print"}, {"value": "1029-2403", "type": "electronic"}], "assertion": [{"value": "The publishing and review policy for this title is described in its Aims & Scope.", "order": 1, "name": "peerreview_statement", "label": "Peer Review Statement"}, {"value": "http://www.tandfonline.com/action/journalInformation?show=aimsScope&journalCode=ilal20", "URL": "http://www.tandfonline.com/action/journalInformation?show=aimsScope&journalCode=ilal20", "order": 2, "name": "aims_and_scope_url", "label": "Aim & Scope"}]}, {"indexed": {"date-parts": [[2019, 12, 2]], "date-time": "2019-12-02T02:02:32Z", "timestamp": 1575252152050}, "reference-count": 138, "publisher": "Elsevier BV", "issue": "5", "content-domain": {"domain": ["bloodreviews.com", "elsevier.com", "sciencedirect.com"], "crossmark-restriction": true}, "short-container-title": ["Blood Reviews"], "published-print": {"date-parts": [[2013, 9]]}, "DOI": "10.1016/j.blre.2013.06.006", "type": "journal-article", "created": {"date-parts": [[2013, 7, 18]], "date-time": "2013-07-18T12:47:26Z", "timestamp": 1374151646000}, "page": "209-216", "update-policy": "http://dx.doi.org/10.1016/elsevier_cm_policy", "source": "Crossref", "is-referenced-by-count": 40, "title": ["Immunotherapeutic strategies for relapse control in acute myeloid leukemia"], "prefix": "10.1016", "volume": "27", "author": [{"given": "Anna", "family": "Martner", "sequence": "first", "affiliation": []}, {"given": "Fredrik Bergh", "family": "Thor\u00e9n", "sequence": "additional", "affiliation": []}, {"given": "Johan", "family": "Aurelius", "sequence": "additional", "affiliation": []}, {"given": "Kristoffer", "family": "Hellstrand", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Blood Reviews"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0268960X13000350?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0268960X13000350?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 7, 18]], "date-time": "2019-07-18T18:48:34Z", "timestamp": 1563475714000}, "score": 25.687141, "issued": {"date-parts": [[2013, 9]]}, "references-count": 138, "journal-issue": {"published-print": {"date-parts": [[2013, 9]]}, "issue": "5"}, "alternative-id": ["S0268960X13000350"], "URL": "http://dx.doi.org/10.1016/j.blre.2013.06.006", "ISSN": ["0268-960X"], "issn-type": [{"value": "0268-960X", "type": "print"}], "subject": ["Oncology", "Hematology"], "assertion": [{"value": "Elsevier", "name": "publisher", "label": "This article is maintained by"}, {"value": "Immunotherapeutic strategies for relapse control in acute myeloid leukemia", "name": "articletitle", "label": "Article Title"}, {"value": "Blood Reviews", "name": "journaltitle", "label": "Journal Title"}, {"value": "https://doi.org/10.1016/j.blre.2013.06.006", "name": "articlelink", "label": "CrossRef DOI link to publisher maintained version"}, {"value": "article", "name": "content_type", "label": "Content Type"}, {"value": "Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.", "name": "copyright", "label": "Copyright"}]}, {"indexed": {"date-parts": [[2019, 11, 21]], "date-time": "2019-11-21T11:56:15Z", "timestamp": 1574337375416}, "reference-count": 16, "publisher": "Informa UK Limited", "issue": "12", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Leukemia & Lymphoma"], "published-print": {"date-parts": [[2007, 1]]}, "DOI": "10.1080/10428190701671036", "type": "journal-article", "created": {"date-parts": [[2007, 12, 8]], "date-time": "2007-12-08T06:17:04Z", "timestamp": 1197094624000}, "page": "2418-2423", "source": "Crossref", "is-referenced-by-count": 1, "title": ["Specific pattern of protein expression in acute myeloid leukemia harboring FLT3-ITD mutations"], "prefix": "10.1080", "volume": "48", "author": [{"given": "Sebastian", "family": "Scholl", "sequence": "first", "affiliation": []}, {"given": "Christian", "family": "Melle", "sequence": "additional", "affiliation": []}, {"given": "Annett", "family": "Bleul", "sequence": "additional", "affiliation": []}, {"given": "Baerbel", "family": "Spies-Weisshart", "sequence": "additional", "affiliation": []}, {"given": "Christa", "family": "Kunert", "sequence": "additional", "affiliation": []}, {"given": "Klaus", "family": "H\u00f6ffken", "sequence": "additional", "affiliation": []}, {"given": "Ferdinand", "family": "von Eggeling", "sequence": "additional", "affiliation": []}], "member": "301", "published-online": {"date-parts": [[2009, 7]]}, "reference": [{"key": "CIT0001", "DOI": "10.1016/S0268-960X(03)00040-7", "doi-asserted-by": "publisher"}, {"key": "CIT0002", "DOI": "10.1056/NEJMoa041974", "doi-asserted-by": "publisher"}, {"key": "CIT0003", "author": "Nakao M", "volume": "10", "first-page": "1911", "year": "1996", "journal-title": "Leukemia"}, {"key": "CIT0004", "DOI": "10.1182/blood-2005-06-2248", "doi-asserted-by": "publisher"}, {"key": "CIT0005", "DOI": "10.1182/blood-2005-05-2164", "doi-asserted-by": "publisher"}, {"key": "CIT0006", "DOI": "10.1182/blood.V98.6.1752", "doi-asserted-by": "publisher"}, {"key": "CIT0007", "DOI": "10.1182/blood.V99.12.4326", "doi-asserted-by": "publisher"}, {"key": "CIT0008", "DOI": "10.1038/sj.onc.1205332", "doi-asserted-by": "publisher"}, {"key": "CIT0009", "DOI": "10.1182/blood.V97.8.2434", "doi-asserted-by": "publisher"}, {"key": "CIT0010", "DOI": "10.1046/j.1365-2141.2001.02850.x", "doi-asserted-by": "publisher"}, {"key": "CIT0011", "DOI": "10.1182/blood-2002-05-1440", "doi-asserted-by": "publisher"}, {"key": "CIT0012", "DOI": "10.1158/1078-0432.CCR-04-0307", "doi-asserted-by": "publisher"}, {"key": "CIT0013", "DOI": "10.1038/sj.onc.1209689", "doi-asserted-by": "publisher"}, {"key": "CIT0014", "DOI": "10.1016/j.lab.2005.03.005", "doi-asserted-by": "publisher"}, {"key": "CIT0015", "DOI": "10.1182/blood-2004-11-4430", "doi-asserted-by": "publisher"}, {"key": "CIT0016", "DOI": "10.1182/blood-2002-06-1677", "doi-asserted-by": "publisher"}], "container-title": ["Leukemia & Lymphoma"], "language": "en", "link": [{"URL": "http://www.tandfonline.com/doi/pdf/10.1080/10428190701671036", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2016, 12, 15]], "date-time": "2016-12-15T15:51:39Z", "timestamp": 1481817099000}, "score": 25.376225, "issued": {"date-parts": [[2007, 1]]}, "references-count": 16, "journal-issue": {"published-online": {"date-parts": [[2009, 7]]}, "published-print": {"date-parts": [[2007, 1]]}, "issue": "12"}, "alternative-id": ["10.1080/10428190701671036"], "URL": "http://dx.doi.org/10.1080/10428190701671036", "relation": {"cites": []}, "ISSN": ["1042-8194", "1029-2403"], "issn-type": [{"value": "1042-8194", "type": "print"}, {"value": "1029-2403", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 22]], "date-time": "2019-11-22T14:13:49Z", "timestamp": 1574432029472}, "reference-count": 0, "publisher": "INIST-CNRS", "issue": "4", "content-domain": {"domain": [], "crossmark-restriction": false}, "DOI": "10.4267/2042/38003", "type": "journal-article", "created": {"date-parts": [[2011, 12, 9]], "date-time": "2011-12-09T15:27:44Z", "timestamp": 1323444464000}, "source": "Crossref", "is-referenced-by-count": 0, "title": ["DAB2IP (DAB2 interacting protein)"], "prefix": "10.4267", "author": [{"given": "ARM", "family": "von Bergh", "sequence": "first", "affiliation": []}], "member": "2793", "published-online": {"date-parts": [[2011, 2]]}, "container-title": ["Atlas of Genetics and Cytogenetics in Oncology and Haematology"], "deposited": {"date-parts": [[2011, 12, 9]], "date-time": "2011-12-09T15:30:04Z", "timestamp": 1323444604000}, "score": 24.88057, "issued": {"date-parts": [[2011, 2]]}, "references-count": 0, "journal-issue": {"published-online": {"date-parts": [[2011, 2]]}, "issue": "4"}, "URL": "http://dx.doi.org/10.4267/2042/38003", "ISSN": ["1768-3262"], "issn-type": [{"value": "1768-3262", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 12, 1]], "date-time": "2019-12-01T09:56:11Z", "timestamp": 1575194171132}, "edition-number": "1", "reference-count": 1, "publisher": "CRC Press", "isbn-type": [{"value": "9780429164545", "type": "electronic"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2006, 12, 13]]}, "DOI": "10.3109/9780849379567-7", "type": "book-chapter", "created": {"date-parts": [[2013, 3, 1]], "date-time": "2013-03-01T14:00:15Z", "timestamp": 1362146415000}, "page": "79-94", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Resistance to Imatinib"], "prefix": "10.3109", "author": [{"given": "Duyster", "family": "Justus", "sequence": "first", "affiliation": []}, {"given": "Bubnoff", "family": "Nikolas von", "sequence": "additional", "affiliation": []}], "member": "301", "reference": [{"key": "ref7", "unstructured": "le Coutre P , Tassi E , Varella-Garcia M , et al., and Gambacorti-Passerini C . Induction of resistance to the Abelson inhibitor STI571 in human leukemic cells through gene amplification. Blood 2000; 95:1758\u20131766.", "DOI": "10.1182/blood.V95.5.1758.005a41_1758_1766", "doi-asserted-by": "crossref"}], "container-title": ["Chronic Myeloid Leukemia"], "link": [{"URL": "http://www.crcnetbase.com/doi/pdf/10.3109/9780849379567-7", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 11, 28]], "date-time": "2019-11-28T10:09:33Z", "timestamp": 1574935773000}, "score": 24.871004, "issued": {"date-parts": [[2006, 12, 13]]}, "ISBN": ["9780429164545"], "references-count": 1, "URL": "http://dx.doi.org/10.3109/9780849379567-7", "relation": {"cites": []}}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T12:11:09Z", "timestamp": 1574511069871}, "publisher-location": "New York, NY", "reference-count": 202, "publisher": "Springer New York", "isbn-type": [{"value": "9781441984586", "type": "print"}, {"value": "9781441984593", "type": "electronic"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2011]]}, "DOI": "10.1007/978-1-4419-8459-3_12", "type": "book-chapter", "created": {"date-parts": [[2011, 5, 6]], "date-time": "2011-05-06T19:01:43Z", "timestamp": 1304708503000}, "page": "221-271", "source": "Crossref", "is-referenced-by-count": 3, "title": ["Monoclonal Antibodies in Paediatric Acute Lymphoblastic Leukemia"], "prefix": "10.1007", "author": [{"given": "Arend", "family": "von Stackelberg", "sequence": "first", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2011, 3, 31]]}, "reference": [{"key": "12_CR1_12", "doi-asserted-by": "crossref", "first-page": "495", "DOI": "10.1038/256495a0", "volume": "256", "author": "G Kohler", "year": "1975", "unstructured": "Kohler G, Milstein C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature. 1975;256:495\u2013497.", "journal-title": "Nature."}, {"key": "12_CR2_12", "doi-asserted-by": "crossref", "first-page": "323", "DOI": "10.1038/332323a0", "volume": "332", "author": "L Riechmann", "year": "1988", "unstructured": "Riechmann L, Clark M, Waldmann H, Winter G. Reshaping human antibodies for therapy. Nature. 1988;332:323\u2013327.", "journal-title": "Nature."}, {"key": "12_CR3_12", "doi-asserted-by": "crossref", "first-page": "1986", "DOI": "10.1016/j.molimm.2006.09.029", "volume": "44", "author": "GA Lazar", "year": "2007", "unstructured": "Lazar GA, Desjarlais JR, Jacinto J, Karki S, Hammond PW. A molecular immunology approach to antibody humanization and functional optimization. Mol Immunol. 2007;44:1986\u20131998.", "journal-title": "Mol Immunol."}, {"key": "12_CR4_12", "doi-asserted-by": "crossref", "first-page": "479", "DOI": "10.1016/j.coi.2008.05.010", "volume": "20", "author": "AF Labrijn", "year": "2008", "unstructured": "Labrijn AF, Aalberse RC, Schuurman J. When binding is enough: nonactivating antibody formats. Curr Opin Immunol. 2008;20:479\u2013485.", "journal-title": "Curr Opin Immunol."}, {"key": "12_CR5_12", "doi-asserted-by": "crossref", "first-page": "1", "DOI": "10.2165/00063030-200923010-00001", "volume": "23", "author": "RJ Kreitman", "year": "2009", "unstructured": "Kreitman RJ. Recombinant immunotoxins containing truncated bacterial toxins for the \u00adtreatment of hematologic malignancies. BioDrugs. 2009;23:1\u201313.", "journal-title": "BioDrugs."}, {"key": "12_CR6_12", "doi-asserted-by": "crossref", "first-page": "6300", "DOI": "10.1158/0008-5472.CAN-08-0461", "volume": "68", "author": "X Du", "year": "2008", "unstructured": "Du X, Beers R, Fitzgerald DJ, Pastan I. Differential cellular internalization of anti-CD19 and -CD22 immunotoxins results in different cytotoxic activity. Cancer Res. 2008;68:6300\u20136305.", "journal-title": "Cancer Res."}, {"key": "12_CR7_12", "first-page": "7190", "volume": "62", "author": "P Sapra", "year": "2002", "unstructured": "Sapra P, Allen TM. Internalizing antibodies are necessary for improved therapeutic efficacy of antibody-targeted liposomal drugs. Cancer Res. 2002;62:7190\u20137194.", "journal-title": "Cancer Res."}, {"key": "12_CR8_12", "doi-asserted-by": "crossref", "first-page": "327", "DOI": "10.1055/s-2006-942273", "volume": "218", "author": "S Gudowius", "year": "2006", "unstructured": "Gudowius S, Recker K, Laws HJ, Dirksen U, Troger A, Wieczorek U, Furlan S, Gobel U, Hanenberg H. Identification of candidate target antigens for antibody-based immunotherapy in childhood B-cell precursor ALL. Klin Padiatr. 2006;218:327\u2013333.", "journal-title": "Klin Padiatr."}, {"key": "12_CR9_12", "doi-asserted-by": "crossref", "first-page": "9", "DOI": "10.1016/j.imlet.2004.10.008", "volume": "98", "author": "MC Bene", "year": "2005", "unstructured": "Bene MC. Immunophenotyping of acute leukemias. Immunol Lett. 2005;98:9\u201321.", "journal-title": "Immunol Lett."}, {"key": "12_CR10_12", "doi-asserted-by": "crossref", "first-page": "289", "DOI": "10.1111/j.1365-2141.1988.tb02484.x", "volume": "70", "author": "FW Preijers", "year": "1988", "unstructured": "Preijers FW, Tax WJ, De Witte T, Janssen A, vd Heijden H, Vidal H, Wessels JM, Capel PJ. Relationship between internalization and cytotoxicity of ricin A-chain immunotoxins. Br J Haematol. 1988;70:289\u2013294.", "journal-title": "Br J Haematol."}, {"key": "12_CR11_12", "doi-asserted-by": "crossref", "first-page": "898", "DOI": "10.1016/j.drudis.2007.08.009", "volume": "12", "author": "JR Desjarlais", "year": "2007", "unstructured": "Desjarlais JR, Lazar GA, Zhukovsky EA, Chu SY. Optimizing engagement of the immune system by anti-tumor antibodies: an engineer\u2019s perspective. Drug Discov Today. 2007;12:898\u2013910.", "journal-title": "Drug Discov Today."}, {"key": "12_CR12_12", "doi-asserted-by": "crossref", "first-page": "584", "DOI": "10.1182/blood-2005-12-4997", "volume": "108", "author": "E Mirre van", "year": "2006", "unstructured": "van Mirre E, Breunis WB, Geissler J, Hack CE, de Boer M, Roos D, Kuijpers TW. Neutrophil responsiveness to IgG, as determined by fixed ratios of mRNA levels for activating and inhibitory FcgammaRII (CD32), is stable over time and unaffected by cytokines. Blood. 2006;108:584\u2013590.", "journal-title": "Blood."}, {"key": "12_CR13_12", "doi-asserted-by": "crossref", "first-page": "531", "DOI": "10.4049/jimmunol.166.1.531", "volume": "166", "author": "L Pricop", "year": "2001", "unstructured": "Pricop L, Redecha P, Teillaud JL, Frey J, Fridman WH, Sautes-Fridman C, Salmon JE. Differential modulation of stimulatory and inhibitory Fc gamma receptors on human monocytes by Th1 and Th2 cytokines. J Immunol. 2001;166:531\u2013537.", "journal-title": "J Immunol."}, {"key": "12_CR14_12", "doi-asserted-by": "crossref", "first-page": "11", "DOI": "10.1038/nrc1252", "volume": "4", "author": "G Dranoff", "year": "2004", "unstructured": "Dranoff G. Cytokines in cancer pathogenesis and cancer therapy. Nat Rev Cancer. 2004;4:11\u201322.", "journal-title": "Nat Rev Cancer."}, {"key": "12_CR15_12", "first-page": "5358", "volume": "163", "author": "Y Kashii", "year": "1999", "unstructured": "Kashii Y, Giorda R, Herberman RB, Whiteside TL, Vujanovic NL. Constitutive expression and role of the TNF family ligands in apoptotic killing of tumor cells by human NK cells. J Immunol. 1999;163:5358\u20135366.", "journal-title": "J Immunol."}, {"key": "12_CR16_12", "doi-asserted-by": "crossref", "first-page": "2914", "DOI": "10.1172/JCI24772", "volume": "115", "author": "AM Boruchov", "year": "2005", "unstructured": "Boruchov AM, Heller G, Veri MC, Bonvini E, Ravetch JV, Young JW. Activating and inhibitory IgG Fc receptors on human DCs mediate opposing functions. J Clin Invest. 2005;115:2914\u20132923.", "journal-title": "J Clin Invest."}, {"key": "12_CR17_12", "doi-asserted-by": "crossref", "first-page": "550", "DOI": "10.1046/j.1365-2141.1998.00597.x", "volume": "100", "author": "JM Michon", "year": "1998", "unstructured": "Michon JM, Gey A, Moutel S, Tartour E, Meresse V, Fridman W, Teillaud JL. In vivo induction of functional Fc gammaRI (CD64) on neutrophils and modulation of blood cytokine mRNA levels in cancer patients treated with G-CSF (rMetHuG-CSF). Br J Haematol. 1998;100:550\u2013556.", "journal-title": "Br J Haematol."}, {"key": "12_CR18_12", "doi-asserted-by": "crossref", "first-page": "2147", "DOI": "10.1080/10428190600757944", "volume": "47", "author": "J Rech", "year": "2006", "unstructured": "Rech J, Repp R, Rech D, Stockmeyer B, Dechant M, Niedobitek G, Gramatzki M, Valerius T. A humanized HLA-DR antibody (hu1D10, apolizumab) in combination with granulocyte colony-stimulating factor (filgrastim) for the treatment of non-Hodgkin\u2019s lymphoma: a pilot study. Leuk Lymphoma. 2006;47:2147\u20132154.", "journal-title": "Leuk Lymphoma."}, {"key": "12_CR19_12", "doi-asserted-by": "crossref", "first-page": "465", "DOI": "10.1016/S0093-7754(03)00252-5", "volume": "30", "author": "M Dechant", "year": "2003", "unstructured": "Dechant M, Bruenke J, Valerius T. HLA class II antibodies in the treatment of hematologic malignancies. Semin Oncol. 2003;30:465\u2013475.", "journal-title": "Semin Oncol."}, {"key": "12_CR20_12", "doi-asserted-by": "crossref", "first-page": "124", "DOI": "10.1023/A:1015463811683", "volume": "22", "author": "N Selenko", "year": "2002", "unstructured": "Selenko N, Majdic O, Jager U, Sillaber C, Stockl J, Knapp W. Cross-priming of cytotoxic T cells promoted by apoptosis-inducing tumor cell reactive antibodies? J Clin Immunol. 2002;22:124\u2013130.", "journal-title": "J Clin Immunol."}, {"key": "12_CR21_12", "doi-asserted-by": "crossref", "first-page": "1619", "DOI": "10.1038/sj.leu.2402226", "volume": "15", "author": "N Selenko", "year": "2001", "unstructured": "Selenko N, Maidic O, Draxier S, Berer A, Jager U, Knapp W, Stockl J. CD20 antibody (C2B8)-induced apoptosis of lymphoma cells promotes phagocytosis by dendritic cells and cross-priming of CD8+ cytotoxic T cells. Leukemia. 2001;15:1619-1626.", "journal-title": "Leukemia."}, {"key": "12_CR22_12", "doi-asserted-by": "crossref", "first-page": "2571", "DOI": "10.4049/jimmunol.166.4.2571", "volume": "166", "author": "EE Idusogie", "year": "2001", "unstructured": "Idusogie EE, Wong PY, Presta LG, Gazzano-Santoro H, Totpal K, Ultsch M, Mulkerrin MG. Engineered antibodies with increased activity to recruit complement. J Immunol. 2001;166:2571\u20132575.", "journal-title": "J Immunol."}, {"key": "12_CR23_12", "doi-asserted-by": "crossref", "first-page": "1129", "DOI": "10.4049/jimmunol.177.2.1129", "volume": "177", "author": "WF Dall\u2019Acqua", "year": "2006", "unstructured": "Dall\u2019Acqua WF, Cook KE, Damschroder MM, Woods RM, Wu H. Modulation of the effector functions of a human IgG1 through engineering of its hinge region. J Immunol. 2006;177:1129\u20131138.", "journal-title": "J Immunol."}, {"key": "12_CR24_12", "doi-asserted-by": "crossref", "first-page": "1510", "DOI": "10.1126/science.1118948", "volume": "310", "author": "F Nimmerjahn", "year": "2005", "unstructured": "Nimmerjahn F, Ravetch JV. Divergent immunoglobulin g subclass activity through selective Fc receptor binding. Science. 2005;310:1510\u20131512.", "journal-title": "Science."}, {"key": "12_CR25_12", "doi-asserted-by": "crossref", "first-page": "2517", "DOI": "10.1158/1535-7163.MCT-08-0201", "volume": "7", "author": "JO Richards", "year": "2008", "unstructured": "Richards JO, Karki S, Lazar GA, Chen H, Dang W, Desjarlais JR. Optimization of antibody binding to FcgammaRIIa enhances macrophage phagocytosis of tumor cells. Mol Cancer Ther. 2008;7:2517\u20132527.", "journal-title": "Mol Cancer Ther."}, {"key": "12_CR26_12", "doi-asserted-by": "crossref", "first-page": "4005", "DOI": "10.1073/pnas.0508123103", "volume": "103", "author": "GA Lazar", "year": "2006", "unstructured": "Lazar GA, Dang W, Karki S, Vafa O, Peng JS, Hyun L, Chan C, Chung HS, Eivazi A, Yoder SC, Vielmetter J, Carmichael DF, Hayes RJ, Dahiyat BI. Engineered antibody Fc variants with enhanced effector function. Proc Natl Acad Sci U S A. 2006;103:4005\u20134010.", "journal-title": "Proc Natl Acad Sci U S A."}, {"key": "12_CR27_12", "doi-asserted-by": "crossref", "first-page": "2648", "DOI": "10.1182/blood-2006-04-020057", "volume": "108", "author": "JA Bowles", "year": "2006", "unstructured": "Bowles JA, Wang SY, Link BK, Allan B, Beuerlein G, Campbell MA, Marquis D, Ondek B, Wooldridge JE, Smith BJ, Breitmeyer JB, Weiner GJ. Anti-CD20 monoclonal antibody with enhanced affinity for CD16 activates NK cells at lower concentrations and more effectively than rituximab. Blood. 2006;108:2648\u20132654.", "journal-title": "Blood."}, {"key": "12_CR28_12", "first-page": "1390", "volume": "83", "author": "OW Press", "year": "1994", "unstructured": "Press OW, Howell-Clark J, Anderson S, Bernstein I. Retention of B-cell-specific monoclonal antibodies by human lymphoma cells. Blood. 1994;83:1390\u20131397.", "journal-title": "Blood."}, {"key": "12_CR29_12", "first-page": "2249", "volume": "48", "author": "OW Press", "year": "1988", "unstructured": "Press OW, Hansen JA, Farr A, Martin PJ. Endocytosis and degradation of murine anti-human CD3 monoclonal antibodies by normal and malignant T-lymphocytes. Cancer Res. 1988;48: 2249\u20132257.", "journal-title": "Cancer Res."}, {"key": "12_CR30_12", "doi-asserted-by": "crossref", "first-page": "468", "DOI": "10.1038/sj.leu.2402749", "volume": "17", "author": "CM Zwaan", "year": "2003", "unstructured": "Zwaan CM, Reinhardt D, Jurgens H, Huismans DR, Hahlen K, Smith OP, Biondi A, van Wering ER, Feingold J, Kaspers GJ. Gemtuzumab ozogamicin in pediatric CD33-positive acute lymphoblastic leukemia: first clinical experiences and relation with cellular sensitivity to single agent calicheamicin. Leukemia. 2003;17:468\u2013470.", "journal-title": "Leukemia."}, {"key": "12_CR31_12", "doi-asserted-by": "crossref", "first-page": "988", "DOI": "10.1182/blood.V98.4.988", "volume": "98", "author": "ML Linenberger", "year": "2001", "unstructured": "Linenberger ML, Hong T, Flowers D, Sievers EL, Gooley TA, Bennett JM, Berger MS, Leopold LH, Appelbaum FR, Bernstein ID. Multidrug-resistance phenotype and clinical responses to gemtuzumab ozogamicin. Blood. 2001;98:988\u2013994.", "journal-title": "Blood."}, {"key": "12_CR32_12", "first-page": "325", "volume": "4", "author": "FD Arditti", "year": "2005", "unstructured": "Arditti FD, Rabinkov A, Miron T, Reisner Y, Berrebi A, Wilchek M, Mirelman D. Apoptotic killing of B-chronic lymphocytic leukemia tumor cells by allicin generated in situ using a rituximab-alliinase conjugate. Mol Cancer Ther. 2005;4:325\u2013331.", "journal-title": "Mol Cancer Ther."}, {"key": "12_CR33_12", "first-page": "2123", "volume": "56", "author": "OW Press", "year": "1996", "unstructured": "Press OW, Shan D, Howell-Clark J, Eary J, Appelbaum FR, Matthews D, King DJ, Haines AM, Hamann P, Hinman L, Shochat D, Bernstein ID. Comparative metabolism and retention of iodine-125, yttrium-90, and indium-111 radioimmunoconjugates by cancer cells. Cancer Res. 1996;56:2123\u20132129.", "journal-title": "Cancer Res."}, {"key": "12_CR34_12", "doi-asserted-by": "crossref", "first-page": "226", "DOI": "10.3322/canjclin.56.4.226", "volume": "56", "author": "RM Sharkey", "year": "2006", "unstructured": "Sharkey RM, Goldenberg DM. Targeted therapy of cancer: new prospects for antibodies and immunoconjugates. CA Cancer J Clin. 2006;56:226\u2013243.", "journal-title": "CA Cancer J Clin."}, {"key": "12_CR35_12", "doi-asserted-by": "crossref", "first-page": "S57", "DOI": "10.1016/j.ijrobp.2006.04.058", "volume": "66", "author": "RF Meredith", "year": "2006", "unstructured": "Meredith RF, Buchsbaum DJ. Pretargeted radioimmunotherapy. Int J Radiat Oncol Biol Phys. 2006;66:S57\u201359.", "journal-title": "Int J Radiat Oncol Biol Phys."}, {"key": "12_CR36_12", "doi-asserted-by": "crossref", "first-page": "238", "DOI": "10.1016/j.tibtech.2004.03.006", "volume": "22", "author": "P Kufer", "year": "2004", "unstructured": "Kufer P, Lutterbuse R, Baeuerle PA. A revival of bispecific antibodies. Trends Biotechnol. 2004;22:238\u2013244.", "journal-title": "Trends Biotechnol."}, {"key": "12_CR37_12", "doi-asserted-by": "crossref", "first-page": "763", "DOI": "10.1016/j.molimm.2005.03.007", "volume": "43", "author": "S Offner", "year": "2006", "unstructured": "Offner S, Hofmeister R, Romaniuk A, Kufer P, Baeuerle PA. Induction of regular cytolytic T cell synapses by bispecific single-chain antibody constructs on MHC class I-negative tumor cells. Mol Immunol. 2006;43:763\u2013771.", "journal-title": "Mol Immunol."}, {"key": "12_CR38_12", "doi-asserted-by": "crossref", "first-page": "974", "DOI": "10.1126/science.1158545", "volume": "321", "author": "R Bargou", "year": "2008", "unstructured": "Bargou R, Leo E, Zugmaier G, Klinger M, Goebeler M, Knop S, Noppeney R, Viardot A, Hess G, Schuler M, Einsele H, Brandl C, Wolf A, Kirchinger P, Klappers P, Schmidt M, Riethmuller G, Reinhardt C, Baeuerle PA, Kufer P. Tumor regression in cancer patients by very low doses of a T cell-engaging antibody. Science. 2008;321:974\u2013977.", "journal-title": "Science."}, {"key": "12_CR39_12", "first-page": "2098", "volume": "95", "author": "A Loffler", "year": "2000", "unstructured": "Loffler A, Kufer P, Lutterbuse R, Zettl F, Daniel PT, Schwenkenbecher JM, Riethmuller G, Dorken B, Bargou RC. A recombinant bispecific single-chain antibody, CD19 X CD3, induces rapid and high lymphoma-directed cytotoxicity by unstimulated T lymphocytes. Blood. 2000;95:2098\u20132103.", "journal-title": "Blood."}, {"key": "12_CR40_12", "doi-asserted-by": "crossref", "first-page": "3879", "DOI": "10.1158/1078-0432.CCR-04-2290", "volume": "11", "author": "DA Vallera", "year": "2005", "unstructured": "Vallera DA, Todhunter DA, Kuroki DW, Shu Y, Sicheneder A, Chen H. A bispecific recombinant immunotoxin, DT2219, targeting human CD19 and CD22 receptors in a mouse xenograft model of B-cell leukemia/lymphoma. Clin Cancer Res. 2005;11:3879\u20133888.", "journal-title": "Clin Cancer Res."}, {"key": "12_CR41_12", "unstructured": "WHO Expert Committee on Specifications for Pharmaceutical Preparations. World Health Organ Tech Rep Ser. 2008:1\u2013138."}, {"key": "12_CR42_12", "doi-asserted-by": "crossref", "first-page": "7174", "DOI": "10.1158/1078-0432.CCR-06-1275", "volume": "12", "author": "SJ Rodig", "year": "2006", "unstructured": "Rodig SJ, Abramson JS, Pinkus GS, Treon SP, Dorfman DM, Dong HY, Shipp MA, Kutok JL. Heterogeneous CD52 expression among hematologic neoplasms: implications for the use of alemtuzumab (CAMPATH-1H). Clin Cancer Res. 2006;12:7174\u20137179.", "journal-title": "Clin Cancer Res."}, {"key": "12_CR43_12", "first-page": "322", "volume": "91", "author": "J Golay", "year": "2006", "unstructured": "Golay J, Cortiana C, Manganini M, Cazzaniga G, Salvi A, Spinelli O, Bassan R, Barbui T, Biondi A, Rambaldi A, Introna M. The sensitivity of acute lymphoblastic leukemia cells carrying the t(12;21) translocation to campath-1H-mediated cell lysis. Haematologica. 2006;91:322\u2013330.", "journal-title": "Haematologica."}, {"key": "12_CR44_12", "doi-asserted-by": "crossref", "first-page": "217", "DOI": "10.1016/j.ejphar.2005.03.024", "volume": "514", "author": "H Nuckel", "year": "2005", "unstructured": "Nuckel H, Frey UH, Roth A, Duhrsen U, Siffert W. Alemtuzumab induces enhanced apoptosis in vitro in B-cells from patients with chronic lymphocytic leukemia by antibody-dependent cellular cytotoxicity. Eur J Pharmacol. 2005;514:217\u2013224.", "journal-title": "Eur J Pharmacol."}, {"key": "12_CR45_12", "doi-asserted-by": "crossref", "first-page": "272", "DOI": "10.1038/sj.leu.2404014", "volume": "20", "author": "AP Mone", "year": "2006", "unstructured": "Mone AP, Cheney C, Banks AL, Tridandapani S, Mehter N, Guster S, Lin T, Eisenbeis CF, Young DC, Byrd JC. Alemtuzumab induces caspase-independent cell death in human chronic lymphocytic leukemia cells through a lipid raft-dependent mechanism. Leukemia. 2006;20:272\u2013279.", "journal-title": "Leukemia."}, {"key": "12_CR46_12", "doi-asserted-by": "crossref", "first-page": "818", "DOI": "10.1111/j.1365-2141.2008.07557.x", "volume": "144", "author": "JG Gribben", "year": "2009", "unstructured": "Gribben JG, Hallek M. Rediscovering alemtuzumab: current and emerging therapeutic roles. Br J Haematol. 2009;144:818\u2013831.", "journal-title": "Br J Haematol."}, {"key": "12_CR47_12", "doi-asserted-by": "crossref", "first-page": "220", "DOI": "10.3816/CLM.2004.n.002", "volume": "4", "author": "M Keating", "year": "2004", "unstructured": "Keating M, Coutre S, Rai K, Osterborg A, Faderl S, Kennedy B, Kipps T, Bodey G, Byrd JC, Rosen S, Dearden C, Dyer MJ, Hillmen P. Management guidelines for use of alemtuzumab in B-cell chronic lymphocytic leukemia. Clin Lymphoma. 2004;4:220\u2013227.", "journal-title": "Clin Lymphoma."}, {"key": "12_CR48_12", "doi-asserted-by": "crossref", "first-page": "1245", "DOI": "10.1016/j.bbmt.2008.08.010", "volume": "14", "author": "AA Kennedy-Nasser", "year": "2008", "unstructured": "Kennedy-Nasser AA, Bollard CM, Myers GD, Leung KS, Gottschalk S, Zhang Y, Liu H, Heslop HE, Brenner MK, Krance RA. Comparable outcome of alternative donor and matched sibling donor hematopoietic stem cell transplant for children with acute lymphoblastic leukemia in first or second remission using alemtuzumab in a myeloablative conditioning regimen. Biol Blood Marrow Transplant. 2008;14:1245\u20131252.", "journal-title": "Biol Blood Marrow Transplant."}, {"key": "12_CR49_12", "doi-asserted-by": "crossref", "first-page": "1001", "DOI": "10.1038/sj.bmt.1705164", "volume": "36", "author": "GD Myers", "year": "2005", "unstructured": "Myers GD, Krance RA, Weiss H, Kuehnle I, Demmler G, Heslop HE, Bollard CM. Adenovirus infection rates in pediatric recipients of alternate donor allogeneic bone marrow transplants receiving either antithymocyte globulin (ATG) or alemtuzumab (Campath). Bone Marrow Transplant. 2005;36:1001\u20131008.", "journal-title": "Bone Marrow Transplant."}, {"key": "12_CR50_12", "doi-asserted-by": "crossref", "first-page": "584", "DOI": "10.1016/j.bbmt.2007.01.076", "volume": "13", "author": "AJ Shah", "year": "2007", "unstructured": "Shah AJ, Kapoor N, Crooks GM, Weinberg KI, Azim HA, Killen R, Kuo L, Rushing T, Kohn DB, Parkman R. The effects of Campath 1H upon graft-versus-host disease, infection, relapse, and immune reconstitution in recipients of pediatric unrelated transplants. Biol Blood Marrow Transplant. 2007;13:584\u2013593.", "journal-title": "Biol Blood Marrow Transplant."}, {"key": "12_CR51_12", "first-page": "2208", "volume": "94", "author": "RE Curtis", "year": "1999", "unstructured": "Curtis RE, Travis LB, Rowlings PA, Socie G, Kingma DW, Banks PM, Jaffe ES, Sale GE, Horowitz MM, Witherspoon RP, Shriner DA, Weisdorf DJ, Kolb HJ, Sullivan KM, Sobocinski KA, Gale RP, Hoover RN, Fraumeni JF, Jr., Deeg HJ. Risk of lymphoproliferative disorders after bone marrow transplantation: a multi-institutional study. Blood. 1999;94:2208\u20132216.", "journal-title": "Blood."}, {"key": "12_CR52_12", "doi-asserted-by": "crossref", "first-page": "599", "DOI": "10.1016/j.nucmedbio.2008.03.001", "volume": "35", "author": "M Decker De", "year": "2008", "unstructured": "De Decker M, Bacher K, Thierens H, Slegers G, Dierckx RA, De Vos F. In vitro and in vivo evaluation of direct rhenium-188-labeled anti-CD52 monoclonal antibody alemtuzumab for radioimmunotherapy of B-cell chronic lymphocytic leukemia. Nucl Med Biol. 2008;35:599\u2013604.", "journal-title": "Nucl Med Biol."}, {"key": "12_CR53_12", "doi-asserted-by": "crossref", "first-page": "311", "DOI": "10.1093/nar/gkg070", "volume": "31", "author": "J Robinson", "year": "2003", "unstructured": "Robinson J, Waller MJ, Parham P, de Groot N, Bontrop R, Kennedy LJ, Stoehr P, Marsh SG. IMGT/HLA and IMGT/MHC: sequence databases for the study of the major histocompatibility complex. Nucleic Acids Res. 2003;31:311\u2013314.", "journal-title": "Nucleic Acids Res."}, {"key": "12_CR54_12", "doi-asserted-by": "crossref", "first-page": "556", "DOI": "10.1002/ijc.1366", "volume": "93", "author": "SA Kostelny", "year": "2001", "unstructured": "Kostelny SA, Link BK, Tso JY, Vasquez M, Jorgensen BH, Wang H, Hall WC, Weiner GJ. Humanization and characterization of the anti-HLA-DR antibody 1D10. Int J Cancer. 2001;93:556\u2013565.", "journal-title": "Int J Cancer."}, {"key": "12_CR55_12", "doi-asserted-by": "crossref", "first-page": "959", "DOI": "10.1046/j.1365-2141.2002.03722.x", "volume": "118", "author": "B Stockmeyer", "year": "2002", "unstructured": "Stockmeyer B, Schiller M, Repp R, Lorenz HM, Kalden JR, Gramatzki M, Valerius T. Enhanced killing of B lymphoma cells by granulocyte colony-stimulating factor-primed effector cells and Hu1D10 \u2013 a humanized human leucocyte antigen DR antibody. Br J Haematol. 2002;118:959\u2013967.", "journal-title": "Br J Haematol."}, {"key": "12_CR56_12", "doi-asserted-by": "crossref", "first-page": "921", "DOI": "10.1111/j.1349-7006.2007.00469.x", "volume": "98", "author": "T Tawara", "year": "2007", "unstructured": "Tawara T, Hasegawa K, Sugiura Y, Tahara T, Ishida I, Kataoka S. Fully human antibody exhibits pan-human leukocyte antigen-DR recognition and high in vitro/vivo efficacy against human leukocyte antigen-DR-positive lymphomas. Cancer Sci. 2007;98:921\u2013928.", "journal-title": "Cancer Sci."}, {"key": "12_CR57_12", "doi-asserted-by": "crossref", "first-page": "4903", "DOI": "10.1182/blood-2008-11-187401", "volume": "113", "author": "JM Pagel", "year": "2009", "unstructured": "Pagel JM, Orgun N, Hamlin DK, Wilbur DS, Gooley TA, Gopal AK, Park SI, Green DJ, Lin Y, Press OW. A comparative analysis of conventional and pretargeted radioimmunotherapy of B-cell lymphomas by targeting CD20, CD22, and HLA-DR singly and in combinations. Blood. 2009;113:4903\u20134913.", "journal-title": "Blood."}, {"key": "12_CR58_12", "first-page": "1094", "volume": "79", "author": "FM Uckun", "year": "1992", "unstructured": "Uckun FM, Kersey JH, Haake R, Weisdorf D, Ramsay NK. Autologous bone marrow transplantation in high-risk remission B-lineage acute lymphoblastic leukemia using a cocktail of three monoclonal antibodies (BA-1/CD24, BA-2/CD9, and BA-3/CD10) plus complement and 4-hydroperoxycyclophosphamide for ex vivo bone marrow purging. Blood. 1992;79:1094\u20131104.", "journal-title": "Blood."}, {"key": "12_CR59_12", "doi-asserted-by": "crossref", "first-page": "3190", "DOI": "10.4049/jimmunol.167.6.3190", "volume": "167", "author": "M Hasegawa", "year": "2001", "unstructured": "Hasegawa M, Fujimoto M, Poe JC, Steeber DA, Tedder TF. CD19 can regulate B lymphocyte signal transduction independent of complement activation. J Immunol. 2001;167:3190\u20133200.", "journal-title": "J Immunol."}, {"key": "12_CR60_12", "doi-asserted-by": "crossref", "first-page": "8049", "DOI": "10.1158/0008-5472.CAN-08-2268", "volume": "68", "author": "HM Horton", "year": "2008", "unstructured": "Horton HM, Bernett MJ, Pong E, Peipp M, Karki S, Chu SY, Richards JO, Vostiar I, Joyce PF, Repp R, Desjarlais JR, Zhukovsky EA. Potent in vitro and in vivo activity of an Fc-engineered anti-CD19 monoclonal antibody against lymphoma and leukemia. Cancer Res. 2008;68:8049\u20138057.", "journal-title": "Cancer Res."}, {"key": "12_CR61_12", "first-page": "1424", "volume": "63", "author": "KC Anderson", "year": "1984", "unstructured": "Anderson KC, Bates MP, Slaughenhoupt BL, Pinkus GS, Schlossman SF, Nadler LM. Expression of human B cell-associated antigens on leukemias and lymphomas: a model of human B cell differentiation. Blood. 1984;63:1424\u20131433.", "journal-title": "Blood."}, {"key": "12_CR62_12", "first-page": "13", "volume": "71", "author": "FM Uckun", "year": "1988", "unstructured": "Uckun FM, Jaszcz W, Ambrus JL, Fauci AS, Gajl-Peczalska K, Song CW, Wick MR, Myers DE, Waddick K, Ledbetter JA. Detailed studies on expression and function of CD19 surface determinant by using B43 monoclonal antibody and the clinical potential of anti-CD19 immunotoxins. Blood. 1988;71:13\u201329.", "journal-title": "Blood."}, {"key": "12_CR63_12", "doi-asserted-by": "crossref", "first-page": "107", "DOI": "10.1016/S1074-7613(00)80418-5", "volume": "6", "author": "TF Tedder", "year": "1997", "unstructured": "Tedder TF, Inaoki M, Sato S. The CD19-CD21 complex regulates signal transduction thresholds governing humoral immunity and autoimmunity. Immunity. 1997;6:107\u2013118.", "journal-title": "Immunity."}, {"key": "12_CR64_12", "doi-asserted-by": "crossref", "first-page": "15178", "DOI": "10.1073/pnas.0505539102", "volume": "102", "author": "N Yazawa", "year": "2005", "unstructured": "Yazawa N, Hamaguchi Y, Poe JC, Tedder TF. Immunotherapy using unconjugated CD19 monoclonal antibodies in animal models for B lymphocyte malignancies and autoimmune disease. Proc Natl Acad Sci U S A. 2005;102:15178\u201315183.", "journal-title": "Proc Natl Acad Sci U S A."}, {"key": "12_CR65_12", "first-page": "37", "volume": "40", "author": "LT Vlasveld", "year": "1995", "unstructured": "Vlasveld LT, Hekman A, Vyth-Dreese FA, Melief CJ, Sein JJ, Voordouw AC, Dellemijn TA, Rankin EM. Treatment of low-grade non-Hodgkin\u2019s lymphoma with continuous infusion of low-dose recombinant interleukin-2 in combination with the B-cell-specific monoclonal antibody CLB-CD19. Cancer Immunol Immunother. 1995;40:37\u201347.", "journal-title": "Cancer Immunol Immunother."}, {"key": "12_CR66_12", "doi-asserted-by": "crossref", "first-page": "364", "DOI": "10.1007/BF01741331", "volume": "32", "author": "A Hekman", "year": "1991", "unstructured": "Hekman A, Honselaar A, Vuist WM, Sein JJ, Rodenhuis S, ten Bokkel Huinink WW, Somers R, Rumke P, Melief CJ. Initial experience with treatment of human B cell lymphoma with anti-CD19 monoclonal antibody. Cancer Immunol Immunother. 1991;32:364\u2013372.", "journal-title": "Cancer Immunol Immunother."}, {"key": "12_CR67_12", "doi-asserted-by": "crossref", "first-page": "726", "DOI": "10.1200/JCO.1993.11.4.726", "volume": "11", "author": "ML Grossbard", "year": "1993", "unstructured": "Grossbard ML, Lambert JM, Goldmacher VS, Spector NL, Kinsella J, Eliseo L, Coral F, Taylor JA, Blattler WA, Epstein CL, et al. Anti-B4-blocked ricin: a phase I trial of 7-day continuous infusion in patients with B-cell neoplasms. J Clin Oncol. 1993;11:726\u2013737.", "journal-title": "J Clin Oncol."}, {"key": "12_CR68_12", "first-page": "2599", "volume": "4", "author": "PS Multani", "year": "1998", "unstructured": "Multani PS, O\u2019Day S, Nadler LM, Grossbard ML. Phase II clinical trial of bolus infusion anti-B4 blocked ricin immunoconjugate in patients with relapsed B-cell non-Hodgkin\u2019s lymphoma. Clin Cancer Res. 1998;4:2599\u20132604.", "journal-title": "Clin Cancer Res."}, {"key": "12_CR69_12", "doi-asserted-by": "crossref", "first-page": "195", "DOI": "10.1007/BF01525435", "volume": "37", "author": "AJ Rowland", "year": "1993", "unstructured": "Rowland AJ, Pietersz GA, McKenzie IF. Preclinical investigation of the antitumour effects of anti-CD19-idarubicin immunoconjugates. Cancer Immunol Immunother. 1993;37:195\u2013202.", "journal-title": "Cancer Immunol Immunother."}, {"key": "12_CR70_12", "doi-asserted-by": "crossref", "first-page": "2530", "DOI": "10.1158/1078-0432.CCR-03-0376", "volume": "10", "author": "P Sapra", "year": "2004", "unstructured": "Sapra P, Allen TM. Improved outcome when B-cell lymphoma is treated with combinations of immunoliposomal anticancer drugs targeted to both the CD19 and CD20 epitopes. Clin Cancer Res. 2004;10:2530\u20132537.", "journal-title": "Clin Cancer Res."}, {"key": "12_CR71_12", "doi-asserted-by": "crossref", "first-page": "1405", "DOI": "10.1038/sj.leu.2404687", "volume": "21", "author": "M Schwemmlein", "year": "2007", "unstructured": "Schwemmlein M, Stieglmaier J, Kellner C, Peipp M, Saul D, Oduncu F, Emmerich B, Stockmeyer B, Lang P, Beck JD, Fey GH. A CD19-specific single-chain immunotoxin mediates potent apoptosis of B-lineage leukemic cells. Leukemia. 2007;21:1405\u20131412.", "journal-title": "Leukemia."}, {"key": "12_CR72_12", "first-page": "46", "volume": "140", "author": "GS Ingle", "year": "2008", "unstructured": "Ingle GS, Chan P, Elliott JM, Chang WS, Koeppen H, Stephan JP, Scales SJ. High CD21 expression inhibits internalization of anti-CD19 antibodies and cytotoxicity of an anti-CD19-drug conjugate. Br J Haematol. 2008;140:46\u201358.", "journal-title": "Br J Haematol."}, {"key": "12_CR73_12", "doi-asserted-by": "crossref", "first-page": "4352", "DOI": "10.1182/blood-2008-09-179143", "volume": "113", "author": "HP Gerber", "year": "2009", "unstructured": "Gerber HP, Kung-Sutherland M, Stone I, Morris-Tilden C, Miyamoto J, McCormick R, Alley SC, Okeley N, Hayes B, Hernandez-Ilizaliturri FJ, McDonagh CF, Carter PJ, Benjamin D, Grewal IS. Potent antitumor activity of the anti-CD19 auristatin antibody drug conjugate hBU12-vcMMAE against rituximab-sensitive and -resistant lymphomas. Blood. 2009;113:4352\u20134361.", "journal-title": "Blood."}, {"key": "12_CR74_12", "doi-asserted-by": "crossref", "first-page": "233", "DOI": "10.1007/s00262-007-0370-8", "volume": "57", "author": "J Stieglmaier", "year": "2008", "unstructured": "Stieglmaier J, Bremer E, Kellner C, Liebig TM, ten Cate B, Peipp M, Schulze-Koops H, Pfeiffer M, Buhring HJ, Greil J, Oduncu F, Emmerich B, Fey GH, Helfrich W. Selective induction of apoptosis in leukemic B-lymphoid cells by a CD19-specific TRAIL fusion protein. Cancer Immunol Immunother. 2008;57:233\u2013246.", "journal-title": "Cancer Immunol Immunother."}, {"key": "12_CR75_12", "doi-asserted-by": "crossref", "first-page": "1935", "DOI": "10.1016/j.molimm.2006.09.032", "volume": "44", "author": "M Molhoj", "year": "2007", "unstructured": "Molhoj M, Crommer S, Brischwein K, Rau D, Sriskandarajah M, Hoffmann P, Kufer P, Hofmeister R, Baeuerle PA. CD19-/CD3-bispecific antibody of the BiTE class is far superior to tandem diabody with respect to redirected tumor cell lysis. Mol Immunol. 2007;44:1935\u20131943.", "journal-title": "Mol Immunol."}, {"key": "12_CR76_12", "doi-asserted-by": "crossref", "first-page": "1551", "DOI": "10.1007/s00262-007-0298-z", "volume": "56", "author": "C Brandl", "year": "2007", "unstructured": "Brandl C, Haas C, d\u2019Argouges S, Fisch T, Kufer P, Brischwein K, Prang N, Bargou R, Suzich J, Baeuerle PA, Hofmeister R. The effect of dexamethasone on polyclonal T cell activation and redirected target cell lysis as induced by a CD19/CD3-bispecific single-chain antibody construct. Cancer Immunol Immunother. 2007;56:1551\u20131563.", "journal-title": "Cancer Immunol Immunother."}, {"key": "12_CR77_12", "doi-asserted-by": "crossref", "first-page": "465", "DOI": "10.1016/j.leukres.2008.08.025", "volume": "33", "author": "S d\u2019Argouges", "year": "2008", "unstructured": "d\u2019Argouges S, Wissing S, Brandl C, Prang N, Lutterbuese R, Kozhich A, Suzich J, Locher M, Kiener P, Kufer P, Hofmeister R, Baeuerle PA, Bargou RC. Combination of rituximab with blinatumomab (MT103/MEDI-538), a T cell-engaging CD19-/CD3-bispecific antibody, for highly efficient lysis of human B lymphoma cells. Leuk Res. 2008;33:465\u2013473.", "journal-title": "Leuk Res"}, {"key": "12_CR78_12", "first-page": "1926", "volume": "112", "author": "M Topp", "year": "2008", "unstructured": "Topp M, Goekbuget N, Kufer P, Zugmaier G, Degenhard E, Neumann S, Horst HA, Viardot A, Schmid M, Ottmann OG, Schmidt M, Reinhardt C, Baeuerle PA, Nagorsen D, Hoelzer D, Bargou RC. Treatment with Anti-CD19 BiTE Antibody Blinatumomab (MT103 / MEDI-538) Is Able to Eliminate Minimal Residual Disease (MRD) in Patients with B-Precursor Acute Lymphoblastic Leukemia (ALL): First Results of An Ongoing Phase II Study. ASH Annual Meeting Abstracts. 2008;112:1926.", "journal-title": "ASH Annual Meeting Abstracts."}, {"key": "12_CR79_12", "doi-asserted-by": "crossref", "first-page": "871", "DOI": "10.1097/CJI.0b013e318186c8b4", "volume": "31", "author": "C Kellner", "year": "2008", "unstructured": "Kellner C, Bruenke J, Stieglmaier J, Schwemmlein M, Schwenkert M, Singer H, Mentz K, Peipp M, Lang P, Oduncu F, Stockmeyer B, Fey GH. A novel CD19-directed recombinant bispecific antibody derivative with enhanced immune effector functions for human leukemic cells. J Immunother. 2008;31:871\u2013884.", "journal-title": "J Immunother."}, {"key": "12_CR80_12", "doi-asserted-by": "crossref", "first-page": "140", "DOI": "10.1159/000082102", "volume": "8", "author": "MS Cragg", "year": "2005", "unstructured": "Cragg MS, Walshe CA, Ivanov AO, Glennie MJ. The biology of CD20 and its potential as a target for mAb therapy. Curr Dir Autoimmun. 2005;8:140\u2013174.", "journal-title": "Curr Dir Autoimmun."}, {"key": "12_CR81_12", "doi-asserted-by": "crossref", "first-page": "16971", "DOI": "10.1074/jbc.M708459200", "volume": "283", "author": "CA Walshe", "year": "2008", "unstructured": "Walshe CA, Beers SA, French RR, Chan CH, Johnson PW, Packham GK, Glennie MJ, Cragg MS. Induction of cytosolic calcium flux by CD20 is dependent upon B Cell antigen receptor signaling. J Biol Chem. 2008;283:16971\u201316984.", "journal-title": "J Biol Chem."}, {"key": "12_CR82_12", "doi-asserted-by": "crossref", "first-page": "881", "DOI": "10.1002/eji.1830160802", "volume": "16", "author": "TF Tedder", "year": "1986", "unstructured": "Tedder TF, Forsgren A, Boyd AW, Nadler LM, Schlossman SF. Antibodies reactive with the B1 molecule inhibit cell cycle progression but not activation of human B lymphocytes. Eur J Immunol. 1986;16:881\u2013887.", "journal-title": "Eur J Immunol."}, {"key": "12_CR83_12", "doi-asserted-by": "crossref", "first-page": "439", "DOI": "10.1111/j.1365-2249.2005.02720.x", "volume": "139", "author": "E Janas", "year": "2005", "unstructured": "Janas E, Priest R, Wilde JI, White JH, Malhotra R. Rituxan (anti-CD20 antibody)-induced translocation of CD20 into lipid rafts is crucial for calcium influx and apoptosis. Clin Exp Immunol. 2005;139:439\u2013446.", "journal-title": "Clin Exp Immunol."}, {"key": "12_CR84_12", "doi-asserted-by": "crossref", "first-page": "4170", "DOI": "10.1182/blood-2008-04-149161", "volume": "112", "author": "SA Beers", "year": "2008", "unstructured": "Beers SA, Chan CH, James S, French RR, Attfield KE, Brennan CM, Ahuja A, Shlomchik MJ, Cragg MS, Glennie MJ. Type II (tositumomab) anti-CD20 monoclonal antibody out performs type I (rituximab-like) reagents in B-cell depletion regardless of complement activation. Blood. 2008;112:4170\u20134177.", "journal-title": "Blood."}, {"key": "12_CR85_12", "doi-asserted-by": "crossref", "first-page": "235", "DOI": "10.1056/NEJMoa011795", "volume": "346", "author": "B Coiffier", "year": "2002", "unstructured": "Coiffier B, Lepage E, Briere J, Herbrecht R, Tilly H, Bouabdallah R, Morel P, Van Den Neste E, Salles G, Gaulard P, Reyes F, Lederlin P, Gisselbrecht C. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. N Engl J Med. 2002;346:235\u2013242.", "journal-title": "N Engl J Med."}, {"key": "12_CR86_12", "doi-asserted-by": "crossref", "first-page": "897", "DOI": "10.1038/sj.leu.2404613", "volume": "21", "author": "P Rhein", "year": "2007", "unstructured": "Rhein P, Scheid S, Ratei R, Hagemeier C, Seeger K, Kirschner-Schwabe R, Moericke A, Schrappe M, Spang R, Ludwig WD, Karawajew L. Gene expression shift towards normal B cells, decreased proliferative capacity and distinct surface receptors characterize leukemic blasts persisting during induction therapy in childhood acute lymphoblastic leukemia. Leukemia. 2007;21:897\u2013905.", "journal-title": "Leukemia."}, {"key": "12_CR87_12", "doi-asserted-by": "crossref", "first-page": "3982", "DOI": "10.1182/blood-2008-06-164129", "volume": "112", "author": "MN Dworzak", "year": "2008", "unstructured": "Dworzak MN, Schumich A, Printz D, Potschger U, Husak Z, Attarbaschi A, Basso G, Gaipa G, Ratei R, Mann G, Gadner H. CD20 up-regulation in pediatric B-cell precursor acute lymphoblastic leukemia during induction treatment: setting the stage for anti-CD20 directed immunotherapy. Blood. 2008;112:3982\u20133988.", "journal-title": "Blood."}, {"key": "12_CR88_12", "doi-asserted-by": "crossref", "first-page": "327", "DOI": "10.1097/00043426-200304000-00013", "volume": "25", "author": "S Corbacioglu", "year": "2003", "unstructured": "Corbacioglu S, Eber S, Gungor T, Hummerjohann J, Niggli F. Induction of long-term \u00adremission of a relapsed childhood B-acute lymphoblastic leukemia with rituximab chimeric anti-CD20 monoclonal antibody and autologous stem cell transplantation. J Pediatr Hematol Oncol. 2003;25:327\u2013329.", "journal-title": "J Pediatr Hematol Oncol."}, {"key": "12_CR89_12", "first-page": "272", "volume": "91", "author": "A Claviez", "year": "2006", "unstructured": "Claviez A, Eckert C, Seeger K, Schrauder A, Schrappe M, Henze G, von Stackelberg A. Rituximab plus chemotherapy in children with relapsed or refractory CD20-positive B-cell precursor acute lymphoblastic leukemia. Haematologica. 2006;91:272\u2013273.", "journal-title": "Haematologica."}, {"key": "12_CR90_12", "doi-asserted-by": "crossref", "first-page": "344", "DOI": "10.1111/j.1365-2141.2007.06814.x", "volume": "139", "author": "ES Morris", "year": "2007", "unstructured": "Morris ES, Vora A. Remission induction with single agent Rituximab in a child with multiply relapsed precursor-B ALL. Br J Haematol. 2007;139:344\u2013345.", "journal-title": "Br J Haematol."}, {"key": "12_CR91_12", "doi-asserted-by": "crossref", "first-page": "2825", "DOI": "10.1200/JCO.1998.16.8.2825", "volume": "16", "author": "P McLaughlin", "year": "1998", "unstructured": "McLaughlin P, Grillo-Lopez AJ, Link BK, Levy R, Czuczman MS, Williams ME, Heyman MR, Bence-Bruckler I, White CA, Cabanillas F, Jain V, Ho AD, Lister J, Wey K, Shen D, Dallaire BK. Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program. J Clin Oncol. 1998;16:2825\u20132833.", "journal-title": "J Clin Oncol."}, {"key": "12_CR92_12", "doi-asserted-by": "crossref", "first-page": "17", "DOI": "10.1097/MOP.0b013e3282f424b0", "volume": "20", "author": "D Attias", "year": "2008", "unstructured": "Attias D, Weitzman S. The efficacy of rituximab in high-grade pediatric B-cell lymphoma/leukemia: a review of available evidence. Curr Opin Pediatr. 2008;20:17\u201322.", "journal-title": "Curr Opin Pediatr."}, {"key": "12_CR93_12", "doi-asserted-by": "crossref", "first-page": "701", "DOI": "10.1016/j.beha.2006.06.008", "volume": "19", "author": "N Gokbuget", "year": "2006", "unstructured": "Gokbuget N, Hoelzer D. Novel antibody-based therapy for acute lymphoblastic leukemia. Best Pract Res Clin Haematol. 2006;19:701\u2013713.", "journal-title": "Best Pract Res Clin Haematol."}, {"key": "12_CR94_12", "doi-asserted-by": "crossref", "first-page": "372", "DOI": "10.1002/pbc.21388", "volume": "50", "author": "F Kiss", "year": "2008", "unstructured": "Kiss F, Buslig J, Szegedi I, Scholtz B, Kappelmayer J, Kiss C. Early relapse after rituximab chemoimmunotherapy. Pediatr Blood Cancer. 2008;50:372\u2013375.", "journal-title": "Pediatr Blood Cancer."}, {"key": "12_CR95_12", "unstructured": "Kraal K, Schalij-Delfos N, van Buchem M, Egeler M, Ball L. Optic nerve relapse in a child with common acute lymphoblastic leukemia, treated with systemic anti-CD-20 (rituximab). Haematologica. 2005;90 Suppl:ECR24."}, {"key": "12_CR96_12", "first-page": "ECR23", "volume": "91", "author": "G Seifert", "year": "2006", "unstructured": "Seifert G, Reindl T, Lobitz S, Seeger K, Henze G. Fatal course after administration of rituximab in a boy with relapsed all: a case report and review of literature. Haematologica. 2006;91:ECR23.", "journal-title": "Haematologica"}, {"key": "12_CR97_12", "doi-asserted-by": "crossref", "first-page": "1062", "DOI": "10.1182/blood-2008-07-168146", "volume": "113", "author": "DM Goldenberg", "year": "2009", "unstructured": "Goldenberg DM, Rossi EA, Stein R, Cardillo TM, Czuczman MS, Hernandez-Ilizaliturri FJ, Hansen HJ, Chang CH. Properties and structure-function relationships of veltuzumab (hA20), a humanized anti-CD20 monoclonal antibody. Blood. 2009;113:1062\u20131070.", "journal-title": "Blood."}, {"key": "12_CR98_12", "doi-asserted-by": "crossref", "first-page": "3346", "DOI": "10.1200/JCO.2008.19.9117", "volume": "27", "author": "F Morschhauser", "year": "2009", "unstructured": "Morschhauser F, Leonard JP, Fayad L, Coiffier B, Petillon MO, Coleman M, Schuster SJ, Dyer MJ, Horne H, Teoh N, Wegener WA, Goldenberg DM. Humanized anti-CD20 antibody, veltuzumab, in refractory/recurrent non-Hodgkin\u2019s lymphoma: phase I/II results. J Clin Oncol. 2009;27:3346\u20133353.", "journal-title": "J Clin Oncol."}, {"key": "12_CR99_12", "first-page": "29", "volume": "31", "author": "M Nishida", "year": "2007", "unstructured": "Nishida M, Usuda S, Okabe M, Miyakoda H, Komatsu M, Hanaoka H, Teshigawara K, Niwa O. Characterization of novel murine anti-CD20 monoclonal antibodies and their comparison to 2B8 and c2B8 (rituximab). Int J Oncol. 2007;31:29\u201340.", "journal-title": "Int J Oncol."}, {"key": "12_CR100_12", "doi-asserted-by": "crossref", "first-page": "1263", "DOI": "10.3892/ijo_32_6_1263", "volume": "32", "author": "M Nishida", "year": "2008", "unstructured": "Nishida M, Teshigawara K, Niwa O, Usuda S, Nakamura T, Ralph P, Newman R, Padlan EA. Novel humanized anti-CD20 monoclonal antibodies with unique germline VH and VL gene recruitment and potent effector functions. Int J Oncol. 2008;32:1263\u20131274.", "journal-title": "Int J Oncol."}, {"key": "12_CR101_12", "doi-asserted-by": "crossref", "first-page": "1793", "DOI": "10.1182/blood-2004-01-0039", "volume": "104", "author": "JL Teeling", "year": "2004", "unstructured": "Teeling JL, French RR, Cragg MS, van den Brakel J, Pluyter M, Huang H, Chan C, Parren PW, Hack CE, Dechant M, Valerius T, van de Winkel JG, Glennie MJ. Characterization of new human CD20 monoclonal antibodies with potent cytolytic activity against non-Hodgkin lymphomas. Blood. 2004;104:1793\u20131800.", "journal-title": "Blood."}, {"key": "12_CR102_12", "doi-asserted-by": "crossref", "first-page": "5486", "DOI": "10.1182/blood-2007-10-117671", "volume": "111", "author": "A Hagenbeek", "year": "2008", "unstructured": "Hagenbeek A, Gadeberg O, Johnson P, Pedersen LM, Walewski J, Hellmann A, Link BK, Robak T, Wojtukiewicz M, Pfreundschuh M, Kneba M, Engert A, Sonneveld P, Flensburg M, Petersen J, Losic N, Radford J. First clinical use of ofatumumab, a novel fully human anti-CD20 monoclonal antibody in relapsed or refractory follicular lymphoma: results of a phase 1/2 trial. Blood. 2008;111:5486\u20135495.", "journal-title": "Blood."}, {"key": "12_CR103_12", "doi-asserted-by": "crossref", "first-page": "2211", "DOI": "10.1182/blood-2007-08-110072", "volume": "111", "author": "Z Qu", "year": "2008", "unstructured": "Qu Z, Goldenberg DM, Cardillo TM, Shi V, Hansen HJ, Chang CH. Bispecific anti-CD20/22 antibodies inhibit B-cell lymphoma proliferation by a unique mechanism of action. Blood. 2008;111:2211\u20132219.", "journal-title": "Blood."}, {"key": "12_CR104_12", "doi-asserted-by": "crossref", "first-page": "6161", "DOI": "10.1182/blood-2008-10-187138", "volume": "113", "author": "EA Rossi", "year": "2009", "unstructured": "Rossi EA, Goldenberg DM, Cardillo TM, Stein R, Chang CH. Hexavalent bispecific antibodies represent a new class of anticancer therapeutics: 1. Properties of anti-CD20/CD22 antibodies in lymphoma. Blood. 2009;113:6161\u20136171.", "journal-title": "Blood."}, {"key": "12_CR105_12", "doi-asserted-by": "crossref", "first-page": "452", "DOI": "10.1016/j.exphem.2005.01.007", "volume": "33", "author": "JM Gall", "year": "2005", "unstructured": "Gall JM, Davol PA, Grabert RC, Deaver M, Lum LG. T cells armed with anti-CD3 x anti-CD20 bispecific antibody enhance killing of CD20+ malignant B cells and bypass complement-mediated rituximab resistance in vitro. Exp Hematol. 2005;33:452\u2013459.", "journal-title": "Exp Hematol."}, {"key": "12_CR106_12", "doi-asserted-by": "crossref", "first-page": "29", "DOI": "10.1016/S0304-3835(01)00758-3", "volume": "177", "author": "D Xiong", "year": "2002", "unstructured": "Xiong D, Xu Y, Liu H, Peng H, Shao X, Lai Z, Fan D, Yang M, Han J, Xie Y, Yang C, Zhu Z. Efficient inhibition of human B-cell lymphoma xenografts with an anti-CD20 x anti-CD3 bispecific diabody. Cancer Lett. 2002;177:29\u201339.", "journal-title": "Cancer Lett."}, {"key": "12_CR107_12", "doi-asserted-by": "crossref", "first-page": "1181", "DOI": "10.1002/ijc.23626", "volume": "123", "author": "M Stanglmaier", "year": "2008", "unstructured": "Stanglmaier M, Faltin M, Ruf P, Bodenhausen A, Schroder P, Lindhofer H. Bi20 (fBTA05), a novel trifunctional bispecific antibody (anti-CD20 X anti-CD3), mediates efficient killing of B-cell lymphoma cells even with very low CD20 expression levels. Int J Cancer. 2008;123:1181\u20131189.", "journal-title": "Int J Cancer."}, {"key": "12_CR108_12", "doi-asserted-by": "crossref", "first-page": "383", "DOI": "10.1038/bmt.2008.323", "volume": "43", "author": "R Buhmann", "year": "2009", "unstructured": "Buhmann R, Simoes B, Stanglmaier M, Yang T, Faltin M, Bund D, Lindhofer H, Kolb HJ. Immunotherapy of recurrent B-cell malignancies after allo-SCT with Bi20 (FBTA05), a trifunctional anti-CD3 \u00b4 anti-CD20 antibody and donor lymphocyte infusion. Bone Marrow Transplant. 2009;43:383\u2013397.", "journal-title": "Bone Marrow Transplant."}, {"issue": "18", "key": "12_CR109_12", "doi-asserted-by": "crossref", "first-page": "3864", "DOI": "10.1182/blood-2009-06-228890", "volume": "114", "author": "EA Rossi", "year": "2009", "unstructured": "Rossi EA, Goldenberg DM, Cardillo TM, Stein R, Chang CH. CD20-targeted tetrameric interferon-{alpha}, a novel and potent immunocytokine for the therapy of B-cell lymphomas. Blood. 2009;114(18):3864\u20133871.", "journal-title": "Blood."}, {"issue": "Suppl 1", "key": "12_CR110_12", "first-page": "128S", "volume": "46", "author": "RL Wahl", "year": "2005", "unstructured": "Wahl RL. Tositumomab and (131)I therapy in non-Hodgkin\u2019s lymphoma. J Nucl Med. 2005;46 Suppl 1:128S\u2013140S.", "journal-title": "J Nucl Med."}, {"key": "12_CR111_12", "doi-asserted-by": "crossref", "first-page": "2453", "DOI": "10.1200/JCO.2002.11.076", "volume": "20", "author": "TE Witzig", "year": "2002", "unstructured": "Witzig TE, Gordon LI, Cabanillas F, Czuczman MS, Emmanouilides C, Joyce R, Pohlman BL, Bartlett NL, Wiseman GA, Padre N, Grillo-Lopez AJ, Multani P, White CA. Randomized controlled trial of yttrium-90-labeled ibritumomab tiuxetan radioimmunotherapy versus rituximab immunotherapy for patients with relapsed or refractory low-grade, follicular, or transformed B-cell non-Hodgkin\u2019s lymphoma. J Clin Oncol. 2002;20:2453\u20132463.", "journal-title": "J Clin Oncol."}, {"key": "12_CR112_12", "doi-asserted-by": "crossref", "first-page": "90", "DOI": "10.1200/JCO.2007.11.9248", "volume": "26", "author": "A Krishnan", "year": "2008", "unstructured": "Krishnan A, Nademanee A, Fung HC, Raubitschek AA, Molina A, Yamauchi D, Rodriguez R, Spielberger RT, Falk P, Palmer JM, Forman SJ. Phase II trial of a transplantation regimen of yttrium-90 ibritumomab tiuxetan and high-dose chemotherapy in patients with non-Hodgkin\u2019s lymphoma. J Clin Oncol. 2008;26:90\u201395.", "journal-title": "J Clin Oncol."}, {"key": "12_CR113_12", "doi-asserted-by": "crossref", "first-page": "1767", "DOI": "10.2967/jnumed.107.043489", "volume": "48", "author": "HA Jacene", "year": "2007", "unstructured": "Jacene HA, Filice R, Kasecamp W, Wahl RL. Comparison of 90Y-ibritumomab tiuxetan and 131I-tositumomab in clinical practice. J Nucl Med. 2007;48:1767\u20131776.", "journal-title": "J Nucl Med."}, {"key": "12_CR114_12", "doi-asserted-by": "crossref", "first-page": "5652s", "DOI": "10.1158/1078-0432.CCR-07-1060", "volume": "13", "author": "E Cooney-Qualter", "year": "2007", "unstructured": "Cooney-Qualter E, Krailo M, Angiolillo A, Fawwaz RA, Wiseman G, Harrison L, Kohl V, Adamson PC, Ayello J, vande Ven C, Perkins SL, Cairo MS. A phase I study of 90yttrium-ibritumomab-tiuxetan in children and adolescents with relapsed/refractory CD20-positive non-Hodgkin\u2019s lymphoma: a Children\u2019s Oncology Group study. Clin Cancer Res. 2007;13: 5652s\u20135660s.", "journal-title": "Clin Cancer Res"}, {"key": "12_CR115_12", "doi-asserted-by": "crossref", "first-page": "128", "DOI": "10.1111/j.1600-065X.2009.00801.x", "volume": "230", "author": "L Nitschke", "year": "2009", "unstructured": "Nitschke L. CD22 and Siglec-G: B-cell inhibitory receptors with distinct functions. Immunol Rev. 2009;230:128\u2013143.", "journal-title": "Immunol Rev."}, {"key": "12_CR116_12", "doi-asserted-by": "crossref", "first-page": "1", "DOI": "10.1016/S0065-2776(05)88001-0", "volume": "88", "author": "TF Tedder", "year": "2005", "unstructured": "Tedder TF, Poe JC, Haas KM. CD22: a multifunctional receptor that regulates B lymphocyte survival and signal transduction. Adv Immunol. 2005;88:1\u201350.", "journal-title": "Adv Immunol."}, {"key": "12_CR117_12", "doi-asserted-by": "crossref", "first-page": "832", "DOI": "10.1158/1078-0432.CCR-08-1456", "volume": "15", "author": "RF Alderson", "year": "2009", "unstructured": "Alderson RF, Kreitman RJ, Chen T, Yeung P, Herbst R, Fox JA, Pastan I. CAT-8015: a second-generation pseudomonas exotoxin A-based immunotherapy targeting CD22-expressing hematologic malignancies. Clin Cancer Res. 2009;15:832\u2013839.", "journal-title": "Clin Cancer Res."}, {"key": "12_CR118_12", "first-page": "4719", "volume": "150", "author": "P Engel", "year": "1993", "unstructured": "Engel P, Nojima Y, Rothstein D, Zhou LJ, Wilson GL, Kehrl JH, Tedder TF. The same epitope on CD22 of B lymphocytes mediates the adhesion of erythrocytes, T and B lymphocytes, neutrophils, and monocytes. J Immunol. 1993;150:4719\u20134732.", "journal-title": "J Immunol."}, {"key": "12_CR119_12", "doi-asserted-by": "crossref", "first-page": "1331", "DOI": "10.1016/j.molimm.2006.05.007", "volume": "44", "author": "J Carnahan", "year": "2007", "unstructured": "Carnahan J, Stein R, Qu Z, Hess K, Cesano A, Hansen HJ, Goldenberg DM. Epratuzumab, a CD22-targeting recombinant humanized antibody with a different mode of action from rituximab. Mol Immunol. 2007;44:1331\u20131341.", "journal-title": "Mol Immunol."}, {"key": "12_CR120_12", "doi-asserted-by": "crossref", "first-page": "5327", "DOI": "10.1158/1078-0432.CCR-04-0294", "volume": "10", "author": "JP Leonard", "year": "2004", "unstructured": "Leonard JP, Coleman M, Ketas JC, Chadburn A, Furman R, Schuster MW, Feldman EJ, Ashe M, Schuster SJ, Wegener WA, Hansen HJ, Ziccardi H, Eschenberg M, Gayko U, Fields SZ, Cesano A, Goldenberg DM. Epratuzumab, a humanized anti-CD22 antibody, in aggressive non-Hodgkin\u2019s lymphoma: phase I/II clinical trial results. Clin Cancer Res. 2004;10:5327\u20135334.", "journal-title": "Clin Cancer Res."}, {"key": "12_CR121_12", "doi-asserted-by": "crossref", "first-page": "3051", "DOI": "10.1200/JCO.2003.01.082", "volume": "21", "author": "JP Leonard", "year": "2003", "unstructured": "Leonard JP, Coleman M, Ketas JC, Chadburn A, Ely S, Furman RR, Wegener WA, Hansen HJ, Ziccardi H, Eschenberg M, Gayko U, Cesano A, Goldenberg DM. Phase I/II trial of epratuzumab (humanized anti-CD22 antibody) in indolent non-Hodgkin\u2019s lymphoma. J Clin Oncol. 2003;21:3051\u20133059.", "journal-title": "J Clin Oncol."}, {"key": "12_CR122_12", "doi-asserted-by": "crossref", "first-page": "2714", "DOI": "10.1002/cncr.23890", "volume": "113", "author": "JP Leonard", "year": "2008", "unstructured": "Leonard JP, Schuster SJ, Emmanouilides C, Couture F, Teoh N, Wegener WA, Coleman M, Goldenberg DM. Durable complete responses from therapy with combined epratuzumab and rituximab: final results from an international multicenter, phase 2 study in recurrent, indolent, non-Hodgkin lymphoma. Cancer. 2008;113:2714\u20132723.", "journal-title": "Cancer."}, {"key": "12_CR123_12", "doi-asserted-by": "crossref", "first-page": "3756", "DOI": "10.1200/JCO.2007.15.3528", "volume": "26", "author": "EA Raetz", "year": "2008", "unstructured": "Raetz EA, Cairo MS, Borowitz MJ, Blaney SM, Krailo MD, Leil TA, Reid JM, Goldenberg DM, Wegener WA, Carroll WL, Adamson PC. Chemoimmunotherapy reinduction with epratuzumab in children with acute lymphoblastic leukemia in marrow relapse: a Children\u2019s Oncology Group Pilot Study. J Clin Oncol. 2008;26:3756\u20133762.", "journal-title": "J Clin Oncol."}, {"key": "12_CR124_12", "first-page": "2368", "volume": "152", "author": "GL Shen", "year": "1994", "unstructured": "Shen GL, Li JL, Vitetta ES. Bispecific anti-CD22/anti-CD3-ricin A chain immunotoxin is cytotoxic to Daudi lymphoma cells but not T cells in vitro and shows both A-chain-mediated and LAK-T-mediated killing. J Immunol. 1994;152:2368\u20132376.", "journal-title": "J Immunol."}, {"key": "12_CR125_12", "first-page": "4310", "volume": "53", "author": "H Bohlen", "year": "1993", "unstructured": "Bohlen H, Manzke O, Patel B, Moldenhauer G, Dorken B, von Fliedner V, Diehl V, Tesch H. Cytolysis of leukemic B-cells by T-cells activated via two bispecific antibodies. Cancer Res. 1993;53:4310\u20134314.", "journal-title": "Cancer Res."}, {"key": "12_CR126_12", "first-page": "3015", "volume": "53", "author": "MA Bonardi", "year": "1993", "unstructured": "Bonardi MA, French RR, Amlot P, Gromo G, Modena D, Glennie MJ. Delivery of saporin to human B-cell lymphoma using bispecific antibody: targeting via CD22 but not CD19, CD37, or immunoglobulin results in efficient killing. Cancer Res. 1993;53:3015\u20133021.", "journal-title": "Cancer Res."}, {"key": "12_CR127_12", "doi-asserted-by": "crossref", "first-page": "223", "DOI": "10.1016/S0140-6736(95)91271-1", "volume": "346", "author": "RR French", "year": "1995", "unstructured": "French RR, Hamblin TJ, Bell AJ, Tutt AL, Glennie MJ. Treatment of B-cell lymphomas with combination of bispecific antibodies and saporin. Lancet. 1995;346:223\u2013224.", "journal-title": "Lancet."}, {"key": "12_CR128_12", "doi-asserted-by": "crossref", "first-page": "2718", "DOI": "10.1182/blood-2003-04-1317", "volume": "103", "author": "T Decker", "year": "2004", "unstructured": "Decker T, Oelsner M, Kreitman RJ, Salvatore G, Wang QC, Pastan I, Peschel C, Licht T. Induction of caspase-dependent programmed cell death in B-cell chronic lymphocytic leukemia by anti-CD22 immunotoxins. Blood. 2004;103:2718\u20132726.", "journal-title": "Blood."}, {"key": "12_CR129_12", "doi-asserted-by": "crossref", "first-page": "241", "DOI": "10.1056/NEJM200107263450402", "volume": "345", "author": "RJ Kreitman", "year": "2001", "unstructured": "Kreitman RJ, Wilson WH, Bergeron K, Raggio M, Stetler-Stevenson M, FitzGerald DJ, Pastan I. Efficacy of the anti-CD22 recombinant immunotoxin BL22 in chemotherapy-resistant hairy-cell leukemia. N Engl J Med. 2001;345:241\u2013247.", "journal-title": "N Engl J Med."}, {"key": "12_CR130_12", "doi-asserted-by": "crossref", "first-page": "6719", "DOI": "10.1200/JCO.2005.11.437", "volume": "23", "author": "RJ Kreitman", "year": "2005", "unstructured": "Kreitman RJ, Squires DR, Stetler-Stevenson M, Noel P, FitzGerald DJ, Wilson WH, Pastan I. Phase I trial of recombinant immunotoxin RFB4(dsFv)-PE38 (BL22) in patients with B-cell malignancies. J Clin Oncol. 2005;23:6719\u20136729.", "journal-title": "J Clin Oncol."}, {"key": "12_CR131_12", "doi-asserted-by": "crossref", "first-page": "1894", "DOI": "10.1158/1078-0432.CCR-09-2980", "volume": "16", "author": "AS Wayne", "year": "2010", "unstructured": "Wayne AS, Kreitman RJ, Findley HW, Lew G, Delbrook C, Steinberg SM, Stetler-Stevenson M, Fitzgerald DJ, Pastan I. Anti-CD22 immunotoxin RFB4(dsFv)-PE38 (BL22) for CD22-positive hematologic malignancies of childhood: preclinical studies and phase I clinical trial. Clin Cancer Res. 2010;16:1894\u20131903.", "journal-title": "Clin Cancer Res"}, {"key": "12_CR132_12", "doi-asserted-by": "crossref", "first-page": "2240", "DOI": "10.1038/sj.leu.2404866", "volume": "21", "author": "JF Dijoseph", "year": "2007", "unstructured": "Dijoseph JF, Dougher MM, Armellino DC, Evans DY, Damle NK. Therapeutic potential of CD22-specific antibody-targeted chemotherapy using inotuzumab ozogamicin (CMC-544) for the treatment of acute lymphoblastic leukemia. Leukemia. 2007;21:2240\u20132245.", "journal-title": "Leukemia."}, {"key": "12_CR133_12", "doi-asserted-by": "crossref", "first-page": "242", "DOI": "10.1158/1078-0432.CCR-05-1905", "volume": "12", "author": "JF DiJoseph", "year": "2006", "unstructured": "DiJoseph JF, Dougher MM, Kalyandrug LB, Armellino DC, Boghaert ER, Hamann PR, Moran JK, Damle NK. Antitumor efficacy of a combination of CMC-544 (inotuzumab ozogamicin), a CD22-targeted cytotoxic immunoconjugate of calicheamicin, and rituximab against non-Hodgkin\u2019s B-cell lymphoma. Clin Cancer Res. 2006;12:242\u2013249.", "journal-title": "Clin Cancer Res."}, {"key": "12_CR134_12", "doi-asserted-by": "crossref", "first-page": "91", "DOI": "10.3109/10428190009060322", "volume": "38", "author": "JM Vose", "year": "2000", "unstructured": "Vose JM, Colcher D, Gobar L, Bierman PJ, Augustine S, Tempero M, Leichner P, Lynch JC, Goldenberg D, Armitage JO. Phase I/II trial of multiple dose 131Iodine-MAb LL2 (CD22) in patients with recurrent non-Hodgkin\u2019s lymphoma. Leuk Lymphoma. 2000;38:91\u2013101.", "journal-title": "Leuk Lymphoma."}, {"key": "12_CR135_12", "first-page": "3287s", "volume": "5", "author": "O Linden", "year": "1999", "unstructured": "Linden O, Tennvall J, Cavallin-Stahl E, Darte L, Garkavij M, Lindner KJ, Ljungberg M, Ohlsson T, Sjogreen K, Wingardh K, Strand SE. Radioimmunotherapy using 131I-labeled anti-CD22 monoclonal antibody (LL2) in patients with previously treated B-cell lymphomas. Clin Cancer Res. 1999;5:3287s\u20133291s.", "journal-title": "Clin Cancer Res."}, {"key": "12_CR136_12", "doi-asserted-by": "crossref", "first-page": "5215", "DOI": "10.1158/1078-0432.CCR-05-0172", "volume": "11", "author": "O Linden", "year": "2005", "unstructured": "Linden O, Hindorf C, Cavallin-Stahl E, Wegener WA, Goldenberg DM, Horne H, Ohlsson T, Stenberg L, Strand SE, Tennvall J. Dose-fractionated radioimmunotherapy in non-Hodgkin\u2019s lymphoma using DOTA-conjugated, 90Y-radiolabeled, humanized anti-CD22 monoclonal antibody, epratuzumab. Clin Cancer Res. 2005;11:5215\u20135222.", "journal-title": "Clin Cancer Res."}, {"key": "12_CR137_12", "doi-asserted-by": "crossref", "first-page": "6154", "DOI": "10.1158/1078-0432.CCR-08-0404", "volume": "14", "author": "MJ Mattes", "year": "2008", "unstructured": "Mattes MJ, Sharkey RM, Karacay H, Czuczman MS, Goldenberg DM. Therapy of advanced B-lymphoma xenografts with a combination of 90Y-anti-CD22 IgG (epratuzumab) and unlabeled anti-CD20 IgG (veltuzumab). Clin Cancer Res. 2008;14:6154\u20136160.", "journal-title": "Clin Cancer Res."}, {"key": "12_CR138_12", "doi-asserted-by": "crossref", "first-page": "2961", "DOI": "10.4049/jimmunol.181.5.2961", "volume": "181", "author": "Y Li", "year": "2008", "unstructured": "Li Y, Chen F, Putt M, Koo YK, Madaio M, Cambier JC, Cohen PL, Eisenberg RA. B cell depletion with anti-CD79 mAbs ameliorates autoimmune disease in MRL/lpr mice. J Immunol. 2008;181:2961\u20132972.", "journal-title": "J Immunol."}, {"key": "12_CR139_12", "doi-asserted-by": "crossref", "first-page": "616", "DOI": "10.1182/blood-2007-01-066704", "volume": "110", "author": "AG Polson", "year": "2007", "unstructured": "Polson AG, Yu SF, Elkins K, Zheng B, Clark S, Ingle GS, Slaga DS, Giere L, Du C, Tan C, Hongo JA, Gogineni A, Cole MJ, Vandlen R, Stephan JP, Young J, Chang W, Scales SJ, Ross S, Eaton D, Ebens A. Antibody-drug conjugates targeted to CD79 for the treatment of non-Hodgkin lymphoma. Blood. 2007;110:616\u2013623.", "journal-title": "Blood."}, {"key": "12_CR140_12", "doi-asserted-by": "crossref", "first-page": "235", "DOI": "10.1080/15476910802129661", "volume": "5", "author": "JC Morris", "year": "2008", "unstructured": "Morris JC, Waldmann TA, Janik JE. Receptor-directed therapy of T-cell leukemias and lymphomas. J Immunotoxicol. 2008;5:235\u2013248.", "journal-title": "J Immunotoxicol."}, {"key": "12_CR141_12", "first-page": "4879", "volume": "49", "author": "KK Matthay", "year": "1989", "unstructured": "Matthay KK, Abai AM, Cobb S, Hong K, Papahadjopoulos D, Straubinger RM. Role of ligand in antibody-directed endocytosis of liposomes by human T-leukemia cells. Cancer Res. 1989;49:4879\u20134886.", "journal-title": "Cancer Res."}, {"key": "12_CR142_12", "doi-asserted-by": "crossref", "first-page": "284", "DOI": "10.1182/blood-2002-11-3601", "volume": "102", "author": "Z Zhang", "year": "2003", "unstructured": "Zhang Z, Zhang M, Ravetch JV, Goldman C, Waldmann TA. Effective therapy for a murine model of adult T-cell leukemia with the humanized anti-CD2 monoclonal antibody, MEDI-507. Blood. 2003;102:284\u2013288.", "journal-title": "Blood."}, {"key": "12_CR143_12", "doi-asserted-by": "crossref", "first-page": "1588", "DOI": "10.1097/00007890-199911270-00026", "volume": "68", "author": "L Branco", "year": "1999", "unstructured": "Branco L, Barren P, Mao SY, Pfarr D, Kaplan R, Postema C, Langermann S, Koenig S, Johnson S. Selective deletion of antigen-specific, activated T cells by a humanized MAB to CD2 (MEDI-507) is mediated by NK cells. Transplantation. 1999;68:1588\u20131596.", "journal-title": "Transplantation."}, {"key": "12_CR144_12", "doi-asserted-by": "crossref", "first-page": "198", "DOI": "10.1097/TP.0b013e3181abfbf7", "volume": "88", "author": "D Adkins", "year": "2009", "unstructured": "Adkins D, Ratanatharathorn V, Yang H, White B. Safety profile and clinical outcomes in a phase I, placebo-controlled study of siplizumab in acute graft-versus-host disease. Transplantation. 2009;88:198\u2013202.", "journal-title": "Transplantation."}, {"issue": "2", "key": "12_CR145_12", "doi-asserted-by": "crossref", "first-page": "233", "DOI": "10.1111/j.1399-3046.2009.01223.x", "volume": "14", "author": "JA Brochstein", "year": "2010", "unstructured": "Brochstein JA, Grupp S, Yang H, Pillemer SR, Geba GP. Phase-1 study of siplizumab in the treatment of pediatric patients with at least grade II newly diagnosed acute graft-versus-host disease. Pediatr Transplant. 2010;14(2):233\u2013241.", "journal-title": "Pediatr Transplant."}, {"key": "12_CR146_12", "doi-asserted-by": "crossref", "first-page": "2514", "DOI": "10.1158/1078-0432.CCR-08-1254", "volume": "15", "author": "D O\u2019Mahony", "year": "2009", "unstructured": "O\u2019Mahony D, Morris JC, Stetler-Stevenson M, Matthews H, Brown MR, Fleisher T, Pittaluga S, Raffeld M, Albert PS, Reitsma D, Kaucic K, Hammershaimb L, Waldmann TA, Janik JE. EBV-related lymphoproliferative disease complicating therapy with the anti-CD2 monoclonal antibody, siplizumab, in patients with T-cell malignancies. Clin Cancer Res. 2009;15:2514\u20132522.", "journal-title": "Clin Cancer Res."}, {"key": "12_CR147_12", "unstructured": "Wilson WH, National Cancer Institute, US. Siplizumab, combination chemotherapy, and rituximab in treating patients with T-cell or natural killer-cell non-hodgkin lymphoma. In: ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US). NLM identifier: NCT00832936 [cited 2009 Oct 16]; 2008."}, {"key": "12_CR148_12", "first-page": "1271", "volume": "77", "author": "JA Ledbetter", "year": "1991", "unstructured": "Ledbetter JA, Schieven GL, Kuebelbeck VM, Uckun FM. Accessory receptors regulate coupling of the T-cell receptor complex to tyrosine kinase activation and mobilization of cytoplasmic calcium in T-lineage acute lymphoblastic leukemia. Blood. 1991;77:1271\u20131282.", "journal-title": "Blood."}, {"key": "12_CR149_12", "doi-asserted-by": "crossref", "first-page": "10", "DOI": "10.1016/0008-8749(86)90321-7", "volume": "102", "author": "OW Press", "year": "1986", "unstructured": "Press OW, Vitetta ES, Farr AG, Hansen JA, Martin PJ. Evaluation of ricin A-chain immunotoxins directed against human T cells. Cell Immunol. 1986;102:10\u201320.", "journal-title": "Cell Immunol."}, {"issue": "Suppl 1", "key": "12_CR150_12", "doi-asserted-by": "crossref", "first-page": "S73", "DOI": "10.1517/14712598.5.1.S73", "volume": "5", "author": "L Chatenoud", "year": "2005", "unstructured": "Chatenoud L, Bach JF. Resetting the functional capacity of regulatory T cells: a novel immunotherapeutic strategy to promote immune tolerance. Expert Opin Biol Ther. 2005;5 Suppl 1:S73\u201381.", "journal-title": "Expert Opin Biol Ther."}, {"key": "12_CR151_12", "first-page": "382", "volume": "9", "author": "M Gramatzki", "year": "1995", "unstructured": "Gramatzki M, Burger R, Strobel G, Trautmann U, Bartram CR, Helm G, Horneff G, Alsalameh S, Jonker M, Gebhart E, et al. Therapy with OKT3 monoclonal antibody in refractory T cell acute lymphoblastic leukemia induces interleukin-2 responsiveness. Leukemia. 1995;9:382\u2013390.", "journal-title": "Leukemia."}, {"key": "12_CR152_12", "doi-asserted-by": "crossref", "first-page": "155", "DOI": "10.1016/j.intimp.2004.09.023", "volume": "5", "author": "SH Popma", "year": "2005", "unstructured": "Popma SH, Griswold DE, Li L. Anti-CD3 antibodies OKT3 and hOKT3gamma1(Ala-Ala) induce proliferation of T cells but impair expansion of alloreactive T cells; aspecifc T cell proliferation induced by anti-CD3 antibodies correlates with impaired expansion of alloreactive T cells. Int Immunopharmacol. 2005;5:155\u2013162.", "journal-title": "Int Immunopharmacol."}, {"key": "12_CR153_12", "doi-asserted-by": "crossref", "first-page": "302", "DOI": "10.1002/dmrr.933", "volume": "25", "author": "A Kaufman", "year": "2009", "unstructured": "Kaufman A, Herold KC. Anti-CD3 mAbs for treatment of type 1 diabetes. Diabetes Metab Res Rev. 2009;25:302\u2013306.", "journal-title": "Diabetes Metab Res Rev."}, {"key": "12_CR154_12", "doi-asserted-by": "crossref", "first-page": "17", "DOI": "10.1096/fasebj.9.1.7821755", "volume": "9", "author": "DJ Leahy", "year": "1995", "unstructured": "Leahy DJ. A structural view of CD4 and CD8. Faseb J. 1995;9:17\u201325.", "journal-title": "Faseb J."}, {"key": "12_CR155_12", "first-page": "893", "volume": "87", "author": "S Knox", "year": "1996", "unstructured": "Knox S, Hoppe RT, Maloney D, Gibbs I, Fowler S, Marquez C, Cornbleet PJ, Levy R. Treatment of cutaneous T-cell lymphoma with chimeric anti-CD4 monoclonal antibody. Blood. 1996;87:893\u2013899.", "journal-title": "Blood."}, {"key": "12_CR156_12", "doi-asserted-by": "crossref", "first-page": "4655", "DOI": "10.1182/blood-2006-12-062877", "volume": "109", "author": "YH Kim", "year": "2007", "unstructured": "Kim YH, Duvic M, Obitz E, Gniadecki R, Iversen L, Osterborg A, Whittaker S, Illidge TM, Schwarz T, Kaufmann R, Cooper K, Knudsen KM, Lisby S, Baadsgaard O, Knox SJ. Clinical efficacy of zanolimumab (HuMax-CD4): two phase 2 studies in refractory cutaneous T-cell lymphoma. Blood. 2007;109:4655\u20134662.", "journal-title": "Blood."}, {"key": "12_CR157_12", "doi-asserted-by": "crossref", "first-page": "347", "DOI": "10.1615/CritRevImmunol.v20.i4.30", "volume": "20", "author": "F Lozano", "year": "2000", "unstructured": "Lozano F, Simarro M, Calvo J, Vila JM, Padilla O, Bowen MA, Campbell KS. CD5 signal transduction: positive or negative modulation of antigen receptor signaling. Crit Rev Immunol. 2000;20:347\u2013358.", "journal-title": "Crit Rev Immunol."}, {"key": "12_CR158_12", "doi-asserted-by": "crossref", "first-page": "458", "DOI": "10.1046/j.1365-2141.2003.04305.x", "volume": "121", "author": "T Sieber", "year": "2003", "unstructured": "Sieber T, Schoeler D, Ringel F, Pascu M, Schriever F. Selective internalization of monoclonal antibodies by B-cell chronic lymphocytic leukemia cells. Br J Haematol. 2003;121:458\u2013461.", "journal-title": "Br J Haematol."}, {"key": "12_CR159_12", "first-page": "394", "volume": "5", "author": "RO Dillman", "year": "1986", "unstructured": "Dillman RO, Beauregard J, Shawler DL, Halpern SE, Markman M, Ryan KP, Baird SM, Clutter M. Continuous infusion of T101 monoclonal antibody in chronic lymphocytic leukemia and cutaneous T-cell lymphoma. J Biol Response Mod. 1986;5:394\u2013410.", "journal-title": "J Biol Response Mod."}, {"key": "12_CR160_12", "first-page": "2691", "volume": "4", "author": "FM Foss", "year": "1998", "unstructured": "Foss FM, Raubitscheck A, Mulshine JL, Fleisher TA, Reynolds JC, Paik CH, Neumann RD, Boland C, Perentesis P, Brown MR, Frincke JM, Lollo CP, Larson SM, Carrasquillo JA. Phase I study of the pharmacokinetics of a radioimmunoconjugate, 90Y-T101, in patients with CD5-expressing leukemia and lymphoma. Clin Cancer Res. 1998;4:2691\u20132700.", "journal-title": "Clin Cancer Res."}, {"key": "12_CR161_12", "doi-asserted-by": "crossref", "first-page": "1102", "DOI": "10.1002/art.1780390705", "volume": "39", "author": "NJ Olsen", "year": "1996", "unstructured": "Olsen NJ, Brooks RH, Cush JJ, Lipsky PE, St Clair EW, Matteson EL, Gold KN, Cannon GW, Jackson CG, McCune WJ, Fox DA, Nelson B, Lorenz T, Strand V. A double-blind, placebo-controlled study of anti-CD5 immunoconjugate in patients with rheumatoid arthritis. The Xoma RA Investigator Group. Arthritis Rheum. 1996;39:1102\u20131108.", "journal-title": "Arthritis Rheum."}, {"key": "12_CR162_12", "first-page": "77", "volume": "1", "author": "D Przepiorka", "year": "1994", "unstructured": "Przepiorka D, LeMaistre CF, Huh YO, Luna M, Saria EA, Brown CT, Champlin RE. Evaluation of anti-CD5 ricin A chain immunoconjugate for prevention of acute graft-vs.-host disease after HLA-identical marrow transplantation. Ther Immunol. 1994;1:77\u201382.", "journal-title": "Ther Immunol."}, {"key": "12_CR163_12", "first-page": "3259", "volume": "158", "author": "ME Pauza", "year": "1997", "unstructured": "Pauza ME, Doumbia SO, Pennell CA. Construction and characterization of human CD7-specific single-chain Fv immunotoxins. J Immunol. 1997;158:3259\u20133269.", "journal-title": "J Immunol."}, {"key": "12_CR164_12", "first-page": "5787", "volume": "58", "author": "DJ Flavell", "year": "1998", "unstructured": "Flavell DJ, Warnes S, Noss A, Flavell SU. Host-mediated antibody-dependent cellular cytotoxicity contributes to the in vivo therapeutic efficacy of an anti-CD7-saporin immunotoxin in a severe combined immunodeficient mouse model of human T-cell acute lymphoblastic leukemia. Cancer Res. 1998;58:5787\u20135794.", "journal-title": "Cancer Res."}, {"key": "12_CR165_12", "doi-asserted-by": "crossref", "first-page": "571", "DOI": "10.1054/bjoc.2000.1633", "volume": "84", "author": "DJ Flavell", "year": "2001", "unstructured": "Flavell DJ, Boehm DA, Noss A, Warnes SL, Flavell SU. Therapy of human T-cell acute lymphoblastic leukemia with a combination of anti-CD7 and anti-CD38-SAPORIN immunotoxins is significantly better than therapy with each individual immunotoxin. Br J Cancer. 2001;84:571\u2013578.", "journal-title": "Br J Cancer."}, {"key": "12_CR166_12", "first-page": "3693", "volume": "95", "author": "YV Oosterhout van", "year": "2000", "unstructured": "van Oosterhout YV, van Emst L, Schattenberg AV, Tax WJ, Ruiter DJ, Spits H, Nagengast FM, Masereeuw R, Evers S, de Witte T, Preijers FW. A combination of anti-CD3 and anti-CD7 ricin A-immunotoxins for the in vivo treatment of acute graft versus host disease. Blood. 2000;95:3693\u20133701.", "journal-title": "Blood."}, {"key": "12_CR167_12", "doi-asserted-by": "crossref", "first-page": "287", "DOI": "10.3109/10428199709051778", "volume": "26", "author": "AE Frankel", "year": "1997", "unstructured": "Frankel AE, Laver JH, Willingham MC, Burns LJ, Kersey JH, Vallera DA. Therapy of patients with T-cell lymphomas and leukemias using an anti-CD7 monoclonal antibody-ricin A chain immunotoxin. Leuk Lymphoma. 1997;26:287\u2013298.", "journal-title": "Leuk Lymphoma."}, {"key": "12_CR168_12", "first-page": "297", "volume": "96", "author": "L Karawajew", "year": "2000", "unstructured": "Karawajew L, Ruppert V, Wuchter C, Kosser A, Schrappe M, Dorken B, Ludwig WD. Inhibition of in vitro spontaneous apoptosis by IL-7 correlates with bcl-2 up-regulation, cortical/mature immunophenotype, and better early cytoreduction of childhood T-cell acute lymphoblastic leukemia. Blood. 2000;96:297\u2013306.", "journal-title": "Blood."}, {"key": "12_CR169_12", "first-page": "110", "volume": "67", "author": "B Nashan", "year": "1999", "unstructured": "Nashan B, Light S, Hardie IR, Lin A, Johnson JR. Reduction of acute renal allograft rejection by daclizumab. Daclizumab Double Therapy Study Group. Transplantation. 1999;67:110\u2013115.", "journal-title": "Daclizumab Double Therapy Study Group. Transplantation."}, {"key": "12_CR170_12", "first-page": "426", "volume": "83", "author": "RJ Kreitman", "year": "1994", "unstructured": "Kreitman RJ, Bailon P, Chaudhary VK, FitzGerald DJ, Pastan I. Recombinant immunotoxins containing anti-Tac(Fv) and derivatives of Pseudomonas exotoxin produce complete regression in mice of an interleukin-2 receptor-expressing human carcinoma. Blood. 1994;83:426\u2013434.", "journal-title": "Blood."}, {"key": "12_CR171_12", "doi-asserted-by": "crossref", "first-page": "110", "DOI": "10.3816/CLM.2000.n.009", "volume": "1", "author": "FM Foss", "year": "2000", "unstructured": "Foss FM. DAB(389)IL-2 (ONTAK): a novel fusion toxin therapy for lymphoma. Clin Lymphoma. 2000;1:110-116; discussion 117.", "journal-title": "Clin Lymphoma"}, {"key": "12_CR172_12", "first-page": "339", "volume": "3", "author": "M Tanimoto", "year": "1989", "unstructured": "Tanimoto M, Scheinberg DA, Cordon-Cardo C, Huie D, Clarkson BD, Old LJ. Restricted expression of an early myeloid and monocytic cell surface antigen defined by monoclonal antibody M195. Leukemia. 1989;3:339\u2013348.", "journal-title": "Leukemia."}, {"key": "12_CR173_12", "doi-asserted-by": "crossref", "first-page": "431", "DOI": "10.1016/j.coph.2005.03.003", "volume": "5", "author": "PR Crocker", "year": "2005", "unstructured": "Crocker PR. Siglecs in innate immunity. Curr Opin Pharmacol. 2005;5:431\u2013437.", "journal-title": "Curr Opin Pharmacol."}, {"key": "12_CR174_12", "doi-asserted-by": "crossref", "first-page": "240", "DOI": "10.1016/j.tips.2009.02.005", "volume": "30", "author": "MK O\u2019Reilly", "year": "2009", "unstructured": "O\u2019Reilly MK, Paulson JC. Siglecs as targets for therapy in immune-cell-mediated disease. Trends Pharmacol Sci. 2009;30:240\u2013248.", "journal-title": "Trends Pharmacol Sci."}, {"key": "12_CR175_12", "doi-asserted-by": "crossref", "first-page": "478", "DOI": "10.1200/JCO.1991.9.3.478", "volume": "9", "author": "DA Scheinberg", "year": "1991", "unstructured": "Scheinberg DA, Lovett D, Divgi CR, Graham MC, Berman E, Pentlow K, Feirt N, Finn RD, Clarkson BD, Gee TS, et al. A phase I trial of monoclonal antibody M195 in acute myelogenous leukemia: specific bone marrow targeting and internalization of radionuclide. J Clin Oncol. 1991;9:478\u2013490.", "journal-title": "J Clin Oncol."}, {"key": "12_CR176_12", "first-page": "1421", "volume": "4", "author": "PC Caron", "year": "1998", "unstructured": "Caron PC, Dumont L, Scheinberg DA. Supersaturating infusional humanized anti-CD33 monoclonal antibody HuM195 in myelogenous leukemia. Clin Cancer Res. 1998;4: 1421\u20131428.", "journal-title": "Clin Cancer Res."}, {"key": "12_CR177_12", "doi-asserted-by": "crossref", "first-page": "314", "DOI": "10.1038/sj.leu.2402803", "volume": "17", "author": "E Feldman", "year": "2003", "unstructured": "Feldman E, Kalaycio M, Weiner G, Frankel S, Schulman P, Schwartzberg L, Jurcic J, Velez-Garcia E, Seiter K, Scheinberg D, Levitt D, Wedel N. Treatment of relapsed or refractory acute myeloid leukemia with humanized anti-CD33 monoclonal antibody HuM195. Leukemia. 2003;17:314\u2013318.", "journal-title": "Leukemia."}, {"key": "12_CR178_12", "doi-asserted-by": "crossref", "first-page": "1", "DOI": "10.1080/10428190903050013", "volume": "50", "author": "A Raza", "year": "2009", "unstructured": "Raza A, Jurcic JG, Roboz GJ, Maris M, Stephenson JJ, Wood BL, Feldman EJ, Galili N, Grove LE, Drachman JG, Sievers EL. Complete remissions observed in acute myeloid leukemia following prolonged exposure to lintuzumab: a phase 1 trial. Leuk Lymphoma. 2009;50:1\u20139.", "journal-title": "Leuk Lymphoma."}, {"key": "12_CR179_12", "first-page": "372", "volume": "6", "author": "JG Jurcic", "year": "2000", "unstructured": "Jurcic JG, DeBlasio T, Dumont L, Yao TJ, Scheinberg DA. Molecular remission induction with retinoic acid and anti-CD33 monoclonal antibody HuM195 in acute promyelocytic leukemia. Clin Cancer Res. 2000;6:372\u2013380.", "journal-title": "Clin Cancer Res."}, {"key": "12_CR180_12", "doi-asserted-by": "crossref", "first-page": "4110", "DOI": "10.1200/JCO.2005.09.133", "volume": "23", "author": "EJ Feldman", "year": "2005", "unstructured": "Feldman EJ, Brandwein J, Stone R, Kalaycio M, Moore J, O\u2019Connor J, Wedel N, Roboz GJ, Miller C, Chopra R, Jurcic JC, Brown R, Ehmann WC, Schulman P, Frankel SR, De Angelo D, Scheinberg D. Phase III randomized multicenter study of a humanized anti-CD33 monoclonal antibody, lintuzumab, in combination with chemotherapy, versus chemotherapy alone in patients with refractory or first-relapsed acute myeloid leukemia. J Clin Oncol. 2005;23:4110\u20134116.", "journal-title": "J Clin Oncol."}, {"key": "12_CR181_12", "doi-asserted-by": "crossref", "first-page": "821", "DOI": "10.1016/j.leukres.2003.12.001", "volume": "28", "author": "L Balaian", "year": "2004", "unstructured": "Balaian L, Ball ED. Inhibition of acute myeloid leukemia cell growth by mono-specific and bi-specific anti-CD33 x anti-CD64 antibodies. Leuk Res. 2004;28:821\u2013829.", "journal-title": "Leuk Res."}, {"key": "12_CR182_12", "doi-asserted-by": "crossref", "first-page": "1442", "DOI": "10.1002/cncr.21326", "volume": "104", "author": "RA Larson", "year": "2005", "unstructured": "Larson RA, Sievers EL, Stadtmauer EA, Lowenberg B, Estey EH, Dombret H, Theobald M, Voliotis D, Bennett JM, Richie M, Leopold LH, Berger MS, Sherman ML, Loken MR, van Dongen JJ, Bernstein ID, Appelbaum FR. Final report of the efficacy and safety of gemtuzumab ozogamicin (Mylotarg) in patients with CD33-positive acute myeloid leukemia in first recurrence. Cancer. 2005;104:1442\u20131452.", "journal-title": "Cancer."}, {"key": "12_CR183_12", "doi-asserted-by": "crossref", "first-page": "5192", "DOI": "10.1200/JCO.2007.15.9764", "volume": "26", "author": "P Chevallier", "year": "2008", "unstructured": "Chevallier P, Delaunay J, Turlure P, Pigneux A, Hunault M, Garand R, Guillaume T, Avet-Loiseau H, Dmytruk N, Girault S, Milpied N, Ifrah N, Mohty M, Harousseau JL. Long-term disease-free survival after gemtuzumab, intermediate-dose cytarabine, and mitoxantrone in patients with CD33(+) primary resistant or relapsed acute myeloid leukemia. J Clin Oncol. 2008;26:5192\u20135197.", "journal-title": "J Clin Oncol."}, {"key": "12_CR184_12", "doi-asserted-by": "crossref", "first-page": "460", "DOI": "10.1007/s12185-009-0298-1", "volume": "89", "author": "Y Kobayashi", "year": "2009", "unstructured": "Kobayashi Y, Tobinai K, Takeshita A, Naito K, Asai O, Dobashi N, Furusawa S, Saito K, Mitani K, Morishima Y, Ogura M, Yoshiba F, Hotta T, Bessho M, Matsuda S, Takeuchi J, Miyawaki S, Naoe T, Usui N, Ohno R. Phase I/II study of humanized anti-CD33 antibody conjugated with calicheamicin, gemtuzumab ozogamicin, in relapsed or refractory acute myeloid leukemia: final results of Japanese multicenter cooperative study. Int J Hematol. 2009;89:460\u2013469.", "journal-title": "Int J Hematol."}, {"key": "12_CR185_12", "doi-asserted-by": "crossref", "first-page": "1800", "DOI": "10.1016/j.leukres.2008.05.011", "volume": "32", "author": "A Candoni", "year": "2008", "unstructured": "Candoni A, Martinelli G, Toffoletti E, Chiarvesio A, Tiribelli M, Malagola M, Piccaluga PP, Michelutti A, Simeone E, Damiani D, Russo D, Fanin R. Gemtuzumab-ozogamicin in combination with fludarabine, cytarabine, idarubicin (FLAI-GO) as induction therapy in CD33-positive AML patients younger than 65 years. Leuk Res. 2008;32:1800\u20131808.", "journal-title": "Leuk Res."}, {"key": "12_CR186_12", "doi-asserted-by": "crossref", "first-page": "209", "DOI": "10.1007/s12185-008-0123-2", "volume": "88", "author": "P Chevallier", "year": "2008", "unstructured": "Chevallier P, Mahe B, Garand R, Talmant P, Harousseau JL, Delaunay J. Combination of chemotherapy and gemtuzumab ozogamicin in adult Philadelphia positive acute lymphoblastic leukemia patient harboring CD33 expression. Int J Hematol. 2008;88:209\u2013211.", "journal-title": "Int J Hematol."}, {"key": "12_CR187_12", "doi-asserted-by": "crossref", "first-page": "165", "DOI": "10.1038/bmt.2009.153", "volume": "45", "author": "P Chevallier", "year": "2010", "unstructured": "Chevallier P, Prebet T, Turlure P, Hunault M, Vigouroux S, Harousseau JL, Blaise D, Ifrah N, Milpied N, Mohty M. Prior treatment with Gemtuzumab Ozogamicin and the risk of veno-occlusive disease after allogeneic haematopoietic stem cell transplantation. Bone Marrow Transplant. 2010;45:165\u2013170.", "journal-title": "Bone Marrow Transplant."}, {"key": "12_CR188_12", "first-page": "1971", "volume": "4", "author": "LC Pagliaro", "year": "1998", "unstructured": "Pagliaro LC, Liu B, Munker R, Andreeff M, Freireich EJ, Scheinberg DA, Rosenblum MG. Humanized M195 monoclonal antibody conjugated to recombinant gelonin: an anti-CD33 immunotoxin with antileukemic activity. Clin Cancer Res. 1998;4:1971\u20131976.", "journal-title": "Clin Cancer Res."}, {"key": "12_CR189_12", "doi-asserted-by": "crossref", "first-page": "106", "DOI": "10.1177/107327480200900203", "volume": "9", "author": "JM Burke", "year": "2002", "unstructured": "Burke JM, Jurcic JG, Scheinberg DA. Radioimmunotherapy for acute leukemia. Cancer Control. 2002;9:106\u2013113.", "journal-title": "Cancer Control."}, {"key": "12_CR190_12", "doi-asserted-by": "crossref", "first-page": "549", "DOI": "10.1038/sj.bmt.1704201", "volume": "32", "author": "JM Burke", "year": "2003", "unstructured": "Burke JM, Caron PC, Papadopoulos EB, Divgi CR, Sgouros G, Panageas KS, Finn RD, Larson SM, O\u2019Reilly RJ, Scheinberg DA, Jurcic JG. Cytoreduction with iodine-131-anti-CD33 antibodies before bone marrow transplantation for advanced myeloid leukemias. Bone Marrow Transplant. 2003;32:549\u2013556.", "journal-title": "Bone Marrow Transplant."}, {"key": "12_CR191_12", "first-page": "827", "volume": "47", "author": "P Chen", "year": "2006", "unstructured": "Chen P, Wang J, Hope K, Jin L, Dick J, Cameron R, Brandwein J, Minden M, Reilly RM. Nuclear localizing sequences promote nuclear translocation and enhance the radiotoxicity of the anti-CD33 monoclonal antibody HuM195 labeled with 111In in human myeloid leukemia cells. J Nucl Med. 2006;47:827\u2013836.", "journal-title": "J Nucl Med."}, {"key": "12_CR192_12", "doi-asserted-by": "crossref", "first-page": "1546", "DOI": "10.2967/jnumed.107.047399", "volume": "49", "author": "V Kersemans", "year": "2008", "unstructured": "Kersemans V, Cornelissen B, Minden MD, Brandwein J, Reilly RM. Drug-resistant AML cells and primary AML specimens are killed by 111In-anti-CD33 monoclonal antibodies modified with nuclear localizing peptide sequences. J Nucl Med. 2008;49:1546\u20131554.", "journal-title": "J Nucl Med."}, {"key": "12_CR193_12", "first-page": "4072", "volume": "92", "author": "CJ Knechtli", "year": "1998", "unstructured": "Knechtli CJ, Goulden NJ, Hancock JP, Grandage VL, Harris EL, Garland RJ, Jones CG, Rowbottom AW, Hunt LP, Green AF, Clarke E, Lankester AW, Cornish JM, Pamphilon DH, Steward CG, Oakhill A. Minimal residual disease status before allogeneic bone marrow transplantation is an important determinant of successful outcome for children and adolescents with acute lymphoblastic leukemia. Blood. 1998;92:4072\u20134079.", "journal-title": "Blood."}, {"key": "12_CR194_12", "doi-asserted-by": "crossref", "first-page": "47", "DOI": "10.1016/j.ccr.2008.05.015", "volume": "14", "author": "C Viseur le", "year": "2008", "unstructured": "le Viseur C, Hotfilder M, Bomken S, Wilson K, Rottgers S, Schrauder A, Rosemann A, Irving J, Stam RW, Shultz LD, Harbott J, Jurgens H, Schrappe M, Pieters R, Vormoor J. In childhood acute lymphoblastic leukemia, blasts at different stages of immunophenotypic maturation have stem cell properties. Cancer Cell. 2008;14:47\u201358.", "journal-title": "Cancer Cell."}, {"key": "12_CR195_12", "doi-asserted-by": "crossref", "first-page": "3287", "DOI": "10.1182/blood-2008-04-154187", "volume": "113", "author": "CV Cox", "year": "2009", "unstructured": "Cox CV, Diamanti P, Evely RS, Kearns PR, Blair A. Expression of CD133 on leukemia-initiating cells in childhood ALL. Blood. 2009;113:3287\u20133296.", "journal-title": "Blood."}, {"issue": "Suppl 1", "key": "12_CR196_12", "doi-asserted-by": "crossref", "first-page": "S22", "DOI": "10.1016/S0145-2126(06)80005-6", "volume": "30", "author": "M Ghielmini", "year": "2006", "unstructured": "Ghielmini M. Patient benefits of maintenance immunotherapy. Leuk Res. 2006;30 Suppl 1:S22\u201326.", "journal-title": "Leuk Res."}, {"key": "12_CR197_12", "first-page": "248", "volume": "101", "author": "L Vidal", "year": "2009", "unstructured": "Vidal L, Gafter-Gvili A, Leibovici L, Dreyling M, Ghielmini M, Hsu Schmitz SF, Cohen A, Shpilberg O. Rituximab maintenance for the treatment of patients with follicular lymphoma: systematic review and meta-analysis of randomized trials. J Natl Cancer Inst. 2009;101:248\u2013255.", "journal-title": "Shpilberg O. Rituximab maintenance for the treatment of patients with follicular lymphoma: systematic review and meta-analysis of randomized trials. J Natl Cancer Inst."}, {"key": "12_CR198_12", "doi-asserted-by": "crossref", "first-page": "75", "DOI": "10.1053/j.seminhematol.2008.02.006", "volume": "45", "author": "A Moccia", "year": "2008", "unstructured": "Moccia A, Ghielmini M. Monoclonal antibodies for the treatment of hematologic malignancies: schedule and maintenance therapy. Semin Hematol. 2008;45:75\u201384.", "journal-title": "Semin Hematol."}, {"key": "12_CR199_12", "doi-asserted-by": "crossref", "first-page": "49", "DOI": "10.1038/sj.leu.2403559", "volume": "19", "author": "G Gaipa", "year": "2005", "unstructured": "Gaipa G, Basso G, Maglia O, Leoni V, Faini A, Cazzaniga G, Bugarin C, Veltroni M, Michelotto B, Ratei R, Coliva T, Valsecchi MG, Biondi A, Dworzak MN. Drug-induced immunophenotypic modulation in childhood ALL: implications for minimal residual disease detection. Leukemia. 2005;19:49\u201356.", "journal-title": "Leukemia."}, {"key": "12_CR200_12", "doi-asserted-by": "crossref", "first-page": "190", "DOI": "10.1016/j.leukres.2005.06.007", "volume": "30", "author": "HB Koon", "year": "2006", "unstructured": "Koon HB, Severy P, Hagg DS, Butler K, Hill T, Jones AG, Waldmann TA, Junghans RP. Antileukemic effect of daclizumab in CD25 high-expressing leukemias and impact of tumor burden on antibody dosing. Leuk Res. 2006;30:190\u2013203.", "journal-title": "Leuk Res."}, {"key": "12_CR201_12", "first-page": "967", "volume": "83", "author": "R Consolini", "year": "1998", "unstructured": "Consolini R, Legitimo A, Rondelli R, Guguelmi C, Barisone E, Lippi A, Cantu\u2013Rajnoldi A, Arico M, Conter V, Cocito MG, Putti MC, Pession A, Masera G, Biondi A, Basso G. Clinical relevance of CD10 expression in childhood ALL. The Italian Association for Pediatric Hematology and Oncology (AIEOP). Haematologica. 1998;83:967\u2013973.", "journal-title": "Haematologica."}, {"key": "12_CR202_12", "first-page": "2000", "volume": "44", "author": "RM Sharkey", "year": "2003", "unstructured": "Sharkey RM, Brenner A, Burton J, Hajjar G, Toder SP, Alavi A, Matthies A, Tsai DE, Schuster SJ, Stadtmauer EA, Czuczman MS, Lamonica D, Kraeber-Bodere F, Mahe B, Chatal JF, Rogatko A, Mardirrosian G, Goldenberg DM. Radioimmunotherapy of non-Hodgkin\u2019s lymphoma with 90Y-DOTA humanized anti-CD22 IgG (90Y-Epratuzumab): do tumor targeting and dosimetry predict therapeutic response? J Nucl Med. 2003;44:2000\u20132018.", "journal-title": "J Nucl Med."}], "container-title": ["New Agents for the Treatment of Acute Lymphoblastic Leukemia"], "link": [{"URL": "http://link.springer.com/content/pdf/10.1007/978-1-4419-8459-3_12", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 5, 23]], "date-time": "2019-05-23T06:51:10Z", "timestamp": 1558594270000}, "score": 24.450268, "issued": {"date-parts": [[2011]]}, "ISBN": ["9781441984586", "9781441984593"], "references-count": 202, "URL": "http://dx.doi.org/10.1007/978-1-4419-8459-3_12", "relation": {"cites": []}}, {"indexed": {"date-parts": [[2019, 11, 22]], "date-time": "2019-11-22T14:13:49Z", "timestamp": 1574432029448}, "reference-count": 0, "publisher": "INIST-CNRS", "issue": "4", "content-domain": {"domain": [], "crossmark-restriction": false}, "DOI": "10.4267/2042/38009", "type": "journal-article", "created": {"date-parts": [[2011, 12, 9]], "date-time": "2011-12-09T15:27:44Z", "timestamp": 1323444464000}, "source": "Crossref", "is-referenced-by-count": 0, "title": ["LAF4 (lymphoid nuclear protein related to AF4)"], "prefix": "10.4267", "author": [{"given": "ARM", "family": "von Bergh", "sequence": "first", "affiliation": []}], "member": "2793", "published-online": {"date-parts": [[2011, 2]]}, "container-title": ["Atlas of Genetics and Cytogenetics in Oncology and Haematology"], "deposited": {"date-parts": [[2011, 12, 9]], "date-time": "2011-12-09T15:30:01Z", "timestamp": 1323444601000}, "score": 24.307741, "issued": {"date-parts": [[2011, 2]]}, "references-count": 0, "journal-issue": {"published-online": {"date-parts": [[2011, 2]]}, "issue": "4"}, "URL": "http://dx.doi.org/10.4267/2042/38009", "ISSN": ["1768-3262"], "issn-type": [{"value": "1768-3262", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 20]], "date-time": "2019-11-20T04:41:49Z", "timestamp": 1574224909268}, "reference-count": 55, "publisher": "Wiley", "issue": "11", "license": [{"URL": "http://doi.wiley.com/10.1002/tdm_license_1.1", "start": {"date-parts": [[2015, 9, 1]], "date-time": "2015-09-01T00:00:00Z", "timestamp": 1441065600000}, "delay-in-days": 3530, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Genes Chromosom. Cancer"], "published-print": {"date-parts": [[2006, 11]]}, "DOI": "10.1002/gcc.20372", "type": "journal-article", "created": {"date-parts": [[2006, 8, 8]], "date-time": "2006-08-08T22:06:48Z", "timestamp": 1155074808000}, "page": "1041-1049", "source": "Crossref", "is-referenced-by-count": 22, "title": ["Molecular dissection of t(11;17) in acute myeloid leukemia reveals a variety of gene fusions with heterogeneous fusion transcripts and multiple splice variants"], "prefix": "10.1002", "volume": "45", "author": [{"given": "Sabine", "family": "Strehl", "sequence": "first", "affiliation": []}, {"given": "Margit", "family": "K\u00f6nig", "sequence": "additional", "affiliation": []}, {"given": "Claus", "family": "Meyer", "sequence": "additional", "affiliation": []}, {"given": "Bj\u00f6rn", "family": "Schneider", "sequence": "additional", "affiliation": []}, {"given": "Jochen", "family": "Harbott", "sequence": "additional", "affiliation": []}, {"given": "Ulrich", "family": "J\u00e4ger", "sequence": "additional", "affiliation": []}, {"given": "Anne R. M.", "family": "von Bergh", "sequence": "additional", "affiliation": []}, {"given": "Ivan F.", "family": "Loncarevic", "sequence": "additional", "affiliation": []}, {"given": "Marie", "family": "Jarosova", "sequence": "additional", "affiliation": []}, {"given": "Helmut H.", "family": "Schmidt", "sequence": "additional", "affiliation": []}, {"given": "Steven D. P.", "family": "Moore", "sequence": "additional", "affiliation": []}, {"given": "Rolf", "family": "Marschalek", "sequence": "additional", "affiliation": []}, {"given": "Oskar A.", "family": "Haas", "sequence": "additional", "affiliation": []}], "member": "311", "published-online": {"date-parts": [[2006]]}, "reference": [{"key": "10.1002/gcc.20372-BIB1", "author": "Archimbaud", "volume": "12", "first-page": "25", "year": "1998", "journal-title": "Leukemia", "DOI": "10.1038/sj.leu.2400853", "doi-asserted-by": "crossref"}, {"key": "10.1002/gcc.20372-BIB2", "author": "Borkhardt", "volume": "32", "first-page": "82", "year": "2001", "journal-title": "Genes Chromosomes Cancer", "DOI": "10.1002/gcc.1169", "doi-asserted-by": "crossref"}, {"key": "10.1002/gcc.20372-BIB3", "author": "Burset", "volume": "28", "first-page": "4364", "year": "2000", "journal-title": "Nucleic Acids Res", "DOI": "10.1093/nar/28.21.4364", "doi-asserted-by": "crossref"}, {"key": "10.1002/gcc.20372-BIB4", "author": "Cerveira", "journal-title": "Oncogene"}, {"key": "10.1002/gcc.20372-BIB5", "author": "Chaplin", "volume": "85", "first-page": "1435", "year": "1995", "journal-title": "Blood"}, {"key": "10.1002/gcc.20372-BIB6", "author": "Chen", "volume": "91", "first-page": "1178", "year": "1994", "journal-title": "Proc Natl Acad Sci USA", "DOI": "10.1073/pnas.91.3.1178", "doi-asserted-by": "crossref"}, {"key": "10.1002/gcc.20372-BIB7", "author": "Classen", "volume": "84", "first-page": "774", "year": "2005", "journal-title": "Ann Hematol", "DOI": "10.1007/s00277-005-1089-2", "doi-asserted-by": "crossref"}, {"key": "10.1002/gcc.20372-BIB8", "author": "Dal Cin", "volume": "148", "first-page": "178", "year": "2004", "journal-title": "Cancer Genet Cytogenet", "DOI": "10.1016/S0165-4608(03)00268-1", "doi-asserted-by": "crossref"}, {"key": "10.1002/gcc.20372-BIB9", "author": "Daser", "volume": "18", "first-page": "965", "year": "2004", "journal-title": "Genes Dev", "DOI": "10.1101/gad.1195504", "doi-asserted-by": "crossref"}, {"key": "10.1002/gcc.20372-BIB10", "author": "DiMartino", "volume": "99", "first-page": "3780", "year": "2002", "journal-title": "Blood", "DOI": "10.1182/blood.V99.10.3780", "doi-asserted-by": "crossref"}, {"key": "10.1002/gcc.20372-BIB11", "author": "Divoky", "volume": "247", "first-page": "111", "year": "2000", "journal-title": "Gene", "DOI": "10.1016/S0378-1119(00)00111-6", "doi-asserted-by": "crossref"}, {"key": "10.1002/gcc.20372-BIB12", "author": "Douet-Guilbert", "volume": "157", "first-page": "169", "year": "2005", "journal-title": "Cancer Genet Cytogenet", "DOI": "10.1016/j.cancergencyto.2004.08.004", "doi-asserted-by": "crossref"}, {"key": "10.1002/gcc.20372-BIB13", "author": "Dube", "volume": "145", "first-page": "54", "year": "2003", "journal-title": "Cancer Genet Cytogenet", "DOI": "10.1016/S0165-4608(03)00056-6", "doi-asserted-by": "crossref"}, {"key": "10.1002/gcc.20372-BIB14", "author": "Eguchi", "volume": "103", "first-page": "3876", "year": "2004", "journal-title": "Blood", "DOI": "10.1182/blood-2003-11-3817", "doi-asserted-by": "crossref"}, {"key": "10.1002/gcc.20372-BIB15", "author": "Fu", "volume": "38", "first-page": "253", "year": "2003", "journal-title": "Genes Chromosomes Cancer", "DOI": "10.1002/gcc.10272", "doi-asserted-by": "crossref"}, {"key": "10.1002/gcc.20372-BIB16", "author": "Futreal", "volume": "4", "first-page": "177", "year": "2004", "journal-title": "Nat Rev Cancer", "DOI": "10.1038/nrc1299", "doi-asserted-by": "crossref"}, {"key": "10.1002/gcc.20372-BIB17", "author": "Greaves", "volume": "3", "first-page": "639", "year": "2003", "journal-title": "Nat Rev Cancer", "DOI": "10.1038/nrc1164", "doi-asserted-by": "crossref"}, {"key": "10.1002/gcc.20372-BIB18", "author": "Harrison", "volume": "12", "first-page": "811", "year": "1998", "journal-title": "Leukemia", "DOI": "10.1038/sj.leu.2401017", "doi-asserted-by": "crossref"}, {"key": "10.1002/gcc.20372-BIB19", "author": "Huret", "volume": "50", "first-page": "805", "year": "2004", "journal-title": "Cell Mol Biol (Noisy-le-grand)"}, {"key": "10.1002/gcc.20372-BIB20", "author": "Kalikin", "volume": "63", "first-page": "165", "year": "2000", "journal-title": "Genomics", "DOI": "10.1006/geno.1999.6077", "doi-asserted-by": "crossref"}, {"key": "10.1002/gcc.20372-BIB21", "author": "Kang", "volume": "159", "first-page": "168", "year": "2005", "journal-title": "Cancer Genet Cytogenet", "DOI": "10.1016/j.cancergencyto.2004.10.009", "doi-asserted-by": "crossref"}, {"key": "10.1002/gcc.20372-BIB22", "author": "Kim", "volume": "38", "first-page": "8", "year": "2003", "journal-title": "Genes Chromosomes Cancer", "DOI": "10.1002/gcc.10235", "doi-asserted-by": "crossref"}, {"key": "10.1002/gcc.20372-BIB23", "author": "Kojima", "volume": "18", "first-page": "998", "year": "2004", "journal-title": "Leukemia", "DOI": "10.1038/sj.leu.2403334", "doi-asserted-by": "crossref"}, {"key": "10.1002/gcc.20372-BIB24", "author": "K\u00f6nig", "volume": "116", "first-page": "758", "year": "2002", "journal-title": "Br J Haematol", "DOI": "10.1046/j.0007-1048.2002.03340.x", "doi-asserted-by": "crossref"}, {"key": "10.1002/gcc.20372-BIB25", "author": "Macara", "volume": "13", "first-page": "4111", "year": "2002", "journal-title": "Mol Biol Cell", "DOI": "10.1091/mbc.e02-07-0438", "doi-asserted-by": "crossref"}, {"key": "10.1002/gcc.20372-BIB26", "author": "Maroc", "volume": "18", "first-page": "1522", "year": "2004", "journal-title": "Leukemia", "DOI": "10.1038/sj.leu.2403439", "doi-asserted-by": "crossref"}, {"key": "10.1002/gcc.20372-BIB27", "author": "McIlhatton", "volume": "20", "first-page": "5930", "year": "2001", "journal-title": "Oncogene", "DOI": "10.1038/sj.onc.1204752", "doi-asserted-by": "crossref"}, {"key": "10.1002/gcc.20372-BIB28", "author": "Megonigal", "volume": "97", "first-page": "2814", "year": "2000", "journal-title": "Proc Natl Acad Sci USA", "DOI": "10.1073/pnas.050397097", "doi-asserted-by": "crossref"}, {"key": "10.1002/gcc.20372-BIB29", "author": "Megonigal", "volume": "95", "first-page": "6413", "year": "1998", "journal-title": "Proc Natl Acad Sci USA", "DOI": "10.1073/pnas.95.11.6413", "doi-asserted-by": "crossref"}, {"key": "10.1002/gcc.20372-BIB30", "author": "Meyer", "volume": "20", "first-page": "777", "year": "2006", "journal-title": "Leukemia", "DOI": "10.1038/sj.leu.2404150", "doi-asserted-by": "crossref"}, {"key": "10.1002/gcc.20372-BIB31", "author": "Meyer", "volume": "102", "first-page": "449", "year": "2005", "journal-title": "Proc Natl Acad Sci USA", "DOI": "10.1073/pnas.0406994102", "doi-asserted-by": "crossref"}, {"key": "10.1002/gcc.20372-BIB32", "author": "Mitelman", "year": "1995", "unstructured": "editor. 1995. ISCN 1995. An international system for human cytogenetic nomenclature. Basel: Karger.", "volume-title": "ISCN 1995. An international system for human cytogenetic nomenclature"}, {"key": "10.1002/gcc.20372-BIB33", "author": "Mitelman", "volume": "36", "first-page": "331", "year": "2004", "journal-title": "Nat Genet", "DOI": "10.1038/ng1335", "doi-asserted-by": "crossref"}, {"key": "10.1002/gcc.20372-BIB34", "author": "Mitterbauer-Hohendanner", "volume": "34", "first-page": "12", "year": "2004", "journal-title": "Eur J Clin Invest", "DOI": "10.1111/j.0960-135X.2004.01366.x", "doi-asserted-by": "crossref"}, {"key": "10.1002/gcc.20372-BIB35", "author": "Moore", "volume": "157", "first-page": "87", "year": "2005", "journal-title": "Cancer Genet Cytogenet", "DOI": "10.1016/j.cancergencyto.2004.06.015", "doi-asserted-by": "crossref"}, {"key": "10.1002/gcc.20372-BIB36", "author": "Nilson", "volume": "93", "first-page": "966", "year": "1996", "journal-title": "Br J Haematol", "DOI": "10.1046/j.1365-2141.1996.d01-1748.x", "doi-asserted-by": "crossref"}, {"key": "10.1002/gcc.20372-BIB37", "author": "Ono", "volume": "62", "first-page": "333", "year": "2002", "journal-title": "Cancer Res"}, {"key": "10.1002/gcc.20372-BIB38", "author": "Osaka", "volume": "96", "first-page": "6428", "year": "1999", "journal-title": "Proc Natl Acad Sci USA", "DOI": "10.1073/pnas.96.11.6428", "doi-asserted-by": "crossref"}, {"key": "10.1002/gcc.20372-BIB39", "author": "Perrin", "volume": "23", "first-page": "119", "year": "2003", "journal-title": "Mol Cell Biol", "DOI": "10.1128/MCB.23.1.119-130.2003", "doi-asserted-by": "crossref"}, {"key": "10.1002/gcc.20372-BIB40", "author": "Prasad", "volume": "91", "first-page": "8107", "year": "1994", "journal-title": "Proc Natl Acad Sci USA", "DOI": "10.1073/pnas.91.17.8107", "doi-asserted-by": "crossref"}, {"key": "10.1002/gcc.20372-BIB41", "author": "Reeves", "volume": "74", "first-page": "50", "year": "1994", "journal-title": "Cancer Genet Cytogenet", "DOI": "10.1016/0165-4608(94)90028-0", "doi-asserted-by": "crossref"}, {"key": "10.1002/gcc.20372-BIB42", "author": "Robertson", "volume": "203", "first-page": "519", "year": "2004", "journal-title": "J Pathol", "DOI": "10.1002/path.1551", "doi-asserted-by": "crossref"}, {"key": "10.1002/gcc.20372-BIB43", "author": "Schoch", "volume": "102", "first-page": "2395", "year": "2003", "journal-title": "Blood", "DOI": "10.1182/blood-2003-02-0434", "doi-asserted-by": "crossref"}, {"key": "10.1002/gcc.20372-BIB44", "author": "Shekhter-Levin", "volume": "14", "first-page": "520", "year": "2000", "journal-title": "Leukemia", "DOI": "10.1038/sj.leu.2401707", "doi-asserted-by": "crossref"}, {"key": "10.1002/gcc.20372-BIB45", "author": "Slater", "volume": "21", "first-page": "4706", "year": "2002", "journal-title": "Oncogene", "DOI": "10.1038/sj.onc.1205572", "doi-asserted-by": "crossref"}, {"key": "10.1002/gcc.20372-BIB46", "author": "So", "volume": "104", "first-page": "919", "year": "2004", "journal-title": "Blood", "DOI": "10.1182/blood-2004-03-0992", "doi-asserted-by": "crossref"}, {"key": "10.1002/gcc.20372-BIB47", "author": "So", "volume": "103", "first-page": "3192", "year": "2004", "journal-title": "Blood", "DOI": "10.1182/blood-2003-10-3722", "doi-asserted-by": "crossref"}, {"key": "10.1002/gcc.20372-BIB48", "author": "So", "volume": "4", "first-page": "99", "year": "2003", "journal-title": "Cancer Cell", "DOI": "10.1016/S1535-6108(03)00188-0", "doi-asserted-by": "crossref"}, {"key": "10.1002/gcc.20372-BIB49", "author": "Strehl", "volume": "22", "first-page": "157", "year": "2003", "journal-title": "Oncogene", "DOI": "10.1038/sj.onc.1206042", "doi-asserted-by": "crossref"}, {"key": "10.1002/gcc.20372-BIB50", "author": "Strehl", "volume": "97", "first-page": "805", "year": "2001", "journal-title": "Blood", "DOI": "10.1182/blood.V97.3.805", "doi-asserted-by": "crossref"}, {"key": "10.1002/gcc.20372-BIB51", "author": "Suzukawa", "volume": "82", "first-page": "38", "year": "2005", "journal-title": "Int J Hematol", "DOI": "10.1532/IJH97.05025", "doi-asserted-by": "crossref"}, {"key": "10.1002/gcc.20372-BIB52", "author": "Taki", "volume": "59", "first-page": "4261", "year": "1999", "journal-title": "Cancer Res"}, {"key": "10.1002/gcc.20372-BIB53", "author": "von Bergh", "volume": "28", "first-page": "14", "year": "2000", "journal-title": "Genes Chromosomes Cancer", "DOI": "10.1002/(SICI)1098-2264(200005)28:1<14::AID-GCC2>3.0.CO;2-X", "doi-asserted-by": "crossref"}, {"key": "10.1002/gcc.20372-BIB54", "author": "Wells", "volume": "17", "first-page": "109", "year": "1997", "journal-title": "Nat Genet", "DOI": "10.1038/ng0997-109", "doi-asserted-by": "crossref"}, {"key": "10.1002/gcc.20372-BIB55", "author": "Yamamoto", "volume": "75", "first-page": "503", "year": "2002", "journal-title": "Int J Hematol", "DOI": "10.1007/BF02982114", "doi-asserted-by": "crossref"}], "container-title": ["Genes, Chromosomes and Cancer"], "language": "en", "link": [{"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fgcc.20372", "content-type": "unspecified", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://onlinelibrary.wiley.com/doi/full/10.1002/gcc.20372", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 1, 12]], "date-time": "2019-01-12T11:22:35Z", "timestamp": 1547292155000}, "score": 24.294216, "issued": {"date-parts": [[2006]]}, "references-count": 55, "journal-issue": {"published-print": {"date-parts": [[2006, 11]]}, "issue": "11"}, "URL": "http://dx.doi.org/10.1002/gcc.20372", "relation": {"cites": []}, "ISSN": ["1045-2257", "1098-2264"], "issn-type": [{"value": "1045-2257", "type": "print"}, {"value": "1098-2264", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 25]], "date-time": "2019-11-25T14:46:33Z", "timestamp": 1574693193199}, "reference-count": 0, "publisher": "AVES Publishing Co.", "issue": "1", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Turk J Gastroenterol"], "published-print": {"date-parts": [[2015, 4, 22]]}, "DOI": "10.5152/tjg.2014.5281", "type": "journal-article", "created": {"date-parts": [[2015, 4, 22]], "date-time": "2015-04-22T14:35:33Z", "timestamp": 1429713333000}, "page": "233-233", "source": "Crossref", "is-referenced-by-count": 4, "title": ["Acute colitis presenting with hematochezia in a patient with chronic myeloid leukemia during dasatinib therapy"], "prefix": "10.5152", "volume": "25", "author": [{"given": "Ahmet Emre", "family": "Eskazan", "sequence": "first", "affiliation": []}, {"given": "Ibrahim", "family": "Hatemi", "sequence": "additional", "affiliation": []}, {"given": "Seniz", "family": "Ongoren Aydin", "sequence": "additional", "affiliation": []}, {"given": "Muhlis Cem", "family": "Ar", "sequence": "additional", "affiliation": []}, {"given": "Teoman", "family": "Soysal", "sequence": "additional", "affiliation": []}], "member": "3111", "container-title": ["The Turkish Journal of Gastroenterology"], "deposited": {"date-parts": [[2019, 8, 2]], "date-time": "2019-08-02T13:15:58Z", "timestamp": 1564751758000}, "score": 24.211899, "issued": {"date-parts": [[2015, 4, 22]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2015, 4, 22]]}, "issue": "1"}, "URL": "http://dx.doi.org/10.5152/tjg.2014.5281", "ISSN": ["1300-4948", "2148-5607"], "issn-type": [{"value": "1300-4948", "type": "print"}, {"value": "2148-5607", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 12, 2]], "date-time": "2019-12-02T06:10:26Z", "timestamp": 1575267026981}, "reference-count": 0, "publisher": "Galenos Yayinevi", "issue": "2", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Istanbul Med J"], "published-print": {"date-parts": [[2013, 8, 26]]}, "DOI": "10.5152/imj.2013.33", "type": "journal-article", "created": {"date-parts": [[2013, 8, 26]], "date-time": "2013-08-26T12:08:01Z", "timestamp": 1377518881000}, "page": "124-125", "source": "Crossref", "is-referenced-by-count": 0, "title": ["A Rare Skin Lesion Seen in Acute Myeloid Leukemia: Skin Infiltration"], "prefix": "10.4274", "volume": "14", "author": [{"given": "Guven", "family": "Cetin", "sequence": "first", "affiliation": []}, {"given": "M. Cem", "family": "Ar", "sequence": "additional", "affiliation": []}, {"given": "Betul", "family": "Borku", "sequence": "additional", "affiliation": []}, {"given": "Abdullah", "family": "Cerit", "sequence": "additional", "affiliation": []}, {"given": "Kubra", "family": "Gozubenli", "sequence": "additional", "affiliation": []}], "member": "2811", "container-title": ["Istanbul Medical Journal"], "deposited": {"date-parts": [[2019, 1, 2]], "date-time": "2019-01-02T12:43:59Z", "timestamp": 1546433039000}, "score": 24.005615, "issued": {"date-parts": [[2013, 8, 26]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2013, 8, 26]]}, "issue": "2"}, "URL": "http://dx.doi.org/10.5152/imj.2013.33", "ISSN": ["1304-8503"], "issn-type": [{"value": "1304-8503", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 12, 2]], "date-time": "2019-12-02T16:56:27Z", "timestamp": 1575305787486}, "reference-count": 35, "publisher": "Springer Science and Business Media LLC", "issue": "4", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Ann Hematol"], "published-print": {"date-parts": [[2009, 4]]}, "DOI": "10.1007/s00277-008-0593-6", "type": "journal-article", "created": {"date-parts": [[2008, 9, 10]], "date-time": "2008-09-10T12:23:10Z", "timestamp": 1221049390000}, "page": "319-324", "source": "Crossref", "is-referenced-by-count": 1, "title": ["Determination of Ras-GTP and Ras-GDP in patients with acute myelogenous leukemia (AML), myeloproliferative syndrome (MPS), juvenile myelomonocytic leukemia (JMML), acute lymphocytic leukemia (ALL), and malignant lymphoma: assessment of mutational and indirect activation"], "prefix": "10.1007", "volume": "88", "author": [{"given": "D.", "family": "Raepple", "sequence": "first", "affiliation": []}, {"given": "F.", "family": "von Lintig", "sequence": "additional", "affiliation": []}, {"given": "T.", "family": "Zemojtel", "sequence": "additional", "affiliation": []}, {"given": "M.", "family": "Duchniewicz", "sequence": "additional", "affiliation": []}, {"given": "A.", "family": "Jung", "sequence": "additional", "affiliation": []}, {"given": "M.", "family": "L\u00fcbbert", "sequence": "additional", "affiliation": []}, {"given": "G. R.", "family": "Boss", "sequence": "additional", "affiliation": []}, {"given": "J. S.", "family": "Scheele", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2008, 9, 11]]}, "reference": [{"issue": "13", "key": "593_CR1", "doi-asserted-by": "crossref", "first-page": "4008", "DOI": "10.1073/pnas.81.13.4008", "volume": "81", "author": "O Fasano", "year": "1984", "unstructured": "Fasano O, Aldrich T et al (1984) Analysis of the transforming potential of the human H-ras gene by random mutagenesis. Proc Natl Acad Sci U S A 81(13):4008\u20134012. doi: 10.1073/pnas.81.13.4008", "journal-title": "Proc Natl Acad Sci U S A"}, {"key": "593_CR2", "first-page": "343", "volume": "111", "author": "W Guo", "year": "1998", "unstructured": "Guo W, Tang B et al (1998) N-ras mutations in 43 Chinese cases of acute myeloid leukemia. Chin Med J (Engl) 111:343\u2013345", "journal-title": "Chin Med J (Engl)"}, {"key": "593_CR3", "doi-asserted-by": "crossref", "first-page": "323", "DOI": "10.1111/j.1365-2141.1991.tb08578.x", "volume": "77", "author": "C Farr", "year": "1991", "unstructured": "Farr C, Gill R et al (1991) Analysis of ras gene mutations in childhood myeloid leukaemia. Br J Haematol 77:323\u2013327. doi: 10.1111/j.1365-2141.1991.tb08578.x", "journal-title": "Br J Haematol"}, {"key": "593_CR4", "doi-asserted-by": "crossref", "first-page": "466", "DOI": "10.1038/sj.leu.2403274", "volume": "18", "author": "LY Shih", "year": "2004", "unstructured": "Shih LY, Huang CF et al (2004) Acquisition of FLT3 or N-ras mutations is frequently associated with progression of myelodysplastic syndrome to acute myeloid leukemia. Leukemia 18:466\u2013475. doi: 10.1038/sj.leu.2403274", "journal-title": "Leukemia"}, {"key": "593_CR5", "doi-asserted-by": "crossref", "first-page": "887", "DOI": "10.1038/sj.leu.2401044", "volume": "12", "author": "RA Padua", "year": "1998", "unstructured": "Padua RA, Guinn BA et al (1998) RAS, FMS and p53 mutations and poor clinical outcome in myelodysplasias: a 10-year follow-up. Leukemia 12:887\u2013892. doi: 10.1038/sj.leu.2401044", "journal-title": "Leukemia"}, {"key": "593_CR6", "doi-asserted-by": "crossref", "first-page": "333", "DOI": "10.1016/S0092-8674(00)81872-3", "volume": "88", "author": "T Hunter", "year": "1997", "unstructured": "Hunter T (1997) Oncoprotein networks. Cell 88:333\u2013346. doi: 10.1016/S0092-8674(00)81872-3", "journal-title": "Cell"}, {"key": "593_CR7", "first-page": "486", "volume": "4", "author": "K Tobal", "year": "1990", "unstructured": "Tobal K, Pagliuca A et al (1990) Mutation of the human FMS gene (M-CSF receptor) in myelodysplastic syndromes and acute myeloid leukemia. Leukemia 4:486\u2013489", "journal-title": "Leukemia"}, {"key": "593_CR8", "first-page": "3074", "volume": "93", "author": "H Kiyoi", "year": "1999", "unstructured": "Kiyoi H, Naoe T et al (1999) Prognostic implication of FLT3 and N-RAS gene mutations in acute myeloid leukemia. Blood 93:3074\u20133080", "journal-title": "Blood"}, {"key": "593_CR9", "doi-asserted-by": "crossref", "first-page": "96", "DOI": "10.1002/(SICI)1098-2795(199701)46:1<96::AID-MRD15>3.0.CO;2-1", "volume": "46", "author": "LR Rohrschneider", "year": "1997", "unstructured": "Rohrschneider LR, Bourette RP et al (1997) Growth and differentiation signals regulated by the M-CSF receptor. Mol Reprod Dev 46:96\u2013103. doi: 10.1002/(SICI)1098-2795(199701)46:1<96::AID-MRD15>3.0.CO;2-1", "journal-title": "Mol Reprod Dev"}, {"key": "593_CR10", "doi-asserted-by": "crossref", "first-page": "1855", "DOI": "10.1084/jem.179.6.1855", "volume": "179", "author": "T Skorski", "year": "1994", "unstructured": "Skorski T, Kanakaraj P et al (1994) Negative regulation of pl20GAP GTPase promoting activity by p210bcr/abl: implication for RAS-dependent Philadelphia chromosome positive cell growth. J Exp Med 179:1855\u20131865. doi: 10.1084/jem.179.6.1855", "journal-title": "J Exp Med"}, {"key": "593_CR11", "doi-asserted-by": "crossref", "first-page": "307", "DOI": "10.1084/jem.181.1.307", "volume": "181", "author": "CL Sawyers", "year": "1995", "unstructured": "Sawyers CL, McLaughlin J et al (1995) Genetic requirement for Ras in the transformation of fibroblasts and hematopoietic cells by the Bcr-Abl oncogene. J Exp Med 181:307\u2013313. doi: 10.1084/jem.181.1.307", "journal-title": "J Exp Med"}, {"key": "593_CR12", "doi-asserted-by": "crossref", "first-page": "307", "DOI": "10.1016/0092-8674(94)90322-0", "volume": "77", "author": "TR Golub", "year": "1994", "unstructured": "Golub TR, Barker GF et al (1994) Fusion of PDGF receptor beta to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation. Cell 77:307\u2013316. doi: 10.1016/0092-8674(94)90322-0", "journal-title": "Cell"}, {"key": "593_CR13", "doi-asserted-by": "crossref", "first-page": "4107", "DOI": "10.1128/MCB.16.8.4107", "volume": "16", "author": "TR Golub", "year": "1996", "unstructured": "Golub TR, Goga A et al (1996) Oligomerization of the ABL tyrosine kinase by the Ets protein TEL in human leukemia. Mol Cell Biol 16:4107\u20134116", "journal-title": "Mol Cell Biol"}, {"key": "593_CR14", "first-page": "3517", "volume": "86", "author": "PG Elmberger", "year": "1995", "unstructured": "Elmberger PG, Lozano MD et al (1995) Transcripts of the npm-alk fusion gene in anaplastic large cell lymphoma, Hodgkin\u2019s disease, and reactive lymphoid lesions. Blood 86:3517\u20133521", "journal-title": "Blood"}, {"key": "593_CR15", "doi-asserted-by": "crossref", "first-page": "905", "DOI": "10.1111/j.1365-2141.1995.tb08434.x", "volume": "89", "author": "W Waggott", "year": "1995", "unstructured": "Waggott W, Lo YM et al (1995) Detection of NPM-ALK DNA rearrangement in CD30 positive anaplastic large cell lymphoma. Br J Haematol 89:905\u2013907", "journal-title": "Br J Haematol"}, {"key": "593_CR16", "doi-asserted-by": "crossref", "first-page": "599", "DOI": "10.1016/0092-8674(90)90024-9", "volume": "62", "author": "GF Xu", "year": "1990", "unstructured": "Xu GF, O\u2019Connell P et al (1990) The neurofibromatosis type 1 gene encodes a protein related to GAP. Cell 62:599\u2013608. doi: 10.1016/0092-8674(90)90024-9", "journal-title": "Cell"}, {"key": "593_CR17", "doi-asserted-by": "crossref", "first-page": "265", "DOI": "10.1016/0092-8674(92)90407-4", "volume": "69", "author": "JE DeClue", "year": "1992", "unstructured": "DeClue JE, Papageorge AG et al (1992) Abnormal regulation of mammalian p21ras contributes to malignant tumor growth in von Recklinghausen (type 1) neurofibromatosis. Cell 69:265\u2013273. doi: 10.1016/0092-8674(92)90407-4", "journal-title": "Cell"}, {"key": "593_CR18", "doi-asserted-by": "crossref", "first-page": "1713", "DOI": "10.1056/NEJM199706123362404", "volume": "336", "author": "L Side", "year": "1997", "unstructured": "Side L, Taylor B et al (1997) Homozygous inactivation of the NF1 gene in bone marrow cells from children with neurofibromatosis type 1 and malignant myeloid disorders. N Engl J Med 336:1713\u20131720. doi: 10.1056/NEJM199706123362404", "journal-title": "N Engl J Med"}, {"key": "593_CR19", "first-page": "2248", "volume": "83", "author": "J Miyauchi", "year": "1994", "unstructured": "Miyauchi J, Asada M et al (1994) Mutations of the N-ras gene in juvenile chronic myelogenous leukemia. Blood 83:2248\u20132254", "journal-title": "Blood"}, {"key": "593_CR20", "first-page": "3435", "volume": "84", "author": "R Kalra", "year": "1994", "unstructured": "Kalra R, Paderanga DC et al (1994) Genetic analysis is consistent with the hypothesis that NF1 limits myeloid cell growth through p21ras. Blood 84:3435\u20133439", "journal-title": "Blood"}, {"key": "593_CR21", "doi-asserted-by": "crossref", "first-page": "148", "DOI": "10.1038/ng1156", "volume": "34", "author": "M Tartaglia", "year": "2003", "unstructured": "Tartaglia M, Niemeyer CM et al (2003) Somatic mutations in PTPN11 in juvenile myelomonocytic leukemia, myelodysplastic syndromes and acute myeloid leukemia. Nat Genet 34:148\u2013150. doi: 10.1038/ng1156", "journal-title": "Nat Genet"}, {"key": "593_CR22", "doi-asserted-by": "crossref", "first-page": "2183", "DOI": "10.1182/blood-2005-02-0531", "volume": "106", "author": "CP Kratz", "year": "2005", "unstructured": "Kratz CP, Niemeyer CM et al (2005) The mutational spectrum of PTPN11 in juvenile myelomonocytic leukemia and Noonan syndrome/myeloproliferative disease. Blood 106:2183\u20132185. doi: 10.1182/blood-2005-02-0531", "journal-title": "Blood"}, {"issue": "8", "key": "593_CR23", "doi-asserted-by": "crossref", "first-page": "1007", "DOI": "10.1038/ng2073", "volume": "39", "author": "B Pandit", "year": "2007", "unstructured": "Pandit B, Sarkozy A et al (2007) Gain-of-function RAF1 mutations cause Noonan and LEOPARD syndromes with hypertrophic cardiomyopathy. Nat Genet 39(8):1007\u20131012. doi: 10.1038/ng2073", "journal-title": "Nat Genet"}, {"issue": "8", "key": "593_CR24", "doi-asserted-by": "crossref", "first-page": "1013", "DOI": "10.1038/ng2078", "volume": "39", "author": "MA Razzaque", "year": "2007", "unstructured": "Razzaque MA, Nishizawa T et al (2007) Germline gain-of-function mutations in RAF1 cause Noonan syndrome. Nat Genet 39(8):1013\u20131017. doi: 10.1038/ng2078", "journal-title": "Nat Genet"}, {"key": "593_CR25", "doi-asserted-by": "crossref", "first-page": "1097", "DOI": "10.1073/pnas.92.4.1097", "volume": "92", "author": "JS Scheele", "year": "1995", "unstructured": "Scheele JS, Rhee JM, Boss GR (1995) Determination of absolute amounts of GDP and GTP bound to Ras in mammalian cells: Comparison of parental and ras-overproducing NIH 3T3 fibroblasts. Proc Natl Acad Sci U S A 92:1097\u20131100. doi: 10.1073/pnas.92.4.1097", "journal-title": "Proc Natl Acad Sci U S A"}, {"key": "593_CR26", "first-page": "1804", "volume": "6", "author": "FC Lintig Von", "year": "2000", "unstructured": "Von Lintig FC, Huvar I et al (2000) Ras activation in normal white blood cells and childhood acute lymphoblastic leukemia. Clin Cancer Res 6:1804\u20131810", "journal-title": "Clin Cancer Res"}, {"issue": "5849", "key": "593_CR27", "doi-asserted-by": "crossref", "first-page": "463", "DOI": "10.1126/science.1144642", "volume": "318", "author": "EC Stites", "year": "2007", "unstructured": "Stites EC, Trampont PC et al (2007) Network analysis of oncogenic Ras activation in cancer. Science 318(5849):463\u2013467. doi: 10.1126/science.1144642", "journal-title": "Science"}, {"key": "593_CR28", "first-page": "157", "volume": "1", "author": "WP Shen", "year": "1987", "unstructured": "Shen WP, Aldrich TH et al (1987) Expression of normal and mutant ras proteins in human acute leukemia. Oncogene 1:157\u2013165", "journal-title": "Oncogene"}, {"issue": "2", "key": "593_CR29", "doi-asserted-by": "crossref", "first-page": "143", "DOI": "10.1080/08977190500130480", "volume": "23", "author": "A Bernards", "year": "2005", "unstructured": "Bernards A, Settleman J (2005) GAPs in growth factor signalling. Growth Factors 23(2):143\u2013149. doi: 10.1080/08977190500130480", "journal-title": "Growth Factors"}, {"key": "593_CR30", "first-page": "2844", "volume": "157", "author": "E Gulbins", "year": "1996", "unstructured": "Gulbins E, Brenner B et al (1996) Activation of the Ras signaling pathway by the CD40 receptor. J Immunol 157:2844\u20132850", "journal-title": "J Immunol"}, {"key": "593_CR31", "doi-asserted-by": "crossref", "first-page": "1003", "DOI": "10.1016/S0145-2126(98)00076-9", "volume": "22", "author": "B Garicochea", "year": "1998", "unstructured": "Garicochea B, Giorgi R, Odone VF, Dorlhiac-Llacer PE, Bendit I (1998) Mutational analysis of N-RAS and GAP-related domain of the neurofibromatosis type 1 gene in chronic myelogenous leukemia. Leuk Res 22:1003\u20131007. doi: 10.1016/S0145-2126(98)00076-9", "journal-title": "Leuk Res"}, {"issue": "9", "key": "593_CR32", "doi-asserted-by": "crossref", "first-page": "2000", "DOI": "10.1002/cncr.23006", "volume": "110", "author": "J Cortes", "year": "2007", "unstructured": "Cortes J, Quint\u00e1s-Cardama A, Garcia-Manero G, O\u2019Brien S, Jones D, Faderl S et al (2007) Phase 1 study of tipifarnib in combination with imatinib for patients with chronic myelogenous leukemia in chronic phase after imatinib failure. Cancer 110(9):2000\u20132006. doi: 10.1002/cncr.23006", "journal-title": "Cancer"}, {"key": "593_CR33", "doi-asserted-by": "crossref", "first-page": "1399", "DOI": "10.1182/blood.V97.5.1399", "volume": "97", "author": "A Reichert", "year": "2001", "unstructured": "Reichert A, Heisterkamp N, Daley GQ, Groffen J (2001) Treatment of Bcr/Abl-positive acute lymphoblastic leukemia in P190 transgenic mice with the farnesyl transferase inhibitor SCH66336. Blood 97:1399\u20131403. doi: 10.1182/blood.V97.5.1399", "journal-title": "Blood"}, {"key": "593_CR34", "doi-asserted-by": "crossref", "first-page": "693", "DOI": "10.1007/BF03402049", "volume": "6", "author": "J Halaschek-Wiener", "year": "2000", "unstructured": "Halaschek-Wiener J, Wacheck V, Schlagbauer-Wadl H, Wolff K, Kloog Y, Jansen B (2000) A novel Ras antagonist regulates both oncogenic Ras and the tumor suppressor p53 in colon cancer cells. Mol Med 6:693\u2013704", "journal-title": "Mol Med"}, {"key": "593_CR35", "doi-asserted-by": "crossref", "first-page": "1950", "DOI": "10.1007/PL00000675", "volume": "57", "author": "JS Scheele", "year": "2000", "unstructured": "Scheele JS, Raepple D, Luebbert M (2000) The role of Ras and other low-molecular weight guanine nucleotide (GTP)-binding proteins during hematopoietic cell differentiation. Cell Mol Life Sci 57:1950\u20131963. doi: 10.1007/PL00000675", "journal-title": "Cell Mol Life Sci"}], "container-title": ["Annals of Hematology"], "language": "en", "link": [{"URL": "http://link.springer.com/content/pdf/10.1007/s00277-008-0593-6", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 2, 14]], "date-time": "2019-02-14T05:25:23Z", "timestamp": 1550121923000}, "score": 23.684483, "issued": {"date-parts": [[2008, 9, 11]]}, "references-count": 35, "journal-issue": {"published-print": {"date-parts": [[2009, 4]]}, "issue": "4"}, "alternative-id": ["593"], "URL": "http://dx.doi.org/10.1007/s00277-008-0593-6", "relation": {"cites": []}, "ISSN": ["0939-5555", "1432-0584"], "issn-type": [{"value": "0939-5555", "type": "print"}, {"value": "1432-0584", "type": "electronic"}], "subject": ["Hematology", "General Medicine"]}], "items-per-page": 20, "query": {"start-index": 0, "search-terms": null}}}